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CHAPTER О 
AIM AND SCOPE 

Aim and scope 
This thesis is entitled: "The neuronal substrate of oro-facial dyskinesia in cats: a neuro-
anatomical and a neuro-pharmacological study. Implications for tardive dyskinesia in 
man". The title reflects all aspects dealt with in this thesis, being a survey of the neuronal 
substrate of abnormal involuntary movements of the oral and facial muscles in the cat. In 
our experimental approach, tools of different disciplines were employed, i.e. 
pharmacology, behaviour and functional neuco-anatomy. The data presented are discussed 
in the clinical context of tardive dyskinesia. However, it is not our aim to offer a solution 
for the treatment of tardive dyskinesia nor to reveal its pathophysiology. The main 
purpose of this thesis is a fundamental study to reveal the possible neuronal substrate of 
oral and facial dyskinesia, using the cat as an animal model. 
Part I of this thesis, which is formed by chapters 1 and 2, presents a general introduction 
in the clinical aspects of tardive dyskinesia and in the animal research carried out in this 
context. In chapter 1 several aspects of this syndrome are addressed such as the historical 
perspective, the diagnosis, the prevalence and the risk factors, and in addition, an 
overview of the hypotheses on its pathophysiology is provided. In chapter 2 an 
introduction in different aspects of animal research on tardive dyskinesia is presented. 
Part I forms the background for part II, i.e. the experimental studies in the cat. In 
chapters 3-11 the original findings are presented and discussed as well as their relevance 
to oro-facial dyskinesia. Chapter 3 describes anatomically and pharmacologically the 
involvement of subregions of the caudate nucleus in oro-facial dyskinesia and the 
'interaction of the anterodorsal part of the caudate nucleus with its first order output 
station, i.e. a subregion of the pallidal complex. Chapters 4 and S deal with the 
involvement of different neurotransmitters (acetylcholine, GABA and dopamine) within 
this subregion of the pallidal complex in oro-facial dyskinesia. Chapters 6, 7 and 8 are 
devoted to the immunohistochemistry and efferent connections of the above-mentioned 
sub-region of the pallidal complex. In chapters 9 and 10 two output stations of the pallidal 
subregion are studied pharmacologically with respect to their involvement in oro-facial 
dyskinesia. Finally, in chapter 11 the experimental data are summarized and a general 
network of structures involved in oro-facial dyskinesia is presented and discussed. 
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PART I: GENERAL INTRODUCTION 
CHAPTER 1 
TARDIVE DYSKINESIA IN MAN: 
A BRIEF OVERVIEW 
1.1 TARDIVE DYSKINESIA: AN INTRODUCTION 
1.1.0 Introduction 
Tardive dyskinesia is a somewhat ill-defined syndrome which has challenged scientists 
and clinicians for several decades. Until now the exact mechanisms underlying this 
syndrome are unknown and there is no succesful treatment available. Tardive dyskinesia 
is suggested to be closely associated with the use of anti-psychotic drugs and what we 
presently know is mainly the result of the developments over the last 35 - 40 years. In the 
following chapter some of these developments will be discussed whereas the current 
hypotheses and the research into its neurobiological determinants is also addressed. 
1.1.1 Definition and historical perspective 
Tardive dyskinesia is defined as "an iatrogenic extrapyramidal disorder produced by 
longterm administration of anti-psychotic drugs; it is characterized by oral-lingual-buccal 
dyskinesias that usually resemble continual chewing motions with intermittent darting 
movements of the tongue and abnormal movements of the lips whereas there may also be 
choreoathetoid movements of the extremities" (Taylor, 1988). The initial descriptions of 
this syndrome are usually credited to Schonecker (1957) and Sigwald et al. (1959) who 
described it in patients suffering from schizophrenia medicated with anti-psychotic drugs. 
However, comparable syndromes of abnormal involuntary movements have already been 
described long before the introduction of antipsychotic drugs in a broad spectrum of 
medicated and unmedicated people, among others, in encephalitis epidemica (Marie and 
Levy, 1920), chorea of Huntington (Wilson, 1947) and Parkinson's disease (Cotzias et 
al., 1967; for review: Waddington, 1989). Probably the first description of a combination 
of involuntary movements as present in tardive dyskinesia is that of Griesinger in 1857. 
He reported in his textbook of "mental pathology and therapeutics" the existence of 
"persistent, automatic grimacing and chorea-like movements in adult lunatics". Further-
more, he already noticed that this diagnosis indicated bad prognosis in these patients, an 
observation which was much later confirmed by others (Waddington and Youssef, 1986). 
Meige in 1910 described patients having "contractions, généralement brusques, d'un ou 
de plusiers muscles faciaux, unilatérales ou bilatéral, coïncident ou alternant avec d'autres 
tics de la tête ou des membres". Some people still refer to this combination of movements 
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as the syndrome of Meige (Weiner et al., 1981). Bleuler in 1911 described patients 
"performing all kinds of manipulations with their teeth ... grimaces of all kinds ... 
extraordinary movements of the tongue and lips". A few years later, Kraepelin (1919) 
noted the "spasmodic phenomena in the musculature of the face and of speech which 
often appear extremely peculiar disorders 'reminiscent' of the corresponding disorders of 
choreic patients" and which "in no way bear the stamp of voluntary movements". 
The syndrome of abnormal involuntary movements, as described above, gained special 
attention following the introduction of anti-psychotic drugs. At that time it was suggested 
that "extra-pyramidal effects" were indicative of the therapeutic activity of these drugs 
(Deniker, 1961; Denham and Carrick, 1961). It was referred to as "persistent, involun-
tary dyskinetic movements 'late' in antipsychotic drug treatment" or "buccolinguo-
masticatory syndrome" or as "terminal extrapyramidal insufficiency syndrome" 
(Schonecker, 1957; Sigwald et al., 1959; Uhrbrand and Faurbye, 1960; Haddenbrock, 
1964). Finally the term "tardive dyskinesia" was introduced by Faurbye et al. (1964). 
Derived from the latin word tardus (=Iate), this term clearly refers to the generally late 
onset of this syndrome after continuous use of neuroleptics. Later the term was 
popularized by the work of Ayd (1966) and Crane (1968). 
Thus, abnormal involuntary movements, as described for tardive dyskinesia, occur in a 
variety of medicated and unmedicated people. Despite the fact that the movements, as 
described in the differential neurological/psychiatric disorders, are quite similar it is not 
known whether these movements are behavioural indications of a comparable pathogenesis 
in these different disorders. Nevertheless, in case of tardive dyskinesia it has been 
hypothetized that the association of neuroleptic drugs with tardive dyskinesia has led to a 
drawback in the search for its neurobiological substrate. The close association of tardive 
dyskinesia with neuroleptics resulted in a neglectance of a possible closer association of 
the original disease for which neuroleptics are prescribed and the dyskinesias than with 
the treatment itself (Crow et al., 1982; Crow et al., 1983; Waddington, 1989). Still, 
without the introduction of neuroleptic drugs and the subsequent descriptions of 
involuntary movements, the number of clinical and experimental studies devoted to this 
syndrome would only be a fraction of what has been published today. 
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1.1.2 Assesment of tardive dyskinesia 
In their review of 1982, Kane and Smith already indicated that there are no established or 
universally accepted criteria for the diagnosis of tardive dyskinesia. Moreover, symptoms 
comparable to those present in tardive dyskinesia can also be found in other neurological 
disorders unrelated to tardive dyskinesia (Granacher, 1981; Casey, 1981). Conversely, 
neuroleptic associated movement disorders not choreoathethoid in nature may be excluded 
from the syndrome. The latter may be variants of tardive dyskinesia in its broadest sense 
(Munetz and Comes, 1983; Stahl, 1986; Gardos et al., 1987). 
The above outlined considerations underscore one of the basic problems in the research of 
tardive dyskinesia, i.e. the lack of an adequate universally applicable diagnostic criterium 
or parameter. Presently, qualitative and quantitative evaluation of the dyskinesias is done 
using rating scales. Although many rating scales and variants of rating scales are 
available, the general procedure in all of these methods is briefly as follows: the patient is 
asked to come to the examination room where the presence of involuntary movements as 
well as its severity is assessed. 
Two of the most widely used rating scales are briefly outlined below: 
The Abnormal Involuntary Movement Scale (AIMS-test; Guy, 1976). The inspection 
covers seven areas: facial expression, lips and perioral area, jaw, tongue, upper 
extremities, lower extremities and trunk. Tremors are specifically excluded when 
recording the severity on a five point scale from 0 (absent) to 4 (severe). 
The Simpson-Rockland scale (Simpson-test; Simpson et al., 1979). This scale can be used 
for a very extensive analysis of abnormal movements. It lists a total of 43 items related to 
movements of the face, head, upper limbs, lower limbs and whole body; the severity of 
the scale runs from 0 (absent) to 5 (severe). 
It is evident that factors influencing the reliability and repeatability of such assessments 
include experience of the investigator and the use of video technology (Barnes and 
Trauer, 1982; Firth and Ardem, 1985; Lane et al., 1985; Bergen et al., 1988). 
Furthermore, the results of these standardized rating scales may be considerably 
influenced by the setting of the criteria. For instance, a case of tardive dyskinesia may be 
defined by having at least moderate dyskinetic movements in one body area or mild 
dyskinetic movements in at least two areas (see also Schooler and Kane, 1982). As such, 
even when using standardized rating scales the application of different criteria may still 
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influence the outcome considerably. 
These tests are generally accepted and almost exclusively used to assess involuntary 
movements although the factors of variance, mentioned above, may cumulate and 
seriously affect indicative parameters such as the prevalence rates. 
Due to these factors which may disturb the final diagnosis it is not surprising that 
investigators have sought for electronic or electromechanical devices for a more objective 
and automated evaluation of tardive dyskinesia. Researchers have been creative in this 
field and have utilized several techniques, among others: ultra-sound, doppler radar, 
electromyographic recording of multiple regions and accelerometnc recording for 
detection of limb movements (Buruma et al., 1982; Bathien et al., 1984; Tryon and 
Pologo, 1987; Caligiuri et al., 1991). However, most of these methods have not been 
widely used, so far. One has to bear in mind that although the above mentioned 
approaches are attempts towards a more objective diagnosis of tardive dykinesia, as 
diagnostic instruments they are by no means perfect. 
1.1.3 Conclusions 
Tardive dyskinesia is an iatrogenic syndrome consisting of abnormal involuntary 
movements of the oral and facial muscles but also of the extremities. It is closely 
associated with the use of neuroleptics but involuntary movements as present in tardive 
dyskinesia can also occur in many other neurological disorders or even "spontaneously". 
No adequate universally applicable diagnostic instrument or parameter is available 
defining type and intensity of the dyskinesias. Tardive dyskinesia is in general assessed by 
means of rating scales. The latter is a sensitive method which is not too reliable. 
1.2 PREVALENCE AND RISK FACTORS 
1.2.0 Introduction 
Involuntary movements occur in a broad spectrum of people, including not only those 
treated with neuroleptics but also unmedicated people without any known internal or 
neurological disorder. The incidence of involuntary movements in schizophrenics does not 
stand on itself but can co-occur with a scala of other clinical symptoms. It has been found 
that some of these symptoms have a predictive value for the development for tardive 
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dyskinesia much later in the disease process (see below). Since it is not within the scope 
of the present thesis to discuss the prevalence or risk factors in all the different groups a 
selection has been made. 
1.2.1 Prevalence 
Kane and Smith (1982), reviewing the period from 1959 to 1979, evaluated the incidence 
of tardive dyskinesia on the basis of 56 studies encompassing a total of 34,555 patients 
treated with neuroleptics. In their review, 19 studies reporting dyskinesias in subjects not 
treated with neuroleptics were also included. The prevalence in the group of patients 
treated with neuroleptics was on an average 20%, but the range encountered (0.5 -
56.4%) indicated a highly inhomogenous group of studies. The prevalence for the 
untreated group was 5 %. The true prevalence of tardive dyskinesia caused by neuroleptics 
was said to be 15%, i.e. the difference between the two avarages. The heterogeneity, 
especially in the neuroleptic treated group, is striking and cannot be solely explained by 
differential methods in the diagnosis. Apparently, the different prevalence rates were 
influenced on another level. 
A prominent factor in this respect is formed by the diagnostic composition of the groups 
investigated. This refers to the differential experimental groups (section 1.2.2) but also to 
their controls (Waddington, 1989). 
With respect to the choice of control groups, one encounters specific problems since 
neuroleptics are mostly used for the treatment of schizophrenia. As such, it is hard to find 
(and unethical to create) an untreated control group of patients. Therefore, several other 
kinds of control groups have been studied. These however, lack the essential factor of 
control: the disease process (Waddington, 1989). Accordingly, in attempts to unravel the 
risk factor for the development of tardive dyskinesia in the use of neuroleptics, 
investigators tend to use non-schizophrenics which still receive these drugs. Most often 
demented elderly are used. But, even in these attempts of better matched controls one 
encounters heterogeneity in the investigated group of people. The latter is well illustrated 
by the study of Bourgeois et al. (1980). They investigated the occurence of "spontaneous" 
versus "tardive" dyskinesia in 270 subjects, all residents of a retirement home. The 
frequency of involuntary movements in the group that received neuroleptics was 42%, in 
the untreated group the frequency was 18%. Although both groups were similar in age 
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and many other factors, there must have been one major difference: it is unthinkable that 
neuroleptics had been prescribed simply at random. The treated patients must have 
presented symptoms for which the use of neuroleptics was indicated, the remaining 
residents being free of the same symptoms. 
The latter example is illustrative for the idea that the development of abnormal 
involuntary movements in such patients is more than just a straight forward drug-induced 
development of abnormal movements. Moreover, it gives rise to the hypothesis that the 
development of such movements is possibly an interplay between drugs and specific 
neurological and/or psychiatric disturbances/factors. The latter might in turn explain the 
wide range of prevalences found in the different studies. Several of such factors have 
been identified during the last few years; the most important ones are discussed below. 
1.2.2 Riskfactors 
1.2.2.1 Age 
Age has been identified in several studies as an important riskfactor for the development 
of tardive dyskinesia. An illustrative study is that of Smith and Baldessarini (1980) who 
investigated the changes in prevalence, severity and recovery in tardive dyskinesia with 
age in schizophrenics. Their results indicated that there existed a strong linear correlation 
between age (<40 to 70 years) and both the prevalence and severity of tardive 
dyskinesia, without further changes after the age of 70 years. There was also a strong 
inverse correlation between rates of spontaneous remission of tardive dyskinesia and age 
(<30 to >80 years). Tardive dyskinesia in subjects younger than 60 years improved over 
three times as often as in older patients. These correlations are not readily explained by 
the duration of previous exposures to neuroleptic drugs. However, it has been suggested 
that the increase with age might be due to an increased sensitivity of the aging brain to 
neuroleptics. This idea is supported by findings of Waddington and Yoessef (1985). They 
compared the prevalance of buccal-lingual-masticatory dyskinesias in two different age 
groups (51-70 and >70 years) which were matched for several riskfactors, among others 
for the number of years they had received neuroleptics. The group with the higher age 
showed a marked increase in oral dyskinesias. These data clearly indicate that aging in 
itself is an important riskfactor for the development of tardive dyskinesia. 
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1.2.2.2 Gender 
Females have been thought to develop more easily tardive dyskinesia than males, which is 
usually attributed to the dopamine antagonistic properties of estrogens (Bedard et al., 
1978; Raymond et al., 1978). Kane and Smith (1982) discussed this finding in their 
review, since in most studies the differences do not reach statistically significant levels. 
Waddington and Youssef (1985) found some differences between males and females but 
they also reached no statistically significant levels. Later Kane et al. (1986) confirmed 
these latter findings. Thus, females seem to have a somewhat higher prevalence but the 
data are not conclusive. The situation is complicated by the fact that the magnitude of 
tardive dyskinesia is dependent on the age range of the sample and also on the severity of 
the criteria used to define the disorder (Richardson et al., 1984). In view of the fact that 
females have a tendency to develop more severe forms of tardive dyskinesia one could 
suggest that these factors may play some role in the results of the above mentioned 
studies. The conclusion, whether the differences in tardive dyskinesia between males and 
females are artefacts resulting from differing medications or reflect underlying biological 
differences is still open for discussion. 
1.2.2.3 Cumulative drug exposure 
It is generally assumed that the intensity and endurance of neuroleptic drug exposure can 
be an important risk factor for the development for tardive dyskinesia. However, of the 
18 studies reviewed by Kane and Smith (1982) only four reported a significant positive 
relationship between cumulative drug exposure and tardive dyskinesia whereas 14 did not. 
Waddington in his review (1989) confirmed that there is a lack of correlation between 
cumulative drug exposure and tardive dyskinesia. Furthermore, he added that it is very 
important to define those factors that distinguish patients in whom involuntary movements 
emerge after a given period of treatment from patients in whom they do not appear, since 
other vulnerability factors then neuroleptic drug exposure may interfere. Thus, the display 
of oro-facial dyskinesia in a patient that received neuroleptics for several years may not 
(singly) depend on the exposure to drugs for a certain period but may also or especially 
be related to the increase in age or the interference with some other factor (Guy et al., 
1985). 
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1.2.2.4 Cognitive dysfunction and negative symptoms 
Mölsä et al. (1984) investigated the occurrence of tardive dyskinesia in a group of 143 
patients with dementia of the Alzheimer type. Only 8% was free of extrapyramidal 
disorders. 17% showed oro-facial dyskinetic symptoms. Waddington et al. (1987) 
investigated the occurence of tardive dyskinesia in relation to negative symptoms and 
cognitive dysfunction in a group of 88 schizophrenics. In these patients the presence of 
either marked cognitive dysfunction or muteness was strongly associated with the severity 
of oro-facial movements. No relationship was found between oral dyskinesia and the 
duration of the neuroleptic treatment, the current daily dose of neuroleptics and 
edentulousness. Furthermore, no association was found between cognitive dysfunction and 
limb-trunk dyskinesias. Dewolfe et al. (1988) also found that oro-facial dyskinetic 
symptoms correlated positively with cognitive symptoms (cf. Bartzokis et al., 1989). 
Again no correlation was found with limb-trunk dyskinesias (cf. Karson et al., 1990). 
Finally, Waddington et al. (1990) found in a five year follow up study on cognitive 
dysfunction in schizophrenia and the emergence of tardive dyskinesia that there was a 
correlation between new cases of oro-facial dyskinesia and cognitive dysfunction whereas 
no such correlation existed with limb-trunk dyskinesias. These data suggest a strong 
association of certain involuntary movements with the disease process rather than with the 
use of neuroleptics. The latter is underlined by findings of Glazer et al. (1988) in a 
multivariate analysis of tardive dyskinesia. They found that the severity of oro-facial 
scores was positively associated with age, schizoaffective or affective disorder, and living 
alone, while severity of non-oro-facial movements was positively associated with current 
neuroleptic dose, non-use of psychiatric medication, and living alone. These findings 
together suggest that oro-facial and non-oro-facial dyskinetic movements may involve 
distinct clinical syndromes of tardive dyskinesia, each having a different set of prognostic 
and aetiological determinants. 
1.2.2.5 Structural brain pathology 
The above mentioned associations of oro-facial dyskinesia with other neurological diseases 
are behavioural indications of a dysfunctioning brain. It may be asked whether there is 
any morphological substrate for OFD. In several studies modem visualization techniques 
such as CT-techniques (computed tomography) have been used. Of the 13 studies 
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reviewed by Waddington (1989) five studies reported ventricular abnormalities to be 
associated with oral dyskinesias whereas four of them lacked such an association. 
However in the latter studies the dyskinesias had not been specified. Waddington et al. 
(1989) concluded that an association could only be found after specification in oral and 
limb-trunk dyskinesias. Only oral dyskinesias were positively associated with ventricular 
abnormalities. In this respect it is interesting to mention that schizophrenics with negative 
symptoms most often have ventricular abnormalities whereas this group of patients is also 
predisposed to the development of tardive dyskinesia (Waddington and Youssef, 1986). 
Finally, caudate- and cortical atrophy have also been reported, however, such an 
association was only found in cases of severe forms of dyskinesia (Pandurangi et al., 
1980; Brainin et al., 1983; Albus et al., 1985; Gimenez-Roldan et al., 1985). 
1.2.2.6 Parkinsonism 
Many investigators have reported the coexistence of parkinsonism with tardive dyskinesia 
(Crane 1972; Fann and Lake, 1974; Gerlach, 1977; Richardson and Craig, 1982; Wolf et 
al., 1983; Jankovic and Casabona, 1987). Chouinard et al. (1986) found that the initial 
display of parkinsonism was the best predictor for the development of tardive dyskinesia 
five years later. Accordingly, parkinsonism may thus form an important parameter in the 
evaluation of the use of neuroleptics in individual patients with respect to the possible 
development of involuntary movements. The latter is even more relevant in view of the 
fact that this correlation is not an isolated one. Parkinsonism has been found to be 
positively correlated with three other important risk factors, i.e. cognitive dysfunction, 
negative symptoms and structural brain pathology (Luchins et al., 1983; Hoffman et al., 
1987). Although these symptoms are positively correlated in a number of studies, it is not 
yet clear to what extent they originate from a common substrate. 
1.2.3 Conclusions 
The literature reviewed above clearly reveals that tardive dyskinesia is by no means an 
unitary syndrome. It is a syndrome that is highly associated with several neurological and 
psychiatric disorders and one has to realize that its display may (strongly) depend on 
(various) additional triggering factors (risk factor). The literature is quite conclusive in 
showing that neuroleptic drugs may represent one of the main risk factors. 
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1.3 PATHOPHYSIOLOGY IN TARDIVE DYSKINESIA 
1.3.0 Introduction 
The neurobiological substrate of tardive dyskinesia has remained unknown, despite 
decades of clinical and animal research. However, several hypotheses have been 
postulated on various grounds, as outlined below. 
1.3.1 Dopaminergic hypotheses 
1.3.1.1 The dopamine receptor supersensitivity hypothesis 
1.3.1.1.1 Background 
This hypothesis is based on striatal (caudate-putamen) dopaminergic hyperfunctioning and 
has long been the leading hypothesis for tardive dyskinesia. The basic idea is that 
dopamine as a synaptic neurotransmitter, or some other dopamine-related factor in the 
basal ganglia and limbic forebrain, may be overactive or be represented in excess. Such a 
state of relative excess of dopaminergic activity may come about through several 
mechanisms: (a) presynaptic dys-control of dopamine synthesis and release; (b) decreased 
availability of other modulating systems such as certain peptides, and (c) increased 
quantity or effectiveness (sensitivity) of postsynaptic dopamine receptors (Baldessarini, 
1979). Especially the latter aspect has played a central role in the dopamine hypothesis. It 
originates from animal research (Klawans and Rubovitz, 1972) in which rodents are 
treated for several weeks (2 or more) with anti-psychotic drugs. Following the withdrawal 
from this treatment these animals are highly sensitive for the development of perioral 
stereotyped behaviours when challenged with dopamine agonists. The mechanism 
underlying this effect is thought to be an adaptive response consisting of an increase in 
the number of dopamine receptors after the chronic block of dopamine receptors by the 
neuroleptic drugs. Following withdrawal from the neuroleptic drugs the "unused" 
(=blocked) dopamine receptor becomes available again. The additional number of 
receptors together with the "unused" receptors subsequently create a supersensitive state. 
Therefore this hypothesis has also been refered to as "disuse supersensitivity" hypothesis. 
Such a receptor supersensitivity can be directly demonstrated in the striatum of 
neuroleptic-treated animals using radioligand binding (Muller and Seeman, 1978). 
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Although this hypothesis has been the most widely quoted hypothesis for years it has 
some serious and prohibitive objections which have led by most investigators to the reject 
this hypothesis (however cf. Jenner and Marsden, 1986). Some of its major shortcomings 
are outlined below. 
1.3.1.1.2 Shortcomings of the dopamine receptor supersensitivity hypothesis 
A major shortcoming of this hypothesis is the temporal discrepancy between the onset and 
offset of increase/decrease in dopamine receptors and the display of tardive dyskinesia. 
The receptor effect usually develops rapidly (within weeks) whereas the dyskinesia effect 
is often a long-term process occurring sometimes after years (Christensen et al., 1976; 
Dewey and Fibiger, 1983) since tardive dyskinesia may develop after several years of 
neuroleptic administration and can also persist for several years after withdrawal from 
neuroleptic treatment (Crane and Naranjo, 1971). 
Secondly, the hypothesis fails to explain the lack of spontaneous behavioural changes in 
animals treated with neuroleptics for two - four weeks, which is sufficient to produce a 
maximum increase in the number of 3H-neuroleptic bindings sites (Clow et al., 1980; 
Dewey and Fibiger, 1983). In order to obtain behavioural changes in these animals they 
have to be treated with relatively high doses of dopamine agonists. Apparently, the brain 
has enough adaptive capacity to compensate for the unusual state of its dopamine 
receptors. 
Thirdly, at least one report indicates that there is no correlation between the occurrence 
of spontaneous behavioural changes, such as vacuous chewing movements after chronic 
treatments with neuroleptics, and changes in striatal dopamine receptors as reflected by 
specific 3H-neuroleptic binding (Waddington et al., 1983). 
Another shortcoming of the dopamine receptor hypothesis is the fact that dopamine 
supersensitivity is an invariable response to exposure of neuroleptics whereas only a 
subpopulation of patients that receive these drugs develop tardive dyskinesia (Waddington, 
1989). 
Finally, the dopamine receptor hypothesis cannot explain why tardive dyskinesia and 
(pseudo)parkinsonism can co-exist in one patient at the same time (Richardson and Craig, 
1982; Wolf et al., 1983; Jankovic and Casabona, 1987). Parkinsonism is a presumed 
dopaminergic hypofunctioning which would appear to be pathophysiologically 
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incompatible with dopaminergic hyperfunctioning. 
In view of these objections against this dopaminergic hypothesis several new hypotheses 
have been postulated for tardive dyskinesia, as will be discussed below. 
1.3.1.2 Dysbalance between different dopamine receptors 
This hypothesis is based on experimental animal research. Rosengarten et al. (1983; 
1986) found that systemic injections of the selective Dl agonist SK&F38393 elicited an 
increase in perioral movements ("vacuous chewing movements") which could also be 
elicited by selective D2 antagonists. They postulated that tardive dyskinesia resulted from 
an increase in the D1/D2 ratio probably in striatal structures. Later these findings were 
confirmed and extended by several other investigators (Johansson et al, 1987; Molloy and 
Waddington, 1987; Ellison et al, 1988). 
From the therapeutic point of view there is not much evidence supporting this theory 
since Dl antagonists are not yet available for use in humans. However, post mortem 
studies of the brains of schizophrenics which suffered from tardive dyskinesia, revealed 
that there were no differences in either Dl or D2 receptor binding in the putamen 
compared to the brains of schizophrenics without such involuntary movements syndrome 
(Crow et al., 1982). These findings were confirmed and extended by Cross et al. (1985) 
who showed that there were also no differences in the number of Dl and D2 receptors 
within the nucleus accumbens or in the concentrations of dopamine and DOPAC 
(dihydroxyphenylacetic acid, i.e. a metabolite of dopamine). In contrast, a slight increase 
was found in the concentration of HVA (homovanillic acid) in the nucleus accumbens and 
putamen. 
Recently, the striatal dopamine D2 receptors have been investigated in living human 
brains of neuroleptic-free schizophrenics with and without oro-facial dyskinesia using the 
PET-scan technique (Blin et al., 1989). The results indicated that orofacial dyskinesia was 
associated with normal levels of striatal D2 receptors, but the severity of the dyskinesias 
seemed to depend on the relative density of striatal D2 receptors. Although these data 
indicate that the relative amount of D2 receptors may play (merely) an exacerbating role 
in oro-facial dyskinesia, these findings are unfortunately not conclusive with respect to the 
D1/D2 hypothesis on tardive dyskinesia since the state of Dl receptors was not 
investigated. 
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1.3.1.3 Mesolimbic-dopamine system 
Cools (1980; 1982; 1983) postulated that oro-facial dyskinesia is a disturbance in the 
mesolimbic dopaminergic and in the noradrenergic systems. According to this theory, 
neuroleptics induce a hyperactive mesolimbic dopaminergic DAi system via two 
differential mechanisms: 
a) Inhibition of the striatal DAe-receptors (Cools and Van Rossum, 1976; 1980), which 
are localized in the terminal fields of the nigrostriatal pathway and form the main target 
of neuroleptics, induce a relative dominance of the DAi-system. This would explain the 
acute form of oro-facial dyskinesia following the exposure to neuroleptics, b) Inhibition of 
the α-noradrenergic receptors in the anterodorsal part of the caudate nucleus (r-CRM), 
which results in a compensatory hyperactive DAi-system; this would explain the chronic 
form of oro-facial dyskinesia. 
This hypothesis is based on behavioural studies in which selective stimulation of DAi-
receptors in the anterodorsal part of the caudate nucleus (r-CRM) in the cat elicits ticlike 
contractions of the facial muscles in combination with abnormal tongue protrusions (Cools 
et al., 1976). 
Noradrenaline is found to be an important neurotransmitter within the r-CRM, moreover, 
the α-noradrenergic receptors are probably present on the presynaptic side of the DAi-
system (Cools et al., 1978). The α-noradrenergic receptors have, in contrast to the 
dopaminergic DAe and DAi receptors, the capability to develop a relative long sensitivity 
change following a relatively brief inhibition (Dinan and Aston-jones, 1985). Neuroleptics 
not only have affinity for the DAe receptors but at certain dosage levels also for the a-
noradrenergic receptors. On this basis, it can be explained why pseudo-parkinsonism, 
which is thought to be the effect of a decreased nigrostriatal dopaminergic activity as a 
result of the direct effects of neuroleptic drugs, disappears in due course. The initial 
dominance of the mesolimbic system is subsequently compensated by the fast development 
of hypersensitive α-noradrenergic receptors. As a consequence of this development the 
DAi-system, which is under inhibitory control of α-noradrenaline, is inhibited. 
Subsequently, the dopaminergic system compensates this state by developing a 
hypersensitive DAi-system. The latter, according to Cools (1980; 1982; 1983), could play 
an essential role in the Pathogenese of oro-facial dyskinesia in man. 
This hypothesis is supported by clinical findings. Piribedil, i.e. a DAi antagonist, is 
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therapeutically effective in the treatment of tardive dyskinesia (Offermeier and Van 
Rooyen, 1983). Ceruletide, i.e. a drug which inhibits the development of hypersensitive 
mesolimbic dopamine receptors (Fuxe et al., 1981; Stoessl et al., 1989), is also 
therapeutically effective (Nishikawa et al., 1985; Nishikawa et al., 1986). Moreover, this 
hypothesis may explain why not all individuals that receive neuroleptics develop oro-facial 
dyskinesia, since the response of the noradrenergic system has been found to vary 
extensively between individuals (Cools et al., 1990). However, on the other hand a-
noradrenergic drugs have until now not been described to be specifically therapeutically 
effective in tardive dyskinesia. 
1.3.2 Non-dopaminergic hypotheses 
1.3.2.1 The GABA hypothesis 
This hypothesis is based on early findings of Pakkenberg et al. (1973) and Nielsen and 
Lyon (1978) and was postulated by Fibiger and Lloyd (1984). Pakkenberg et al. (1973) 
first demonstrated that the number of striatal neurons in rodents significantly decreases 
after chronic treatment with a neuroleptic drug (perphenazine). Nielson and Lyon (1978) 
confirmed this finding and extended it by showing that the neuronal cell loss was confined 
to the ventrolateral region of the caudate-putamen. 
The striatum predominantly consists of spiny, medium sized neurons which project to the 
pallidal complex and the substantia nigra. These cells are for the greater part GABAergic 
(Ribak et al., 1979). Accordingly, it was predicted that the glutamic acid decarboxylase 
activity (GAD), which synthesizes GABA, following the degeneration as an effect of the 
chronic treatment with a neuroleptic drug (see above) would be decreased in the output 
regions of the striatum (the substantia nigra and the globus pallidus). This prediction was 
confirmed by experimental evidence in monkeys. Gunne and coworkers (1984; cf. Gunne 
et al., 1983) treated monkeys for several years with neuroleptic drugs. Like in humans, 
some of them developed movement disorders reminiscent of tardive dyskinesia (limb-
trunk dyskinesias). Characteristically, only the animals that had developed the movement 
disorders had a significant and selective decrease of GAD activity in the globus pallidus 
(internal segment), subthalamic nucleus and substantia nigra, but the animals without the 
movement disorders did not show any changes. These findings directly associate the 
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reduced GAD-activity with the involuntary movement syndrome rather than being ал 
invariant response to chronic neuroleptic administration. Subsequently, many reports were 
published on the beneficial effects of GABAergic drugs on tardive dyskinesia (Mohan 
Singh et al., 1983; Stahl et al., 1985). However, in most of these studies it is unclear to 
which extent the beneficial effects are the results of the therapeutic efficacy of 
GABAergic drugs rather than from the sedative side effects of these drugs. 
1.3.2.2 Free radicals and tardive dyskinesia 
Free radicals are highly reactive compounds with very short half lives and which contain 
at least one unpaired electron. Their presence in living material is not unusual since they 
are byproducts of many biochemical reactions which take place under normal conditions 
in the cell. The oxidative potentials of these compounds give them extreme destructive 
capacities. Cells usually have supportive systems which protect them from oxidative 
damage. Antioxidants and free radical scavengers such as vitamin E and glutathione 
protect cells from oxidative stress, but when stress exceeds the capacity of the protective 
systems, oxyradicals destabilize cell membranes and lead to cell death (Cadet et al., 1987; 
Cadet, 1988). Structural damage induced by free radicals, which are known to be formed 
as metabolic products of neuroleptics, may contribute to the pathogenesis of tardive 
dyskinesia (Rollema et al., 1991). 
This hypothesis is supported by at least two animal studies. Lohr et al. (1988a) treated 
rats with the neurotoxin iminodipropionitnle (IDPN) which resulted in movement 
disorders. Since IDPN-toxicity and vitamin E deficiency share neuro-pathological 
features, it was postulated that the behavioural changes could be attributed to the 
production of free radicals. Furthermore, recent evidence is available that the neurotoxic 
effect of 6-hydroxydopamine (6-OHDA), which might be related to the production of free 
radicals, is counteracted by vitamin E (Cadet et al., 1989). Finally, Lohr et al. (1988b) 
recently found in a double-blind placebo crossover study that the involuntary movements 
of schizophrenic and schizo-affective patients was significantly reduced following 
treatment with α-tocopherol, i.e. a free radical scavenger, while placebo treatment did not 
have any effect. This hypothesis in itself cannot explain all phenomena of tardive dyskine­
sia. However, neuronal loss which forms the core of the GABA hypothesis could be 
explained by production of free radicals. The latter clearly remains to be investigated. 
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1.3.2.3 Brainstem mechanisms in tardive dyskinesia 
Most theories on the pathophysiological basis of tardive dyskinesia focus on the neuro-
chemical dysfunction of the basal ganglia. However, the basal ganglia need not to be the 
main target in the syndrome. The latter is specifically expressed in the idea that the 
buccal-lingual-masticatory syndrome need not to be abnormal per se, but rather forms an 
inappropriate and overelaborated manifestation of innate and even fundamental motor 
patterns (Waddington, 1989). According to this view the core of the pathophysiology in 
tardive dyskinesia may be found in centres directly generating motor patterns, i.e. the 
motor nuclei. These nuclei can be found in the reticular formation. The pathophysiology 
of tardive dyskinesia may thus be found in these brain areas. 
However, the principle that oro-facial dyskinesia is not abnormal per se but (merely) an 
overelaborated manifestation of innate behaviour seems to be an oversimplification of the 
distorted abnormal motor patterns occurring in tardive dyskinesia. Moreover, the 
mentioned correlations with several kinds of neurological symptoms, including cognitive 
functions, are difficult to explain if the pathogenesis of tardive dyskinesia is confined to 
these lower brainstem areas. 
It is most certain that the motor nuclei will anyhow be involved in tardive dyskinesia 
since they are in command of the movements but they probably produce abnormal and 
involuntary movements on the basis of distorted information from higher brain regions 
(cf. Jaspers, 1991). 
1.3.3 Conclusions 
Currently, several hypotheses exist on the pathogenesis of tardive dyskinesia, which 
explain certain characteristics of this syndrome. The different hypotheses are quite diverse 
which may be due to the fact that tardive dyskinesia is not a unitary syndrome, and 
multiple causes may be superimposed. Apparently, we know too little about the specific 
neuronal substrate which may be involved in tardive dyskinesia in order to understand the 
syndrome itself, as well as the different associations of the syndrome with other neurolo-
gical disorders. A multidisciplinar investigation into the neuronal substrate involved in 
tardive dyskinesia may create new insight in the syndrome as such, as well as in factors 
related to this syndrome. 
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PART I: GENERAL INTRODUCTION 
CHAPTER 2 
ANIMAL RESEARCH: AN INTRODUCTION 
2.1 ANIMAL MODELS 
2.1.0 Introduction 
To investigate tardive dyskinesia from an experimental point of view it is necessary to 
have an animal model. Over the last few years many models have been developed in 
which oral behaviour was evaluated in possibly just as many different ways. Most of 
these models were developed with respect to certain clinical symptoms or factors, such as 
longterm neuroleptic treatment, riskfactors, disease process, type of movements or 
pharmacological sensitivity (Grossman, 1987; Waddington, 1990). In this research 
different species have been used like rats, cats and monkeys. 
2.1.1 Rats 
Rats are the most widely used species in the research of tardive dyskinesia. Several 
models have been developed which can be subdivided into two groups: 
A: models in which stereotyped oral behaviours directed towards objects, like gnawing 
and licking, are taken as dependent variables of increased oral activity (Amt and Scheel-
Kruger, 1980; Molloy and Waddington, 1985; Amt et al., 1987; Limminga et al., 1989). 
В: models using stereotyped oral behaviours not directed towards objects, i.e. the socalled 
vacuous chewing movements (or repetitive jaw movements) as dependent variables of 
increased oral activity (Gunne et al., 1982; Rosengarten et al., 1983; 1986; Ellison et al., 
1987; Stewart et al., 1987; 1988; 1989; Koshikawa et al., 1989). 
Rat studies using vacuous chewing movements are thought to have a higher validity since 
oro-facial dyskinesia in man is usually not directed towards objects. However, it is 
unclear whether this is a valid assumption. Moreover, the vacuous chewing movements 
displayed by rats have been suggested to be a model for nausea rather then dyskinesia 
(Rupniak et al., 1990), whereas others have suggested that peri-oral movements are 
merely a reflection of oral dyskinesias (Marco et al., 1988; Aides et al., 1988). 
Anyhow, vacuous chewing movements in rats have been studied in different experimental 
paradigms which can be subdivided into two groups. 
Firstly, studies in which oral behaviour is quantified and evaluated in short but continuous 
periods, either by direct visual observation or closed circuit TV monitoring. Behaviour is 
quantified in terms of duration, frequency or numbers of episodes and by means of rating 
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scales. However, these methods only allow to score those movements that are clearly 
visible whereas considerable oral activity may be present which cannot be detected by 
visual inspection due to the limited amplitude of the movements (cf. Ellison et al., 1987). 
Still, most studies presently available belong to this categoric. 
Secondly, studies using more objective techniques. Recently, three new models have been 
developed. A) Koshikawa et al. (1989) developed a model in which jaw movements of CI 
transected rats are measured using a small light emitting diode placed on the mandible of 
the rat. Subsequently, vertical movements bf the mandible are detected by the transducing 
system and recorded on a polygraph for counting. This method allows to measure 
acurately the number of jaw movements in rats which is a distinct advantage over studies 
using the observation technique. However, a major disadvantage of this technique is of 
course the transection of the animal which limits the animal's behaviour to the oro-facial 
region. 
B) Ellison and colleagues (1987) have devised a system where two small dots of an 
ultraviolet-sensitive dye are painted on the animals snout; one on the lower and one on 
the upper jaw. With the animal restrained in a tube, the output of an appropriate 
positioned and filtered, closed-circuit TV camera is adjusted so that only the two 
fluorescent spots are visible, and then the resultant digital signal is fed directly into the 
movement detection circuitry. The basic unit of analysis is the movelet: changes in the 
vertical distance between the upper and lower dots, which were sorted into five categories 
corresponding to absolute amplitudes of between 0.4 and >2.8 mm. Using this technique, 
highly detailed information has become available (Ellison et al., 1987; Ellison et al., 
1988; See et al., 1988; See and Ellison, 1990). However, this method has the major 
disadvantage that the animal is considerably restrained in its behaviour. Moreover, it 
cannot perform any other behaviour than oral behaviour. The latter, of course, may 
influence the total outcome of oral behaviour extensively. 
B) Prinssen et al. (1992) have developed a new method in which the animal is free to 
move and the investigator is still able to acquire highly detailed information about oral 
behaviour using EMG-signals of the two oral muscles, i.e. the masseter and digaster 
muscles. The EMG-signals are analysed in terms of power, i.e. overall muscle activity, 
and the numbers of seconds marked by distinct frequency ranges. The major advantage of 
this model is the fact that the animal is free to move, but a disadvantage is the placement 
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of the electrodes directly in the muscles which is a major source of variability. Moreover, 
it might be experienced as irritable by the animals and induce additional aspecific oral 
activity. 
Finally, rats may be attractive as an animal model for pragmatic reasons since the animals 
are cheap, easy to handle etc.. However, their oral musculature tends to produce only 
simple motor patterns and complex oral behaviour as described in humans cannot be 
studied in this species. In this respect, animals with more extensive and further developed 
oral and facial musculature, like monkeys and cats, appear to be more appropriate. 
2.1.2 Monkeys 
Most primate models of tardive dyskinesia are based on the chronic administration of 
neuroleptic drugs (for review see: Grossman, 1987). They have the distinct advantage 
over those of non-primates that the formed dyskinesias are readily recognizable. In some 
respect, however, primates react different to neuroleptics than man. This has led to both 
confusion over terminology and criticism of the validity of primate models of tardive 
dyskinesia (Goetz and Klawans, 1982). 
However, persistent dyskinesias have been reported in the monkey following chronic 
exposure to neuroleptics, which seem to represent a realistic form of human tardive 
dyskinesia (Gunne et al., 1984; Johansson et al., 1990). Although, the involuntary 
movements induced in this way in monkeys seem to be pharmacologically different from 
those induced in man (Andersson and Haggstrom., 1988; cf. Stahl et al., 1985). 
2.1.3 Cats 
Cools et al. (1976) found that bilateral injections of dopamine and dopamine agonists into 
a circumscnpt part of the caudate nucleus (the so-called r-CRM) elicits a syndrome of 
abnormal involuntary movements of the facial and oral muscles, especially tongue 
protrusions. These tongue protrusions have been found to show an increase which 
corresponds nicely with the progression of the syndrome as a whole. For this reason they 
have been taken as the dependent variable in the quantitative evaluation (Cools et al., 
1989a,b; Spooren et al., 1991). More recent evidence indicates that comparable 
movements are also elicited via inhibition of GABA from the subpallidal areas. The latter 
was found to receive input from the r-CRM (Cools et al., 1989b). In view of the 
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involvement of dopamine and GABA in the oro-facial syndrome elicited in cats, it was 
postulated that this cat model is a valid model for human oro-facial dyskinesia (Cools et 
al., 1989b). As such, these findings form the basis for the present thesis (see below). 
2.2 INTRODUCTION TO THE EXPERIMENTS 
From chapters 1 and 2 it can be concluded that there is little knowledge about the 
involvement of specific neuronal substrata in abnormal involuntary movements. The 
animal models which have been developed during the last few years have approached the 
problem of involuntary movements especially from a pharmacological point of view. 
Although this approach might be highly relevant for the development of a new and better 
therapy, it appears to neglect the need for a detailed information on the involvement of 
specific neuronal substrata in involuntary movements. Such detailed information is 
essential for a better understanding of the underlying mechanisms of tardive dyskinesia 
but also for a more rational approach of its pharmacology. 
In view of these considerations it was decided to approach the problem of involuntary 
movements in a multi-disciplinary investigation in which specific parts of the brain are 
studied on their involvement in abnormal involuntary movements, whereas such areas will 
not only be characterized in terms of pharmacology and behaviour but also in terms of 
neuro-anatomy (connectivity-patterns and immunohistochemistry). The cat was chosen as 
animal model for several reasons but the two most important ones will be outlined here. 
Firstly, the cat has the distinct advantage over rats that it has a well developed oral and 
facial musculature of which movements can be studied well. Furthermore, compared with 
monkeys they have specifically pragmatic advantages. Secondly, highly detailed 
information is available considering the organization of striatal structures in cats whereas 
there is also an extensive literature on the function of the caudate nucleus, even of sub-
systems of the caudate nucleus (Cools, 1973; Gelissen, 1987; Jaspers, 1991). Especially 
the latter is of interest (see above section 2.1.3) since a specific subregion of the caudate 
nucleus has been implicated to play a role in oro-facial dyskinesia, i.e. the r-CRM. 
In the following chapters this subsystem of the caudate nucleus as well as its first and 
second order output stations will be studied functionally, pharmacologically and neuro-
anatomically. The experimental results will be discussed with respect to their relevance 
for oro-facial dyskinesia. 
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CHAPTER 3 
SUBREGIONS OF THE CAUDATE NUCLEUS AND THEIR IN- AND OUTPUT 
CHANNELS IN ORO-FACIAL DYSKINESIA: A BEHAVIOURAL AND 
RETROGRADE TRACING STUDY IN THE CAT 
Published in: Brain Research 539 (1991) 85-93 
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3.1 ABSTRACT 
Previous studies have shown that the feline caudate nucleus contains DPI-sensitive (caput 
nuclei caudati, anterodorsal part; r-CRM) and DPI-insensitive (caput nuclei caudati, rostr-
omedial part; CRM) regions. Stimulation of dopamine receptors within the r-CRM by 
dopamine or DPI are known to elicit ого-facial dyskinesia (OFD), i.e. a syndrome of tic­
like contractions of the facial muscles in combination with tongue protrusions. OFD is 
also elicited from the sub-commissural part of the globus pallidus (scGP), a first order 
output station of the r-CRM, but not from the CRM. On the basis of these data it has 
been hypothetized that (1) OFD is a specific feature of the r-CRM, but not the CRM; (2) 
effects elicited from the r-CRM are funneled via the scGP.and that (3) r-CRM and CRM 
are differentially innervated. Cats were bilaterally equipped with cannulas directed at the 
CRM or r-CRM and scGP. Following recovery from the operation the cats received 
bilateral injections of DPI into CRM (5 /igr/5 μΐ) or r-CRM (5 and 10 μgr/5 μΐ), the 
latter in combination with muscimol (50 and 100 ngr/ 1 μΐ) into the scGP or its solvent. 
Subsequently behaviour was analyzed. OFD, quantified in number of tongue protrusions, 
was only elicited from the r-CRM, but not from the CRM confirming previously reported 
data in this respect. Furthermore the effect varied according to the dose used. The OFD 
elicited from the r-CRM was found to be blocked at the level of the scGP by local 
injections of muscimol, a GABA agonist. Furthermore it was found that the OFD elicited 
from the scGP by injections of picrotoxin or carbachol, i.e. a syndrome which was 
previously studied, was highly comparable with that elicited from the r-CRM. These data 
together allow the conclusion that effects elicited from the r-CRM such as OFD are 
anyhow funneled via the scGP. Finally it was found in retrograde tracing experiments that 
r-CRM and CRM are differentially innervated by mesencephalic A8 and A9 cells. In 
sum, the present study provides direct evidence that OFD is a characteristic feature of a 
particular subregion within the caudate nucleus which has its own input and output 
channels. 
3.2 INTRODUCTION 
Previous studies have shown that the feline caudate nucleus (CN) can be subdivided into 
at least two subregions, i.e. the rostromedial CN (caput nuclei caudati, rostromedial part; 
CRM) and the rostrodorsal CN (caput nuclei caudati, anterodorsal part: r-CRM; Cools et 
al., 1976; Cools et al., 1989). 
The dopamine sensitive CRM - delineated on the basis of its susceptibility to apomorphine 
and haloperidol - is characterized by a relative high content of striosomes, although it is 
certainly not devoid of extra-striosomal matrix (Cools et al., 1976; Jiménez-Castellanos 
and Graybiel, 1987; Desban et al., 1989). According to Jiménez-Castellanos and Graybiel 
(1987), striosomes are mainly innervated by neurons located within a subdivision of the 
substantia nigra, pars compacta (SNc) i.e. the denzocellular part of the SNc (SNcfdz), 
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whereas the extra-striosomal matrix is mainly innervated by neurons located in the 
retrorubral nucleus, the so-called A8 cells, in the mesencephalic tegmental area. The 
dopaminergic activity within the CRM has been found to allow the animal to switch 
arbitrarily from one behaviour to another (Jaspers and Cools, 1988; Jaspers et al., 1989), 
i.e. a function which is funneled via the well-known striato-nigro-collicular pathway 
(Gelissen and Cools, 1986; Gelissen and Cools, 1988; Jaspers et al., 1989). 
In contrast, the dopamine sensitive r-CRM is unsusceptible to apomorphine and haloperi-
dol, but susceptible to (3,4-dihydroxyphenylamino)-2-imidazoline (DPI; Cools et al., 
1976; Cools et al., 1978), a potent agonist of the inhibition mediating dopamine receptor 
in the dopamine receptor classification of Cools and van Rossum (Struyker Boudier et al., 
1975; Cools and van Rossum, 1976; Cools and van Rossum, 1980). This region -
delineated on the basis of this latter characteristic - has been characterized by a relative 
low content of striosomes and is therefore primarily marked by extra-striosomal matrix, 
although it is certainly not devoid of striosomes (Groves et al., 1988; Desban et al., 
1989). The dopaminergic activity within the r-CRM mediates the display of oro-facial 
dyskinesia (OFD; Cools et al., 1976), i.e. a syndrome of sudden attacks of tic-like 
contractions of the ear, eye and cheek, in combination with abnormal tongue protrusions 
(Cools et al., 1976; Cools et al., 1989; Spooren et al., 1989; cf. Sigwald et al., 1959; 
Klawans, 1980). The attack which is elicited by local injections of DPI or dopamine into 
the r-CRM, usually starts unilaterally at the tip of one ear. Subsequently the eye is 
opened and closed or kept (half) closed, whereas the cheek displays fast contractions in 
various degrees of intensity. The attack always ends with an abnormal tongue protrusion. 
The tongue protrusions themselves are characterized by upward curling of the lateral 
side(s) or tip of the tongue inside or outside the oral cavity (Cools et al., 1976). 
In a recent anterograde tracing study using WGA-HRP, in which the efferent connections 
of the CRM and r-CRM subregions of the caudate nucleus were investigated, it was found 
that only the r-CRM innervates the sub-commissural part of the Globus Pallidus (scGP) 
whereas the CRM has no such connection. Following these results it was shown that OFD 
is also elicited from the scGP, now identified as a first order output station of the r-CRM 
(Cools et al., 1989; Jaspers et al., 1989; Spooren et al., 1989). Thus OFD appears after 
inhibition of the GABAergic activity or stimulation of the cholinergic activity within the 
scGP (Cools et al., 1989; Spooren et al., 1989). On the basis of these anatomical and 
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behavioural data we have suggested that the effects elicited from the r-CRM are at least in 
part funneled via the scGP towards lower brain centers (Cools et al., 1989; Spooren et 
al., 1989). 
The aim of the present investigation was fourfold. Firstly, it was investigated whether the 
DPI-induced OFD is locus-specific as suggested by previous reports. For that purpose the 
effects of DPI injections into the CRM and r-CRM, respectively, were quantitatively 
analyzed. In case DPI turned out to be effective two different doses were tested. Second-
ly, it was investigated to which degree the DPI-induced OFD is comparable to OFD 
elicited from the scGP. For that purpose the videotapes collected in previous studies on 
the role of the scGP in OFD were re-analyzed, and the outcome was compared with that 
found in the present study. Thirdly, it was investigated whether the DPI-induced OFD is 
indeed funneled via the scGP. For that purpose, the effect of scGP injections of the 
GABAergic agonist muscimol was analyzed in cats showing DPI-induced OFD. Muscimol 
was chosen in view of the fact that it has been found to attenuate OFD elicited by injec-
tions of Picrotoxin into the scGP. Finally, retrograde tracing experiments were performed 
in order to investigate whether the DPI-sensitive resp. DPI-insensitive regions within the 
caudate nucleus are indeed differentially innervated by neurons arising in the mesen-
cephalic tegmental area. As noted above, the CRM and r-CRM regions differ with respect 
to their striosomes-matrix composition, which have been suggested to be differentially 
innervated (Graybiel, 1984; Jiménez-Castellanos and Graybiel, 1987). 
3.3 MATERIALS AND METHODS 
Behavioural studies 
Subjects and surgical procedures 
Male cats (n=15; Animal Laboratory, University of Nijmegen) weighing 3.6 - 5.7 kg were used. Each group, 
composed of seven or eight cats, was housed in a cage (2x3x2 m) with water and food (Hope Farm) ad libitum 
available. The animals, under deep anaesthesia (pentobarbital), were stereotaxically implanted with stainless steel 
guide cannulas (inner and outer diameter of O.SS and 0.8 mm respectively), according to previously reported 
procedures (Cools et al., 1976), and aimed either at the CRM (coordinates A 1S.0, L S.0, H 5.0) or the r-CRM 
(coordinates A 17.5, L 5.0, H 5.5) and the scGP (coordinates A 15.0, L 5.3, H -2.5, aL 7° and aP 5° according 
to Snider and Niemer (1964)). In order to avoid unnecessary damage to the target sites, the cannulas were placed 
2 mm above these sites. 
Apparatus 
Cats were tested in a sound proof observation cage (90x60x60 cm) with a plexiglass front panel. The cage was 
equipped with two ventilators which produced a constant background noise(Cools et al., 1989; Spooren et al., 
1989). 
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Procedures 
After recovery from the operation, the cats were habituated to the experimental cage (each cat 3x1 hr. sessions at 
successive days). During the last habituation session the cats received a dummy injection. After a minimum 
period of 7 days following the operation, the experiments started. Following a IS minute period of rehabituation 
to the cage, the cat's behaviour was recorded for a period of 10 min. preceeding the injection, i.e. pre-injection 
period. Then the injections were given. In case uitra-caudate injections (second injection) and scGP injections 
(first injection) were given, they were interspaced by a S minute penod. The drug-induced behaviour was 
recorded for a penod of 45 minutes, i.e. post-injection penod. In general, the behaviour was stored on videotape 
with the help of a closed TV-circuit. Afterwards, the tapes were used to count the number of tongue protrusions, 
which are known to signal the end of an OFD attack (see introduction; Cools et al., 1989; Spooren et al 1989). 
All injections were bilaterally given with the help of a Hamilton syringe (sharpened tip); the tip of the needle 
was lowered 2 mm below the implanted cannula in order to reach the chosen target site (see above). The 
injection itself lasted 10 sec., and the needle was kept on place for another 10 sec. The following drugs were 
used: (3,4-dihydroxyphenylamino)-2-imidazoline (DPI; Wander-Sandoz) and muscimol (MSM; Serva). Distilled 
water, i.e. the solvent of the drugs, was used in control experiments. The experiments started with the injections 
of the solvent. Subsequently, the CRM-group received intra-cerebral injections of DPI (5 μgr/Sμ\), whereas the 
r-CRM-group received injections of DPI (5 and 10 jigr/5 μ\ resp.) ID combination with solvent injections into the 
scGP. The effects elicited by local injections of DPI into the r-CRM alone were not investigated, for they have 
been previously studied (Cools et al., 1976). Since the injection of 10 μgτ. DPI was twice as potent as 5 μ%ι. in 
eliciting tongue protrusions, the higher dosage was selected for further experiments. Subsequently, the cats 
received mtra-r-CRM injections of 10 μgτ. DPI in combination with 100 and 50 ng muscimol/1 μί into the scGP. 
All experiments were interspaced by a 7 day period. 
In order to compare the OFD elicited from the r-CRM and scGP the videotapes collected in previous ex­
periments, in which the involvement of the scGP in OFD was investigated (Cools et al., 1989; Spooren et al 
1989), were reanalyzed and the OFD elicited from both areas was compared. 
Histological verification 
After the experiments the cats were deeply anaesthetized with pentobarbital (60 mg/kg, intra-pentoneally) and 
transcardially perfused with saline followed by a 4% paraformaldehyde solution. The brains wefe removed and 
subsequently cut on a cryostat into sections of 30 μπι. The sections were stained with cresylviolet in order to 
estimate the location of the injection site. 
Statistics 
Wilcoxon matched-pairs signed-ranks test (two-tailed) was used for statistical analysis. 
Retrograde tracing experiments 
In a pilot study, four animals received unilateral injections of 0.2 - 0 3 μί wheat germ agglutinin conjugated to 
horseradish peroxidase (WGA-HRP; Sigma L9008) within the r-CRM (n=2) or CRM (n=2). The cats were 
allowed to survive for 3 days, after which they were re-anaesthetized and perliised with a buffered (pH 7.6) 
fixative containing 1.25% glutaraldehyde and 1% paraformaldehyde. The brains were removed and stored in a 
30% sucrose solution until they sank Subsequently, the brains were sectioned on a freezing microtome (50 μιη) 
and the sections processed according to the tetramethylbenzidine method (TMB) of Mesulam (1978). 
In order to compare the afférents of the two areas within one and the same subject, two cats were injected with 
the fluorescent tracers Fast Blue (0.3 μί; 5% in distilled water; Elling GMBK) into the CRM on the one side and 
Fluoro-Gold (0.3 μί; 5% in distilled water; Elling GMBK) into the r-CRM on the other side of the brain. These 
cats were allowed to survive for 7 days. Perfusion was done with saline followed by a 4% paraformaldehyde in 
phosphate buffer (pH 7.2) containing 10 % sucrose. The brains were stored in a 4% formaldehyde, 30% sucrose 
solution until they sank. Sections of 40 μιη were cut on a freezing microtome, mounted immediately from a 0.1 
% gelatine solution, and studied with the aid of a Zeis IV F fluorescence illuminator, using filter mirror sytem 
0.1 (345 nm). An electronic drawing board connected to the microscope was used to allow accurate mapping of 
labeled cells. After mapping the various retrogradely labeled mesencephalic cells, all sections were stained with 
cresylviolet, and the cyto-architectomc image was superimposed upon the map of the charted cells. The distri­
bution of the vanous labeled cells was analyzed as far as it concerned their differential location across the three 
major catecholamine containing cell groups A8, A9 and AIO in general and the cellsparse A9 (SNc(cs)) and the 
densocellular A9 (SNc(dz)) in particular cf. Jiménez-Castellanos and Graybiel (1987). 
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3.4 RESULTS 
Behavioural studies 
Histological data 
Histological verification revealed that all sites of injection were correctly placed within 
the borders of the target regions (figs. 1 and 2). 
Fig. 1 Representative locations of cannulas directed at the r-CRM (A) and scGP (B). 
Locus specificity of DPI mediated effects 
Bilateral injections of DPI into the r-CRM induced OFD which was quantified in terms of 
numbers of tongue protrusions. The number of tongue protrusions elicited by 10 μgτ DPI 
was twice the number elicited by 5 μgr DPI (fig 2). Temporal analysis of OFD elicited 
from the r-CRM revealed specific periods in which OFD-attacks were clustered (peak 
frequency periods). These periods occured at different times at different dosages (5 /igr: 
5-15, 25-30 and 35-40 min.; 10 ^gr: 0-5, 10-20 and 40-45 min.). 
DPI injected into the CRM induced no OFD: there were no significant differences 
between the solvent- and DPI-treated cats (table I). 
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r-CRM vs scGP elicited OFD 
A comparison of the OFD elicited from the r-CRM or scGP revealed that there were no 
differences in the morphology of OFD: the various groups of affected muscles, the 
involuntary and abnormal nature of the movements as well as the variant occurence of 
OFD-attacks in time were found to be identical. However, it has to be noted that the 
scGP-elicited OFD was far more intense and vigorous than that elicited from the r-CRM, 
but this observation could not be quantified in view of the lack of an objective and 
adequate variable. 
Fig. 2 Location of the injection sites in the С RM (open dots) or r-CRM and scGP (closed dots) of cats used in 
the behavioural part of this study (coordinates: r-CRM: A 18.0 - 16.0, L 4.75 - 6.8, H 5.7 - 7.5; scGP: A 13.5 
- 15.0, L 5.2 - 8.0, H 2.0 - -3.5; CRM: A 14.0 - 15.5, L 4.8 - 6.2, H 3.0 - 5.5; according to Snider and 
Niemer (1964). 
Table I Total number of tongue protrusions (median value +/-25 %) observed during the 45 min. period after 
local injections of solvent or DPI (5 μgг) into the CRM. 
Treatment Dose η Tongue protrusions 25% - 75% 
(/ig) (median value) 
H 20 - 7 37 5 46 
DPI 5 7 25 11 39 
Striato-pallidofugal pathway 
Injections of muscimol into the scGP (50 and 100 ng/1 μϊ), which per se were ineffective 
(Cools et al., 1989), fully suppressed the display of OFD elicited from the r-CRM by 
local injections of DPI. As shown in fig. 3, the DPI induced increase in the number of 
tongue protrusions was indeed completely counteracted. 
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Fig. 3 Median value of the number of tongue protrusions (TP) in 45 minutes following bilateral injections into 
the r-CRM of solvent (distilled water; 5 μι) or DPI (5 and 10 /jgr/ 5 μϊ) in combination with solvent injections 
into the scGP (1 μ\). Statistical analysis was performed by means of Wilcoxon matched-pairs signed-ranks test 
(two tailed), ·** ρ < 0.01 The number of animals is indicated in each bar. 
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Fig. 4 Median value of the number of tongue protrusions (TP) in 45 minutes following bilateral injections into 
the r-CRM and scGP of resp. solvent/solvent, DPI(10)/soWent, DPI(10)/MSM(50) and DPI(10)/MSM(100). For 
statistics see fig. 2. The number of animals is indicated in each bar. NS = not significant 
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Retrograde tracing experiments 
The injection loci of the retrograde tracers are given in fig. 4a. The distinct injections in 
CRM or r-CRM led to distinct patterns of labeled cells in the mesencephalic A8, A9 and 
AIO regions. The results of the experiments with WGA-HRP and fluorescent tracers were 
highly comparable with respect to the distribution of labeled cells over the various 
dopaminergic cell groups; however, the number of fluorescent cells exceeded the number 
of WGA-HRP labeled neurons. The results of a representative case (cat 232), which 
received an injection of the retrograde tracer .Fluoro-Gold into the CRM (232R in fig. 4a) 
and an injection of Fast Blue (232L in fig. 4a) into the r-CRM, is shown in fig. 4d. 
In all cases hardly any labeled cells were found within the borders of the AIO. However, 
distinct differences were found in the two other dopaminergic fields, i.e. A8 and A9. 
The substantia nigra, pars compacta (A9; SNc): All injections into the CRM resulted in a 
dense pattern of labeled cells within both the densocellular zone and the cell sparse zone 
of the substantia nigra, pars compacta, respectively the SNc(dz) and SNc(cs). The 
SNc(dz) was also labeled after injections into the r-CRM, but the latter injections failed to 
label the SNc(cs) extensively (see thick arrows in fig. 4d). Only the extreme lateral and 
medial part of the rostral SNc(cs) was sparsely labeled. This part of the SNc usually also 
contained some contralaterally labeled neurons of the injection in the CRM, whereas the 
remaining neurons were labeled ipsilateral of the injection site. The retrorubral nucleus 
(A8): All injections into the CRM resulted in some labeling of cell group A8. However 
the pattern of these labeled cells was characterized by a diffuse distribution. All injections 
into the r-CRM, however, resulted in an extensive labeling of this cell group, and the 
labeled cells were strongly clustered within its borders. 
3.5 DISCUSSION 
The present study clearly reveals four findings. 
Firstly, it shows that the feline OFD elicited from the r-CRM is indeed locus specific. 
Intra-cerebral injections of DPI were only effective in eliciting OFD when injected into 
the r-CRM, but not into the CRM. In view of these data it can also be concluded that DPI 
injected into the CRM did not diffuse into the r-CRM since that would ultimately have 
resulted in the display of OFD as in the case of the r-CRM injections itself. 
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Fig. 5 A) Injection sites of the retrograde tracer WGA-HRP into the CRM (case 482 and 307) or r-CRM (case 
478 and 299) and injections sites of the retrograde fluorescent tracers Fast Blue and Fluoro-Gold into r-CRM and 
CRM (case 232R and L and 254 R and L). B) Case 232: distríbuüon of the retrogradely labeled cells within the 
mesencephalic A8, A9 and AIO cell groups from rostral (top) to caudal (bottom) levels after injections of Fast 
Blue (232L; closed dots) into the left r-CRM and Fluoro-Gold into the right CRM (232R; open dots). 
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Therefore diffusion in opposite direction, i.e. from the r-CRM to the CRM, will also be 
unlikely. Still, if any diffusion has taken place it will most probably not have influenced 
the effects elicited from the r-CRM since previous investigations as well as the present 
study clearly show that DPI is ineffective within the CRM (Cools et al., 1976). 
Altogether, this outcome confirms and extends previously reported data (Cools et al., 
1976), since the present study not only provides quantitative data on OFD, but also shows 
that the effect varied according to the dose used. Since it was not the goal of the present 
investigation to clarify the nature of the DPI-induced effects, drug-specificity was not 
analyzed. However, it is useful to note that DPI has been recognized as a potent agonist 
of the inhibition mediating dopamine receptor in the dopamine receptor classification of 
Cools and van Rossum (1980). DPI is also known to act as an agonist of noradrenaline 
(NE; Struyker Boudier et al., 1975). However, a substantial role of NE in the DPI-
induced increase in the number of tongue protrusions can be excluded for two main 
reasons. Clonidine, oxymetazoline and phenylephrine, three alpha-noradrenergic agonists, 
have found to be unable to mimic the behavioural effects elicited by DPI within the r-
CRM (Cools, unpublished data). Moreover, it has previously been shown that stimulation 
of alpha-noradrenaline receptors in the r-CRM induces behavioural changes that are 
diametrically opposite to those induced by stimulation of dopamine receptors (Cools et 
al., 1978). 
Secondly, OFD elicited from the r-CRM was highly comparable with OFD elicited from 
the scGP. 
Thirdly, it was found that OFD elicited by local injections of DPI into the r-CRM was 
fully suppressed by local injections of muscimol into the scGP. This finding, together 
with the fact that the scGP is a first order output station of the r-CRM, allow the 
conclusion that the r-CRM funnels its information about OFD via the scGP towards lower 
brain structures. Furthermore, given the fact that OFD is elicited from the scGP by 
Picrotoxin, i.e. an indirect GABA antagonist, as well as from the r-CRM by DPI whereas 
both effects are significantly counteracted by local injections of the GABA agonist 
muscimol into the scGP suggest that DPI in the r-CRM anyhow suppresses the 
transmission of GABA in the scGP (Spooren et al., 1989). In sum, the present 
behavioural data show that the scGP in cats receives and transmits striatal information 
possibly towards lower brain structures, a role which is comparable with the role of the 
51 
ventral pallidum in rodents (Swerdlow et al., 1984a,b; Patel and Slater, 1985; van den 
Bos and Cools, 1989). 
Fourthly, the retrograde tracing experiments show that the r-CRM and CRM are 
innervated by different pools of mesencephalic A8 and A9 cells. The AIO hardly 
contributes in the innervation of the two caudate areas. 
Furthermore, the results show that the CRM is primarily innervated by the SNc whereas 
the r-CRM is primarily innervated by cell group A8. However, CRM and r-CRM are in 
addition, although to a minor degree, also innervated by respectively the A8 and SNc(dz). 
Since it has been shown that stnosomes are primarily innervated by the densocellular zone 
of the SNc and the extra-striosomal matrix by the retrorubral cell group A8 and taking 
into account that the CRM is characterized by a relative high content of striosomes, 
whereas the r-CRM predominantly contains extra-striosomal matrix, our data are fully 
interpretable using those previous data (Jiménez-Castellanos and Graybiel, 1978; Groves 
et al., 1988; Desban et al., 1989). So, in light of these findings it is likely that the 
SNc(dz) innervates especially striosomes within the CRM, and the A8 innervates 
especially matrix within the r-CRM. However, it must be noted that the present study 
also indicates that the r-CRM and CRM are in addition innervated by respectively the 
«-scGP 
SNpr 
Q] =matrix 
Щ =siriosomes 
Fig. 6 Hypothetical model of the input and output channels of the caudate subregions, CRM and r-CRM, based 
upon the results of the present investigation and other studies (Graybiel, 1984; Jiménez-Castellanos and Graybiel, 
1987; Groves et al., 1988; Desban et al., 1989). 
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SNc(dz) and A8, although to a much smaller degree. The A8 will therefore possibly also 
contribute in the innervation of the matrix within the CRM whereas striosomes within the 
r-CRM will possibly be innervated by the SNc(dz). Finally, our results show that the 
SNc(cs), a subpart of the SNc, exclusively innervates the CRM and not the r-CRM. Inter-
estingly, Jiménez-Castellanos and Graybiel (1987) have suggested that this part of the 
nigra innervates both striosomes and extra-striosomal matrix. If this is indeed the case our 
data indicate that, apart from the striosomes, even the matrix within the CRM is inner-
vated by a subpart of the SNc. If so, it implies that the CRM area is far more intensively 
innervated by the SNc than it has been realized up to now. Furthermore, since the r-CRM 
appears not to be innervated by the SNc(cs) our data may even indicate that the matrix 
within the r-CRM, which dominates the area, is exclusively innervated by cell group A8. 
Anyhow, the combination of both behavioural and anatomical data anyhow suggest an 
involvement of cell-group A8 in drug-induced OFD or more in general for mesolimbic 
dopamine since the scGP is also innervated by the nucleus accumbens which on its tum is 
heavily innervated by cell-group AIO (Szabo, 1980; Groenewegen and Russchen, 1984). 
However, it will be evident that more experimental as well as clinical data are necessary 
to provide direct proof in favour of the latter hypothesis. 
As summarized in fig. 5, it now seems clear that the CRM and the r-CRM areas in the 
caudate nucleus of the cat receive a different input from the mesencephalic A8 and A9 
cell groups. Apart from a differential input, both areas have also a differential output: 
effects elicited from the CRM are funneled via the nigro-collicular pathway (Gelissen and 
Cools, 1986; 1988; Jaspers et al., 1989), whereas effects elicited from the r-CRM are 
funneled via the scGP towards lower brain structures (present study). These data provide 
an adequate explanation for the fact that each area has its own behavioural role, as shown 
in the present investigation and in previous studies (Cools et al., 1976; Cools et al., 1978; 
Jaspers et al., 1984; Jaspers and Cools., 1988; Cools et al., 1989). 
Abbreviations 
CN ¡caudate nucleus 
CRM :caput nuclei caudati, rostromedial part 
DPI :(3,4-dihydroxy-phenylamino)-2-imidazolme 
MSM ¡muscimol 
NE ¡noradrenaline 
OFD :oro-facial dyskinesia 
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r-CRM :caput nuclei caudati, anterodorsal part 
scGP :sub-commissural part of the globus palhdus 
SNc ¡substantia nigra, pars compacta 
SNc(cs) ¡cell sparse part of the SNc 
SNc(dz) :densocellular part of the SNc 
WGA-HRP :wheat germ agglutimn conjugated to horseradish peroxidase 
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PART Π: ANIMAL RESEARCH 
CHAPTER 4 
ORO-FACIAL DYSKINESIA AND THE SUB-COMMISSURAL PART OF THE 
GLOBUS PALLIDUS IN THE CAT: ROLE OF ACETYLCHOLINE AND ITS 
INTERACTION WITH GABA 
Published in: Psychophannacology 99 (1989) 381-385 
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4.1 ABSTRACT 
The possible role of cholinergic mechanisms in the sub-commissural part of the globus 
pallidus (scGP) in the induction of oro-facial dyskinesia (OFD) was studied in cats. Local 
injections of the cholinergic agonist carbachol into the scGP, elicited tongue protrusions in 
a dose dependent way (100 - 1000 ng/0.5 μΐ). The effect elicited by 1000 ng carbachol was 
selectively antagonized by the cholinergic antagonist scopolamine (10 μg/0.5 μί); this dose 
of scopolamine was ineffective when injected alone. The tongue protrusions resulted from 
both normal and abnormal movements: whereas normal movements simply consisted of 
protruding the flat tongue, abnormal movements implied a variety of movements, especially 
curling upwards the lateral side(s) or tip of the tongue inside or outside the oral cavity. The 
abnormal carbachol-induced tongue protrusions formed part of a syndrome marked by 
dyskinetic movements of the muscles of the eye, ear and cheek, and were identical to those 
seen previously after local injections of picrotoxin (250 - 500 ng/0.5 μί). Intra-pallidal 
injections of the above mentioned dose of scopolamine, had no effect on the tongue 
protrusions induced by local injections of 375 ng picrotoxin. However.local injections of 100 
ng muscimol, which was previously found to attenuate significantly the effect of 375 ng 
picrotoxin and which was ineffective when injected alone, significantly attenuated the tongue 
protrusions induced by local injections of 1000 ng carbachol. These data suggest that the 
cholinergic effects are mediated via a GABAergic mechanism, but not vice versa. The results 
are discussed in view of GABAergic and anti-cholinergic therapies used in oro-facial 
dyskinesia. 
4.2 INTRODUCTION 
Oro-facial dyskinesia (OFD) is a syndrome of abnormal, involuntary persistent movements 
of the tongue, lips and facial muscles such as chewing, sucking, licking movements and 
protruding the tongue (Sigwald et al., 1959). Movements of this nature were first described 
as ал integral part of the hyperkinesia of Huntington's chorea and other choreatic states. 
They are one of the most severe side effects of a chronic treatment with neuroleptics 
(dopamine antagonists) or L-DOPA (precursor of dopamine). Furthermore they rarely occur 
in otherwise non-treated elderly people (Klawans et al., 1980). It has been hypothesized that 
OFD is due, at least in part, to alterations in dopaminergic processes (Klawans et al., 1980), 
although the simple notion that it merely reflects supersensitivity of DA receptors is no 
longer tenable (Cools, 1983; Fibiger and Lloyd, 1984; Waddington, 1985; Jankovic and 
Casabona, 1987). 
The symptoms of OFD, especially tongue protrusions, can be elicited from the anterodorsal, 
but not the medial part of the feline caudate nucleus (CN) by injecting dopamine (DA) or 3,4 
dihydroxyphenylamino-2-imidazoline (DPI) (Cools et al., 1976; Cools, 1986). 
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Recently it has been shown that OFD in the cat can also be elicited from the sub-commissural 
part of the globus pallidus (scGP), a brain region which is innervated by the anterodorsal but 
not the medial (core) part of the CN (Cools et al., 1989a; Cools et al., 1989b). The scGP 
is part of the globus pallidus stretching ventrally and rostrally beneath the commissura 
anterior (Groenewegen and Russchen, 1984; Russchen et al., 1985). In the rat the scGP is 
not differentiated as such (Haber et al., 1983; Haber et al., 1985). Studies using bilateral 
injections into the scGP and its adjacent regions have provided evidence that Picrotoxin, an 
inhibitor of the GABAergic chloride fluxes, results only in a dose-dependent display of OFD 
when injected into a certain circumscribed sub-region (Cools et al., 1989b). These effects 
were GABA-specific since they could be counteracted by muscimol, a GABAergic agonist 
(Cools et al., 1989a; Cools et al., 1989b). The picrotoxin-induced tongue protrusions resulted 
from both normal and abnormal movements. Whereas normal tongue movements simply 
consisted of protruding the flat tongue, abnormal movements implied a variety of movements: 
curling upwards the lateral sides of the tongue and then protruding the curled tongue via the 
left or right comer of the mouth; curling upwards and inwards the tip of the tongue against 
the palatum and then protruding it; and pressing the tip of the tongue against the innerside 
of the cheek and then protruding it. These abnormal tongue protrusions formed part of a 
syndrome marked by dyskinetic movements of facial eye, ear and cheek muscles (Cools et 
al., 1989b). 
At the moment it is not known whether GABA is the sole transmitter within the scGP 
involved in this syndrome. The notion that the scGP contains cholinergic as well as 
cholinoceptive cells (Kimura et al., 1982; Vincent and Reiner 1987; Fischer et al., 1988), 
in combination with the fact that acetylcholine (ACH) appears to play a role in OFD (Gerlach 
et al., 1974; Casey and Denney, 1977; Klawans et al., 1980; Monteiro, 1985) raised the 
question whether ACH in the sCGP is also involved in OFD, and if so, whether it modulates, 
or is modulated by GABA within the scGP. For these reasons it was decided to investigate 
the role of ACH in the scGP in OFD, and to analyse the interaction between ACH and 
GABA within the scGP in the mediation of this behaviour. 
4.3 MATERIALS AND METHODS 
Subjects and surgical procedures 
Male cats (n=25) (animal Laboratory, University of Nijmegen) weighing 3.5-4.8 kg. were used. Each group, 
composed of 8-9 cats (age 12-13 months), was housed in an iron cage (2x1.5x1.5 m) with water and food (Hope 
59 
Farm) available ad libitum. The animals were stereotaxically implanted with stainless-steel guide сашшіае (inner and 
outer diameter of 0.55 and 0.8 mm. respectively), according to previously reported procedures (Cools et al., 1976; 
Jaspers et al., 1984) and aimed at the scGP (coordinates A 15 0, L 5.3, H -2.5, lateral angle 7.0* and caudal angle 
5.0° according to Snider and Niemer, 1964). 
apparatus 
A sound proof wooden observation cage (90x60x60 cm) with a Plexiglas front panel, equipped with two ventilators 
producing a constant background noise was used (Gehssen and Cools, 1988). 
Experimental procedures 
Following standard procedures for habituation to the experimental cage (each cat 3x1 h sessions at successive days) 
and intra-cerebral injections, the cats received bilateral injections using a 5 μΐ Hamilton syringe (sharpened tip). The 
tip of the needle protruded 2 mm below the cannula in order to reach the chosen target site without producing any 
unnecessary damage to the target tissue itself. The injection lasted 10 - 15 seconds. Immediately after the injection, 
the needle was kept on its place for another 15 seconds. The following drugs and combination of drugs were 
injected: 1) the cholinergic agonist carbachol (Sigma), the cholinergic antagonist scopolamine (Sigma), and their 
combination in order to investigate the specificity of the drug induced effects; 2) Picrotoxin (Serva) in combination 
with water or scopolamine, and carbachol in combination with water or muscimol (Serva) in order to investigate the 
possible interaction between GABA and ACH. The doses of Picrotoxin (375 ng) and muscimol (100 ng, i.e. a dose 
which significantly attenuated the effects of 375 ng Picrotoxin) were chosen on basis of the outcome of earlier 
reported experiments (Cools et al., 1989b). The minimal interval between experiments was 7 days, whereas a 
maximum of 6 injections was given per cat. The drugs were injected in a volume of 0.5 μ\ except for muscimol 
which was injected in a volume of 1.0 μ\. Just before the injections, the cat was rehabituated to the experimental 
cage for 15 min Then the experiment was started with a 15 min. pre-injection period, followed by the injection 
(t=0) and a 45 min. post-injection period. In case of combined injections muscimol, scopolamine or water was 
injected first (t=-5 mm.) followed by carbachol, Picrotoxin or water (t=0 min.). During the pre- and postinjection 
periods the feline behaviour was filmed and stored on a videotape with the help of a closed circuit. The whole period 
was analyzed using a standard ethogram (Gehssen and Cools, 1988). Some cats that received more than six injections 
showed abnormal tongue protrusions during the pre-injection period probably due to damage of the target tissue 
caused by the repeated injections. For that reason the data of the latter experiments were discarded, whereas the 
number of injections in the remaining study was limited to six (see above). Each series of experiments was started 
with the injection of the corresponding vehicle (distilled water). 
Statistical analysis 
Wilcoxon matched-pairs signed ranks test (two tailed) was used for statistical analysis. 
Histological verification 
At the end of the experiments the cats were deeply anaesthetized with pentobarbital (60 mg/kg, intra-pentoneally) 
and transcardially perfused with saline followed by a 4% formaldehyde solution. The brains were removed and 
subsequently dissected with the help of a cryostat (temp. -18°). The sections were stained with cresylviolet in order 
to estimate the location of the tip of the needle. 
4.4 RESULTS 
Histological verification 
Histological verification revealed that the injections were correctly placed into the target 
region (A 13.5 - 15.0, L 5.0 - 5.3 and H -1.5 - -3.2; for an exact delineation of the target 
regions see: Cools et al. 1989a). 
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Dyskinetic movements 
The drug-induced tongue protrusions were part of a full blown oro-facial dyskinetic syndrome 
(OFD), which consisted of sudden attacks of oro-facial tic-like contractions involving the ear, 
eye and cheek. The attack usually started at the tip of one ear, moving the ear as if irritation 
or tickling took place. Then the ipsilateral eye and cheeck were affected. The eye was opened 
and closed at a relatively high frequency (3-4 times/sec.) or kept (half) closed. The cheek 
displayed very fast contractions ( > 5 times/sec.) in varying degrees of intensity. Finally, the 
attack ended with a abnormal tongue protrusion (see introduction). Attacks with the complete 
repertoire of dyskinetic movements were rare. Usually an attack consisted out of an at 
random combination of the above mentioned movements, but always ending with a tongue 
protrusion. The different facets of an attack could occur interspaced or simultaneously. These 
attacks appeared in bursts consisting of 2 or 3 ( but up to 7 or 8) attacks and lasting 15-30 
seconds at the most. The bursts on their turn usually appeared clustered in certain post-
injection periods called peak frequency periods. Peak frequency periods of the abnormal 
movements never occurred immediately after the injection; in contrast, tongue protrusions 
in the control experiments were usually clustered in the initial post-injection period of 5 
minutes. Given the fact that each attack always ended with a tongue protrusion, drug induced 
changes in the number of tongue protrusions were used as the dependent variable in the 
present study. 
Acetylcholine mediated effects 
Qualitative behavioural analysis of drug induced effects revealed that the carbachol induced 
syndrome was identical to that induced by Picrotoxin (see also: Cools et al., 1989b). The 
carbachol-induced oro-facial syndrome which was quantified in terms of numbers of tongue 
protrusions, was dose dependent (fig. 1). 
Temporal analysis of carbachol-induced tongue protrusions (time clusters of 5 minutes) 
showed a high basal level at the dosage of 1000 ng. with one peak frequency period (25-30 
min.). At lower dosages lower basal levels were found with several peak frequency periods 
(250 ng.:10-15 min., 20-25 min. and 35-40 min.; 500 ng.: 10-15 min., 25-30 min.; not 
shown). In an additional set of experiments, in which the baseline scores were relatively low 
(fig. 3: median value = 8; range: 6 (25%)23 (75%)) compared to the former group (fig 2: 
median value = 25.5; range: 11.75 (25%) - 58.75 (75%)), 2000 ng of carbachol 
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dose(ng) 0 100 250 500 1000 
Fig. 1 Median value of the number of tongue protrusions in 45 minutes after bilateral injections into the scGP of 
solvent (distilled water 0.5 μ\) and carbachol (100 - 1000 ng/0.5 μ\). Statistical analysis was performed by means 
of wilcoxon matched-pairs signed-ranks test (two tailed), · P< 0.05, * · P< 0.02, · · · P< 0.01. The number of 
animals is indicated in each bar. 
produced even an increase in tongue protrusions from 8 to 45 (median values) i.e. an 
increase of 562 %; 1000 ng of carbachol produced only an increase of 25.5 to 93.5 (median 
values) i.e. an increase of 366 %. In view of these data, the highest dose of carbachol was 
chosen to determine the acetylcholine specificity of the carbachol induced syndrome. As is 
shown in fig. 2, scopolamine, injected in a dose which had no effect when injected alone (10 
ftg), antagonized the carbachol-induced tongue protrusions significantly (fig. 2) and thus, the 
carbachol-induced oro-facial syndrome as such. Given the lack of circumscribed, 
histologically recognizable borders of the scGP, the locus specificity of the carbachol induced 
oro-facial syndrome was determined on basis of the enkephalin immunoreactivity (table I) 
which has been used as a marker to delineate the scGP (Groenewegen and Russchen, 1984). 
Cats in which the injection sites were located within the enkephalin positive region, always 
displayed more carbacholinduced tongue protrusions, i.e. the unimpeachable end of each 
attack (see above), than cats in which the injection sites were located outside this region. 
Interaction between GABA and Acetylcholine 
In order to investigate the possible interaction between GABA and ACH, behaviour elicited 
by combined injections of Picrotoxin with scopolamine and carbachol with muscimol was 
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analyzed (fig. 3). Scopolamine, injected in a dose which significantly attenuated the effect 
of 2000 ng of carbachol, had no influence on the picrotoxin-induced tongue protrusions: in 
fact, it did not change any aspect of the picrotoxin induced oro-facial syndrome. However, 
muscimol, injected in a dose which antagonized the effect of 375 ng picrotoxin, significantly 
attenuated the tongue protrusions elicited by 1000 ng of carbachol and, thus, the oro-facial 
syndrome as such. Although the chosen dose of muscimol did not fully suppres all tongue 
protrusions, higher doses of muscimol were not tested, since the latter are known to produce 
hypokinesia (unpublished data) and, accordingly, might have masked rather than suppressed 
the display of the dyskinetic effects. 
TONGUE PROTRUSIONS: MEDIAN VALUES 
CARB(ng) 0 
SCOP (яд) 0 
2000 
10 
Fíe. 2 Median value of the number of tongue protrusions in 45 minutes after bilateral injections into the scGP of 
solvent alone, scopolamine (10 fig/0.5 μΐ) in combination with solvent, solvent in combination with carbachol (1000 
ng/0.5 μΐ) and finally scopolamine in combination with carbachol. For statistics see fig. 2. The number of animals 
is indicated in each bar. Abbreviations: SCOP = scopolamine, CARB = carbachol. 
Table I: Mean values (+ standard error of mean (SEM)) of the number of tongue protrusions elicited by local injec­
tions of carbachol (CARB) sub-divided to their location inside or outside the enkephalin positive region, η = number 
of animals. 
CARB(ng) 0 100 250 500 1000 
ÌNK + 
+SEM 
η 
ÌNK-
+SEM 
η 
28.69 
6.32 
13 
28.35 
12.68 
5 
62.66 
12.56 
6 
32.50 
14.30 
4 
62.83 
15.29 
6 
57.00 
8.93 
4 
79.00 
10.13 
6 
66.00 
6.24 
4 
91.00 
8.97 
13 
66.20 
12.11 
5 
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TONGUE PROTBUSIONS MEDIAN VALUES 
dose SCOP 0 
( ng ) PTX 0 0 375 
10 000 MSC 0 0 
375 CARB 0 1000 
100 
1000 
Figi ? Median value of the number of tongue protrusions in 45 minutes after bilateral injections into the SCGP of 
solvent alone, solvent in combination with Picrotoxin (375 ng/0.5 μ\), scopolamine (10 ^g/0.5 μϊ) in combination 
With Picrotoxin, solvent in combination with carbachol (1000 ng/0.5 μί) and finally muscimol (100 ng/1 μϊ) ID 
combination with carbachol. For statistics see fig. 2. The number of animals is indicated in each bar. 
4.5 DISCUSSION 
Qualitative analysis of local injections of carbachol into the scGP revealed identical 
behavioural effects to those seen after injections of picrotoxin into this region (Cools et al., 
1989b) i.e. a syndrome of sudden attacks of dyskinetic movements of the facial eye, ear and 
cheek muscles and abnormal tongue protrusions. The abnormal tongue protrusions implied 
a variety of movements, especially upward curling of the lateral side(s) or tip of the tongue 
inside or outside the oral cavity. Since every attack ended with drug induced tongue 
protrusions, drug induced changes in the number of tongue protrusions reflected 
corresponding changes in the syndrome as a whole. Thus the data show that the carbachol-
induced oro-facial syndrome was dose dependent and acetylcholine specific (figs. 1 and 2). 
The finding that ACH plays a role in OFD elicited in cats agrees with its role in oral 
movements in rodents (Rupniak, 1983; Ushijima et al., 1984; Stewart et al., 1988). 
Since injections into the enkephalin positive region were more effective than those outside 
this region, these data suggest that especially the enkephalin postive region is involved in the 
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mediation of the above described syndrome. Although the involvement of ACH in OFD 
within the scGP is clear, the origin of this cholinergic input is unknown. Still, there are at 
least two candidates. First: the nucleus tegmenti pedunculopontinis (NTPP). This structure 
contains cholinergic cells, and is known to have projections to the substantia innominata 
complex (Graybiel, 1977; Moon Edley and Graybiel, 1983). Although it has been recently 
suggested that the cholinergic cells within the NTPP project to the ventrolateral thalamus 
rather than to the substantia innominata (Lee et al., 1988), it is interesting to note that the 
NTPP itself is also involved in OFD (Childs and Gale, 1977). Both findings together fit in 
with the possibility that the NTPP provides the cholinergic input of the scGP of which 
stimulation results in OFD. Second: the whole area ventral to the commissure. As mentioned 
in the introduction, this area is richly endowed with cholinergic cells. It is not impossible that 
collaterals of these cholinergic cells impinge upon GABAergic fibres and/or terminals within 
the scGP and, accordingly, modulate the GABA release from striato-pallidal fibres (see 
below). 
The present data also show that the scopolamine induced inhibition of ACH receptors was 
unable to alter the OFD syndrome elicited by the picrotoxin induced suppression of the 
GABA activity within the scGP. Since the used dose of scopolamine was sufficient to 
attenuate the carbachol-induced OFD syndrome, it can be concluded that GABA does not 
modulate the activity of ACH. On the other hand, a muscimol induced stimulation of GABA 
receptors was effective in attenuating the carbachol induced OFD. Since the used dose of 
muscimol was sufficient to attenuate the picrotoxin induced oro-facial syndrome (Cools et al., 
1989b), it can also be concluded that ACH anyhow modulates the activity of GABA. Both 
sets of data together suggest that ACH modulates the release of GABA, but not vice versa. 
In other words, a decrease in GABAergic activity rather than an increase in cholinergic 
activity appears to be the primary cause of the OFD elicited from the scGP. To which degree 
other neuroactive compounds are also involved remains to be investigated. Anyhow, it is 
important to recall that OFD in the cat can also be induced by injecting dopamine or DPI into 
the anterodorsal part of the caudate nucleus (Cools et al., 1976). Since a dopamine receptor 
blockade facilitates the activity of the inhibitory GABAergic pathway from the nucleus 
accumbens to the globus pallidus in the rodent (Scheel-Kruger et al., 1981), it appears that 
dopamine can inhibit the release of GABA in pallidal structures. From this point of view, 
it is reasonable to suggest that stimulation of dopamine receptors within the anterodorsal part 
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of the caudate nucleus elicits OFD because it actually decreases the release of GABA in the 
scGP. 
Finally, the resemblance between clinical OFD (see introduction) and the carbachol- and 
picrotoxin-induced OFD in cats is not only remarkable, but also far more striking than that 
between the clinical OFD and the OFD seen in rats. This holds especially true for the various 
groups of affected muscles, the involuntary and abnormal nature of the movements, and the 
variant occurence of the attacks in time. Since the brain mechanisms controlling the actual 
parameters of movements such as frequency and velocity profoundly differ between both 
species, it is not amazing that there are also significant differences, especially as far as it 
concerns the spatio-temporal patterning of the movements. The latter underlines the notion 
that a strict comparison between humans and animals is not only unacceptable, but also 
invalid. Given these considerations, it remains important to stress that the above mentioned 
resemblance between the clinical OFD and feline OFD on the one hand and together with the 
pathophysiological role of dopamine in both types of OFD on the other hand, opens the 
perspective that the feline OFD is a valid animal model of OFD in man. From this point of 
view it seems justified to postulate that the scGP is an important target site of orally 
administered anticholinergic drugs in those cases in which these drugs exert therapeutic 
effects upon OFD in man (Monteiro, 1985). It also helps to understand the relative succes 
of treating OFD with GABA agonists (Mohan Singh et al., 1983; Stahl et al., 1985): for 
these drugs may restore the possible deficit of GABA within the scGP. 
Anyhow, the acute effects of (anti-)cholinergic drugs and GABA (ant)agonists in eliciting or 
attenuating the above mentioned OFD in cats corresponds nicely with the acute effects of 
these drugs in a rat model of OFD (Gunhe et al., 1982). 
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PART Π: ANIMAL RESEARCH 
CHAPTERS 
DOPAMINE D, RECEPTORS IN THE SUB-COMMISSURAL PART OF THE 
GLOBUS PALLIDUS AND THEIR ROLE IN ORO-FACIAL DYSKINESIA IN 
CATS 
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5.1 ABSTRACT 
The possible role of dopamine OÍ receptors in the sub-commissural part of the globus 
pallidus in the induction of oro-facial dyskinesia was studied in cats. The present study 
reveals two findings. Firstly, bilateral injections of the D, agonist ±SK&F38393 into the 
ventral pallidal area elicited oro-facial dyskinesia, which was quantified in terms of 
numbers of tongue protrusions. The results show that the dose-effect curve was bell-
shaped (1.0, 1.75, 2.5, 5.0 t^g/O.S /Л ±SK&F38393). The oro-facial dyskinesia elicited 
by ±SK&F38393 was highly comparable to the oro-facial dyskinesia elicited by injections 
of the GABA antagonist Picrotoxin or the acetylcholine agonist carbachol into the sub­
commissural part of the globus pallidus. Secondly, the inactive enantiomer of 
SK&F38393, i.e. S(-)SK&F38393, was found to be ineffective in eliciting oro-facial 
dyskinesia when injected in a dose equivalent to fifty per cent of the most effective dose 
of the racemic mixture of ±SK&F38393. Furthermore, the effect elicited by 2.5 /xg/0.5 
μΐ ±SK&F38393 was significantly attenuated by local injection of the D, antagonist 
R(-I-)SCH23390 in a dose which had no effect itself (1.0 μgτ/0.5 μΐ). These findings 
indicate that the effects elicited by ±SK&F38393 are D,-specific. The present results thus 
clearly indicate that dopamine D, receptors within the sub-commissural part of the globus 
pallidus are involved in mediating oro-facial dyskinesia in cats. 
5.2 INTRODUCTION 
Tardive dyskinesia is a syndrome which can consist of abnormal involuntary movements 
of the limbs and trunk, although its primary symptoms usually involve the "bucco-
-linguo-masticatory triad". The latter is also referred to as oro-facial dyskinesia (Scho-
necker, 1957; Waddington, 1989). 
Oro-facial dyskinesia is considered to be one of the most severe side-effects of a chronic 
treatment with neuroleptics or L-DOPA, although it has also been described in non-
treated elderly people (for review: Waddington, 1989). Because the main characteristic of 
neuroleptics is to block dopamine receptors and because of the fact that L-DOPA is a 
precursor of dopamine, it has been hypothesized that oro-facial dyskinesia is due, at least 
in part, to alterations in dopaminergic systems (Klawans et al., 1980). However, the 
notion that it merely reflects supersensitivity of dopamine receptors is no longer tenable 
(Cools, 1983; Fibiger and Lloyd, 1984; Waddington, 1985). 
Recently, it has been suggested that a specific subset of dopamine receptors is involved in 
mediating oro-facial dyskinesia, i.e. the dopamine D, receptor (Rosengarten et al., 1983; 
Rosengarten et al., 1986). The neuroanatomical substrate involved in the generation of 
these behaviours remains to be elucidated, although drugs acting on the dopamine D, 
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receptor are thought to have their site of action within striatal structures (Koshikawa et 
al., 1989). However, the distribution of dopamine D, receptors is not limited to these 
structures but also extends to output stations of striatal structures, among others (Altar 
and Hauser, 1987; Beckstead, 1988; Beckstead et al., 1988; Besson et al., 1988). 
In the cat, oro-facial dyskinesia can be elicited from a circumscribed subregion of the 
caudate nucleus, i.e. the anterodorsal part of this nucleus (r-CRM), as well as from its 
first order output station, i.e. the sub-commissural part of the globus pallidus (Cools et 
al., 1976; Cools et al., 1989a,b; Spooren et al., 1989). The latter has been found to play 
a crucial role in the generation and/or mediation of oro-facial dyskinesia (Spooren et al., 
1991a). The involvement of dopamine in the feline oro-facial dyskinesia is well es-
tablished, but the role of the dopamine D, receptor has not yet been evaluated (Cools et 
al., 1976; Spooren et al., 1991a). 
Given the above mentioned importance of the sub-commissural part of the globus pallidus 
in eliciting and/or mediating oro-facial dyskinesia in cats together with the recent finding 
that relatively high numbers of D, receptors are present in the ventral pallidal territory 
encompassing the sub-commissural part of the globus pallidus (Beckstead, 1988; Besson 
et al., 1988), it was decided to investigate whether dopamine D, receptors within the sub-
commissural part of the globus pallidus are involved in oro-facial dyskinesia. 
The aim of the present investigation was 2-fold. 
(1) a qualitative and quantitative analysis of oro-facial dyskinesia-like effects elicited by 
local injections of the D, agonist (±)SK&F38393 into the sub-commissural part of the 
globus pallidus and, in addition, a post hoc comparison of these effects with the oro-facial 
dyskinetic syndrome elicited by injections of Picrotoxin and carbachol into the sub-
commissural part of the globus pallidus, and (2) analysis of the receptor specificity of 
these effects by studying (a) the effects of the inactive enantiomer of SK&F38393, i.e. S(-
)SK&F38393, and (b) the ability of the D! antagonist SCH23390 to antagonize these 
SK&F-induced effects. 
5.3 MATERIALS AND METHODS 
Subjects and surgical procedures 
Male cats (N=33; Animal Laboratory, University of Nijmegen) weighing 3.4 - 6.3 kg were used. Each group, 
composed of 7 or 8 cats, was housed m a cage (2x3x2 meter) with water and food (Hope Farm) available ad 
libitum. Under deep anaesthesia (40 mg/kg pentobarbital, intra-pentoneally; Apharmo, Arnhem, the Netherlands) 
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the animals were stereotaxically equipped with stainless steel guide cannulas (inner diameter and outer diameter 
O.SS and 0.8 mm, respectively) aimed at the subcommissural part of the globus palhdus (coordinates A 15.0, L 
5.Э, H -2.5, aL 7° and aP 5°; according to Snider and Niemer, 1964; Cools et al., 1976). In order to avoid 
unnecessary damage to the target site, the cannulas were placed 2 mm above the target region. 
Apparatus 
Cats were tested in a soundproof observation cage (90x60x60 cm) with a plexiglas front panel. The cage was 
equipped with two ventilators which produced a constant background noise. 
Experimental procedures 
After recovering from the operation for a minimum of 3 days, the cats were placed in the observation cage to 
habituate them to the cage and to the experimental procedures (see below; each cat 3x1 h sessions on successive 
days). During the last habituation session the cats received a bilateral 'dummy* injection. The experiments 
started after a minimum penod of 7 days following the operation. 
After a 15-min rehabituation to the observation cage, the experiment was started with a pre-injection period of 15 
mm followed by the bilateral injections and a post-injection penod of 45 mm. When cats received two sets of 
injections ( see below), the first set of bilateral injections was given 3 mm before the end of the pre-injection 
penod followed by the second set of injections at the end of this period. The animals' behaviour during the pre-
and post-injection period was recorded with the help of a closed TV-circuit and stored on videotape. The tapes 
were used by the experimenter to evaluate the oro-facial behaviour and to count the number of tongue 
protrusions which are known to signal the end of an attack of oro-facial dyskinesia (Cools et al., 1989a,b; 
Spooren et al., 1989, Spooren et al., 1991a). All injections were given with the help of a Hamilton synnge 
(sharpened tip). The needle was lowered 2 mm below the end of the cannula in order to reach the chosen target 
site (see above). The injection itself lasted 10 seconds and the needle was kept in place for another 10 seconds. 
The pre-injection period was used to discard animals that displayed abnormal tongue protrusions as a 
consequence of previous treatments. Since this only occurred in cats that had received more than six treatments, 
the total number of treatments was limited to six (Cools et al., 1989a). 
Four cats were found to be unable to habituate to the experimental cage. Their results were not evaluated. 
Experiment 1: In this experiment two groups of cats were used. 
The first group of cats (N—7) received bilateral injections of the solvent (distilled water) and the D, agonist 
SK&F38393 (racemic mixture; Research Biochemical Inc., Natick, USA) in the doses 5 0, 2.5, 1.0 and 1 75 fig, 
respectively. 
Apart from the first drug test (5.0 μ% ±SK&F38393), the animals were not drug-naive in the remaining 
experiments. To control for any possible priming effect of SK&F38393 a second group of cats received 
injections of solvent and ±SK&F38393 (respectively) in the doses 1.75 (N=8) or 2 5 (N=4) pg. The results of 
both groups were evaluated qualitatively and quantitatively and compared with each other. Videotapes from 
previous experiments, in which the oro-facial dyskinesia elicited by injections of Picrotoxin and carbachol into 
the sub-commissural part of the globus pallidus was investigated, were re-analysed to compare the effects with 
those elicited by SK&F38393 (Cools et al., 1989a; Spooren et al , 1989). 
Expenment 2° In this experiment the D, specificity of the ±SK&F38393 induced effects was investigated in two 
ways: 
A) one group of cats (N=7) received solvent injections and injections of S(-)SK&F38393. S(-)SK&F38393 was 
injected in a dose equivalent to fifty per cent of the most effective dose of the racemic mixture of SK&F38393 
(experiment 1). The latter was chosen on the basis of the fact that this dose reflects the amount of S(-)SK&F-
38393 present in the racemic mixture. 
B) Another group of cats (N=7) received two sets of injections in each experiment (see above): Solvent 
injections or injections of the D, antagonist R(+)SCH23390 (first injection; Research Biochemical Inc., Natick, 
USA) followed three minutes later by injection of the solvent or D, agonist SK&F38393 (second injection). For 
this purpose the most effective dose of ±SK&F38393 found in experiment 1 was selected The dose of 
R(+)SCH23390, i.e. 1 pg, was chosen since pilot studies had revealed that it had no effect when injected alone. 
All drugs were dissolved in sterile distilled water (NPBI, The Netherlands) and injected in a volume of 0.5 μΐ 
per side. 
Histological evaluation 
At the end of the experiments the cats were deeply anaesthetized with pentobarbital (60 mg/kg, intra-pentoneal-
ly, Apharmo, Arnhem, the Netherlands) and transcardially perfused with saline followed by a 4% para­
formaldehyde solution The brains were removed and subsequently cut on a cryostat in sections of 30 μπι. The 
sections were stained with cresyl violet in order to estimate the location of the injection site. 
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Statistics 
Wilcoxon matched-pairs signed-ranks test and the Mann-Whitney U test (where necessary) were used for 
statistical analysis. 
5.4 RESULTS 
Histological data 
Histological verification revealed that the injections were correctly placed within the 
target region (A 13.0 - 15.5; L 5.3 - 8.0; H 0.0 - -3.0, according Snider and Niemer 
1964), which encompasses the sub-commissural part of the globus pallidus and regions 
just caudal to the sub-commissural part of the globus pallidus, i.e. the dorsal extended 
amygdala as defined by Alheid and Heimer (1988; see also Spooren et al. 1991b). For an 
exact delineation of the target region see Cools et al. (1989b). 
Experiment 1: 
Dyskinetic movements 
±SK&F38393 locally injected into the sub-commissural part of the globus pallidus 
elicited a full blown oro-facial dyskinetic syndrome which consisted of sudden attacks of 
tic-like contractions involving the ear, eyelid and cheek which were accompanied by 
abnormal tongue protrusions. A comparison of the oro-facial dyskinesia elicited by 
injection of ±SK&F38393 and picrotoxin or carbachol into the sub-commissural part of 
the globus pallidus revealed that there were no differences in the general morphology of 
the oro-facial dyskinesia: the various groups of muscles affected, the involuntary and 
abnormal nature of the movements as well as the varying occurrence of oro-facial 
dyskinetic attacks in time were found to be identical. However it has to be noted that the 
oro-facial dyskinesia induced by ±SK&F38393 was less intense and less vigorous than 
that elicited by picrotoxin or carbachol, but this observation could not be quantified in 
view of the lack of an objective and adequate variable. 
It has been found previously that tongue protrusions signal the end of each dyskinetic 
attack and that the number of tongue protrusions corresponds well with the progression of 
the syndrome as a whole (Cools et al., 1989a,b; Spooren et al., 1989; Spooren et al., 
1991a). Therefore, the number of tongue protrusions was taken as the dependent variable 
in the present study. 
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Quantitative effects of ±SK&F38393 
Bilateral injections of ±SK&F38393 induced oro-facial dyskinesia in both groups of 
animals, i.e. drug-naive and drug-pretreated cats (see Materials and methods). Since the 
efficacy of the different doses of ±SK&F38393 (1.75 and 2.5 ¿ig/0.5 μΐ) in eliciting oro­
facial dyskinesia in both groups was comparable (no significant differences), as quantified 
by the number of tongue protrusions (1.75 μ% elicited an increase of 6 vs 9 tongue 
protrusions (median value) in drug-naive and drug-pretreated cats, respectively; 2.5 /ig 
elicited an increase of 27.5 vs 29 tongue protrusions (median value) in drug-naive and 
drug-pretreated cats, respectively), the data of these animals were combined (fig. 1A). 
The most effective dose was 2.5 /tg/0.5 /il whereas a dose twice as high (5.0 μg) lost its 
efficacy; a bell shaped dose response relation was found. 
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Fig. 1 A) Median value of the Dumber of tongue protrusions in 45 minutes following bilateral injections of 
±SK<SF38393 in the doses 0, 1.0, 1.75, 2.5 and 5.0 Mg/O.S μΐ. В) median value of the number of tongue 
protrusions in 45 minutes following bilateral injections of solvent/2.5 /ig ±SK&F38393 and 1.0 /ig SCH-
233390/2.5 μι ±SK&F38393. 
Experiment 2: 
D, specificity 
The effects elicited by S(-)SK&F38393 are outlined in table I. 
S(-)SK&F38393 (1.25 /ig/O.S μι) injected into the sub-commissural part of the globus 
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pallidus induced no oro-facial dyskinesia: there were no significant differences between 
the solvent and S(-)SK&F38393 treated cats. 
As is shown in fig. IB, 2.5 μg ±SK&F38393 induced a significant increase in the 
number of tongue protrusions, an effect which in turn was significantly antagonized by 
R(+)SCH23390 i.e. a highly selective D, antagonist, in a dose which had no effect when 
injected alone (1.0 μ|/0.5 μΐ; not shown). 
Although the absolute number of tongue protrusions elicited by 2.5 μg ±SK&F38393 in 
experiment 2 was higher than that found in experiment 1, the actual increase in the 
number of tongue protrusions between both sets of experiments was not significantly 
different (exp. 2: increase of 33 tongue protrusions (median value); for exp. 1 see above). 
Table I Effects elicited by S(-)SK&F38393 
Treatment η dose tongue protrusions 
Oig) (median value) 
H 20 7 - 17 
S(-)SK&F38393 7 1.25 7 
5.5 DISCUSSION 
The present study has two findings. Firstly, the D, agonist ±SK&F38393 elicits oro­
facial dyskinesia when injected into the sub-commissural part of the globus pallidus. 
Given that there were no significant differences in the efficacy of 1.75 and 2.5 /ig/0.5 μϊ 
±SK&F38393 in drug-naive and drug-pretreated cats, as quantified by the number of 
tongue protrusions, the data were combined. A bell shaped dose-response relation was 
found. 
±SK&F38393 and Picrotoxin or carbachol injected into the sub-commissural part of the 
globus pallidus elicited a highly comparable orofacial dyskinesia. This finding suggests 
that these drugs might act on a common substrate. It has previously been found that the 
cholinergic effects are mediated via GABAergic mechanisms and not vice versa (Spooren 
et al., 1989). To what extent the Di effects, as outlined in the present study, are mediated 
via cholinergic or GABAergic mechanisms remains to be elucidated (see below). 
Secondly, the inactive enantiomer of SK&F38393, S(-)SK&F38393, was ineffective in 
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eliciting oro-facial dyskinesia. Moreover, R(-t-)SCH23390, i.e. a highly specific D, 
antagonist, in a dose which had no effect when injected alone, significantly attenuated the 
effect elicited by 2.5 /ig/0.5 μ\ ±SK&F38393, as quantified by the number of tongue 
protrusions. These data clearly indicate that the behavioural effects were D^specific. At 
present, two alternative sites of action can be postulated. 
Recent anatomical evidence suggests that the A8, A9 and AIO cell groups contribute to 
the innervation of the ventral pallidal area (Lindvall and Bjorklund, 1979; Voom et al., 
1986; Deutch et al., 1988; Smith et al., 1989). This innervation is suggested to be sparse 
but widespread. Thus SK&F38393 might have affected post-synaptic terminals of one of 
these dopaminergic afférents. 
However, it is known that dopamine D, receptors are also located on the terminals of the 
striatal projection neurones (Aiso et al., 1987; Altar and Hauser, 1987; Beckstead, 1988; 
Beckstead et al., 1988; Besson et al., 1988; Richfield et al., 1987). Thus SK&F38393 
might also have affected these presynaptic dopamine receptors. Two independent studies 
have indeed suggested a functional role for these pre-synaptic receptors. In one report it 
is suggested that these receptors are involved in the axonal excitability of striatal 
projection neurones (Ryan et al., 1989), whereas in the other study it is suggested that 
they are involved in the regulation of the state of phosphorylation of synapsin I and 
protein III, two synaptic vesicle-associated proteins, and thus in the regulation of 
neurotransmitter release (Walaas et al., 1989). It is unclear whether these different 
findings reflect one and the same phenomenon measured at a different level, i.e. elect-
rophysiologically and biochemically, respectively. 
The present investigation shows that a behaviour which is thought to be elicited by drugs 
stimulating dopamine Di receptors located within striatal structures can also be elicited by 
stimulation of similar receptors located outside striatal structures. Thus it could be 
suggested that behavioural effects elicited by systemically given dopaminergic drugs might 
not only (or not at all) be mediated by striatal dopamine D, receptors but also (or espe-
cially) by receptors located outside the striatum (Ryan et al., 1989; Walaas et al., 1989; 
this study). 
Given the interaction of dopamine D, receptors with dopamine D2 receptors within the 
striatum of the rat in oral behaviour the question is raised whether these receptors may 
also interact within the ventral pallidal area (Koshikawa et al. 1989). However, since it 
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has been shown that dopamine D2 receptors in the feline ventral pallidal area are not 
detectable (Beckstead et al. 1988), such an interaction will probably not play a role in the 
induction of oro-facial dyskinesia in this area. 
The present findings are in general agreement with findings reported in the literature 
suggesting that dopamine D, receptors are involved in eliciting oro-facial dyskinesia 
(Rosengarten et al., 1983; Rosengarten et al., 1986; Koshikawa et al., 1989). However, 
to our knowledge no data have been presented so far showing the involvement of these 
receptors located in the sub-commissural part of the globus pallidus/(ventral) pallidal area 
in oro-facial dyskinesia. 
In summary, the present study clearly indicates that dopamine D, receptors within the 
target region of the ventral pallidal area, as defined by Cools et al. (1989b), are involved 
in mediating oro-facial dyskinesia in cats. 
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PART Π: ANIMAL RESEARCH 
CHAPTER б 
EFFERENT CONNECTIONS OF THE STRIATOPALLIDAL AND AMYGDALOID 
COMPONENTS OF THE SUBSTANTIA INNOMINATA IN THE CAT: 
PROJECTIONS TO 
THE NUCLEUS ACCUMBENS AND CAUDATE NUCLEUS 
Published in: Neuroscience 44 (1991) 431-447 
81 
6.1 ABSTRACT 
Enkephalin immunoreactivity is used to divide the feline substantia innominata into 
circumscript subregions, i.e. the "striatopallidal system" and the "extended amygdala". 
In addition enkephalin immunoreactivity is used to subdivide the "striatopallidal system" 
into two distinct areas i.e. the subcommissural part of the globus pallidus displaying high 
enkephalin immunoreactivity and the ventral pallidum displaying moderate enkephalin 
immunoreactivity. The anterograde axonal transport of Phaseolus vulgaris-leucoapplutinin 
(PHA-L) is used to study the efferents of these areas innervating the caudate nucleus and 
the nucleus accumbens. It is found that the enkephalin immunoreactive subcommissural 
part of the globus pallidus as well as the dorsal enkephalin-immunoreactive regions of the 
"extended amygdala" project topographically along a rostro-caudal and medio-lateral 
dimension to the nucleus accumbens. The far rostral parts of the caudate nucleus is found 
to be innervated by the subcommissural part of the globus pallidus whereas the "extended 
amygdala" has no such connection. This pathway is also found to be topographically 
organized along a medio-lateral dimension. The поп-enkephalin immunoreactive area 
ventral and lateral to the subcommissural part of the globus pallidus is found to have no 
projections to the nucleus accumbens and caudate nucleus. This region rather innervates 
the olfactory tubercle. In contrast to the "striatopallidal system" the sublenticular part of 
the "extended amygdala" preferentially projects to the adjoining part of the "extended 
amygdala", i.e. the bed nucleus of the stria terminalis. However, the ventral regions 
preferentially innervate the medial division of the bed nucleus of the stria terminalis 
whereas the dorsal regions preferentially innervate the lateral division of the bed nucleus 
of the stria terminalis. These data indicate that the differential forebrain systems 
represented in the feline substantia innominata i.e. the "striatopallidal system" and 
"extended amygdala" have differential output stations. The results are discussed in view 
of the role of the scGP and the nucleus accumbens in respectively oro-facial dyskinesia 
and schizophrenia. 
6.2 INTRODUCTION 
The substantia innominata is an ill-defined area within the basal forebrain generally 
bounded by the nucleus accumbens rostrally, the anterior commissure dorsally, the 
amygdaloid complex ventrolaterally, the ventral surface of the brain or the olfactory 
tubercle ventrally and the septum and preoptic area medially (Russchen et al., 1985). It 
appears as a rather homogeneous area in cresylviolet stained sections but 
compartmentalization becomes apparent when using immunohistochemistry (Switzer et al., 
1982; Haber and Nauta, 1983; Groenewegen and Russchen, 1984; Russchen et al., 1985; 
Heimer et al., 1987; Alheid and Heimer, 1988; Haber et al., 1990). 
Several components of basal forebrain systems seem to be represented in the substantia 
innominata (Heimer and Wilson, 1975; de Olmos et al., 1985; for review see: Alheid and 
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Heimer (1988)). As such, it has been proposed that the rostral portion of the dorsal 
substantia innominata is occupied by a rostroventral extension of the pallidal complex, i.e. 
"the striatopallidal system" (Heimer and Wilson, 1975; Switzer et al., 1982; Haber et al., 
1983; Alheid and Heimer, 1988). Caudal to the "striatopallidal system" and ventral to 
the globus pallidus i.e. the sublenticular substantia innominata, an area is delineated 
sharing many characteristics with the central and medial amygdala i.e. the "extended 
amygdala" (de Olmos et al., 1985; Alheid and Heimer, 1988; Grove, 1988). Dispersed 
within these two systems islands of cortical projection neurons are found belonging to the 
"magnocellular corticopetal system" (Alheid and Heimer, 1988). 
In cats and in primates at least two different areas can be delineated within the "striato­
pallidal system" ventral to the anterior commissure on the basis of the differential 
distribution of enkephalin (ENK) and substance Ρ (SUB-P) immunoreactivity: an area 
immediately ventral to the anterior commissure displaying high ENK-immunoreactivity 
and moderate SUB-P immunoreactivity which has been called the sub-commissural part of 
the globus pallidus (scGP) and an area ventromedial to the scGP displaying moderate 
ENK-immunoreactivity and high SUB-P-immunoreactivity which has been called the 
ventral pallidum (VP; Groenewegen and Russchen, 1984; Haber et al., 1990a,b). Apart 
from the differential immunohistochemical characteristics differences between the scGP 
and VP can also be found in afferent connections, such as from the nucleus accumbens 
(Troiano and Siegel, 1978; Groenewegen and Russchen, 1984; Russchen et al., 1985; 
Haber et al., 1990a,b). From a functional point of view our knowledge about the scGP 
and VP is very limited. Recently we collected evidence that the feline scGP is involved in 
funneling striatally induced oro-facial dyskinesia, i.e. a syndrome of involuntary persistent 
movements of predominantly the oral region (Cools et al., 1975; 1989a,b; Spooren et al., 
1991; cf. Sigwald et al., 1959; Klawans et al., 1980). In analogy of the striato-nigro-
collicular pathway it has been hypothetized that the scGP on its tum funnels the above 
mentioned effects towards lower brain structures (Cools et al., 1989a; Spooren et al., 
1991). In order to study the efferent connections of the scGP and adjoining areas we 
employed the anterograde tracer Phaseolus vulgaris - leuco agglutinin technique (PHA-L; 
Gerfen and Sawchenko, 1984). In the course of this study an extensive ascending 
projection innervating the striatum was noticed. Since this connection, especially in the 
cat, received little attention up to now, it is studied in more detail. 
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6.3 MATERIALS AND METHODS 
Subjects and surgical procedures 
Male cats (n=9; Animal Laboratory, University of Nijmegen) weighing 3.5 - 5.2 kg were used Under deep 
anesthesia (pentobarbital 40 mg/kg, intra-pentoneally; Apharmo, Arnhem, The Netherlands) Phaseolus vuleans -
leuco agglutinin (PHA-L) (Vector laboratories, Burhngame, USA, 25 μί/μ\) dissolved in 50 nM Tns-buffered 
saline (TBS; pH 7,4) was lontophoretically injected into various parts of the basal forebrain. The injections were 
made through glass micropipettes (tip diameter 10 - 25 /im) using a positive pulsed 10 - 12.5 μΑ DC current (7 
sec. on 7 sec. off) for 25-45 minutes. 
Fourteen to seventeen days after surgery, the cats were deeply reanesthetized with pentobarbital (60 mg/kg, 
intra-pentoneally) and transcardially perfused at a constant hydrostatic pressure with 500 ml normal salme 
(20'С; pH 7.0), immediately followed by 2000 ml buffered fixative containing 4% paraformaldehyde, 0 05% 
glularaldehyde in 0.1% phosphate buffer, pH 7.4 at 4°C. Following perfusion the animals were tightly packed in 
ice and were kept in this position for at least 90 minutes after which the brains were removed. Pilot studies 
revealed that the latter procedure resulted in a better fixation of the brain than in cases in which the brain was 
removed immediately following the perfusion. 
Subsequently, the brain was post-fixed overnight in fixative at 4°C and then stored in a 0 1 M phosphate buffer 
(pH 7.4) containing 30% sucrose at 4°C until they sank Then the brains were sectioned at a thickness of 50 pm 
on a freezing microtome. Following sectioning free floating sections (2 adjoining sections out of every 5 or 10) 
were incubated according to a standard PHA-L immunohistochemical procedure described below. 
PHA-L immunohistochemistry 
Following three rinses in 0.05 M Tris - buffered saline (TBS-T; pH 7.6) with 0.5% Triton X-100 (Sigma, St. 
Louis, USA), the sections were incubated overnight under continuous gentle agitation ш a biotinylated antiserum 
against PHA-L (biotinylated goat anti-PHA-L; Vector Laboratories, Burlingame, USA, diluted 1:2000 in TBS-T) 
at 20*C. 
Following three nnses of at least 15 minutes each in TBS-T, the sections were incubated with Vectastain* ABC 
Kit (Vector Laboratories, Burlingame, USA; PK-4000 dilution 1 8000) in TBS-T in the presence of 0 1 % bovine 
serum albumine (BSA) for 90 minutes at 20°C. Subsequently, the sections were rinsed in TBS-T (as descnbed 
above) and Tns buffer (0.05 M Tris pH 7.6). Following these rinses the sections were pre-incubated in 0.05 M 
Tns buffer (pH 7.6) containing 0.02% 3,3'- diamino benzidine tetrahydrohlonde (DAB, Sigma) and 0.6% nickel 
ammoniumsulfate (Fluka; Buch Switzerland) and subsequently reacted in the presence of H,02 (0.015%). The 
reaction was terminated by rinsing several times in Tns buffered saline. The sections were then mounted on 
glass slides and dned. Finally, alternate sections were directly dehydrated through ethanol and xylene and 
coverslipped with Entellan (Merck, Darmstadt, FRG), whereas other sections were first counterstained with 
cresylviolet before dehydrating and coverslipping. 
Leu-enkephalin immunohistochemistry 
The brains of two cats were immunostained for leu-enkephalin (leu-ENK) as descnbed before (Groenewegen and 
Russchen, 1984; cf. Buys et al , 1978). 
6.4 RESULTS 
Enkephalin immunoreactivity 
The distribution of the enkephalin immunoreactive fibers (ENK) in the substantia 
innominata complex and bordering structures, as revealed in the present study, is highly 
comparable with the results of other studies (fig la-5a; Berman and Jones, 1982; 
Groenewegen and Russchen, 1984; Sugimoto and Muzino, 1987). Briefly, the globus 
pallidus (GP) is recognized in these sections as a structure containing an extremely dense 
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plexus of highly ENK- immunoreactive "woolly fibers", a term introduced by Haber and 
Nauta (fig. 3a-5a; Haber and Nauta, 1983). An equally dense plexus extends rostrally 
from the globus pallidus and ventrally to the anterior commissure, forming the so-called 
sub-commissural part of the globus pallidus (scGP; fig. la and 2a). 
Rostrally and medio-ventrally to the scGP and ventral to the nucleus accumbens (ACB) a 
less dense but still easily recognisable area with moderate ENK-immunoreactivity can be 
identified, i.e. the so-called ventral pallidum (VP; Groenewegen and Russchen, 1984). 
The VP and scGP form part of the so-called "striatopallidal system" as introduced by 
Alheid and Heimer (1988). ENK-immunoreactivity in the form of "woolly fibers" invade 
also some parts of the olfactory tubercle (TU). Dorsally, immunoreactive fibers surround 
the inferior tip of the lateral ventricle (LV) and extend into the bed nucleus of the anterior 
commissure (ACN) as well as into the bed nucleus of the stria terminalis (BST; fig. 3a 
and 4a; Herman and Jones, 1982). More caudally, the moderate ENK- fiber plexus 
extends into the dorsomedial parts of the "extended amygdala", i.e. the area ventral to the 
globus pallidus as introduced by Alheid and Heimer, which forms a shell around the 
globus pallidus (Alheid and Heimer, 1988). The ventral parts of the "extended amygdala" 
display no or only very low levels of ENK-immunoreactivity (fig. la-5a). 
Injections of the anterograde tracer PHA-L have been made into the "striatopallidal 
system", the "extended amygdala" and abutting areas in order to investigate the efferent 
connections of these structures. 
Anterograde tracing experiments 
The results of seven injections into the above described regions will be presented: two 
injections into the ENK- immunoreactive "striatopallidal system" (one centromedially and 
one laterally in the scGP; fig. 2b and 2c), three injections into the "extended amygdala" 
(one dorsolaterally (a moderate ENK-immunoreactive area), one medially (a low ENK-
immunoreactive area) and one ventrally (an area with no ENK-immunoreactivity) respec-
tively fig. 4b, 3b and 5b). Finally, the results of two injections outside the "striatopallidal 
system" and "extended amygdala" will be presented (one injection ventrolateral to the 
scGP and one dorsal injection into the ventral putamen). 
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PHA-L injections into the striatopallidal component 
Injection into the medio-central part of the scGP: 
The injection site of PHA-L in cat 479 is located in the medial and central parts of the 
dense plexus of high ENK-immunoreactive ñbers immediately ventral to the commissure 
anterior i.e. the sub-commissural part of the globus pallidus (scGP; fig 2b). The injection 
track is completely free of labeled cells. The injection itself is large but compact and 
totally confined to the scGP. Many different types of labeled cellbodies are observed. One 
frequently observed type of cell is shown in fig. 10c. Varicose fibers are found around 
the injection site in the scGP but not in areas ventral or lateral/medial to the scGP nor in 
the "extended amygdala". A huge bundle of labeled fibers leaves the injection site in 
caudal direction innervating lateral hypothalamic, subthalamic and brainstem areas 
(chapter 7). 
Another bundle of labeled fibers ascends directly into the nucleus accumbens and/or 
caudate nucleus. Within the caudal nucleus accumbens some fibers become varicose 
whereas others traverse through these areas and become varicose within the rostral parts 
of the nucleus accumbens (fig. 6a-d;10a,b). These labeled fibers form a diagonal strip 
within the nucleus accumbens, arising in the far lateral comer just ventral to the anterior 
commissure and running in a dorsomedial direction towards the inferior tip of the lateral 
ventricle (fig. 6c and 6d). Characteristically, they almost completely avoid the medial 
nucleus accumbens (fig. 6a-d;10a). In continuity with the plexus of labeled fibers in the 
nucleus accumbens labeling is present in the ventral and medial parts of the caudate 
nucleus. Within the caudate nucleus the fibers form cluster-like patches against a more 
homogeneous background of labeling. Other parts of the basal forebrain such as the 
olfactory tubercle, the nucleus of the diagonal band of Broca and the bed nucleus of the 
stria terminalis are not labeled in this case. 
Injection into the lateral part of the scGP: 
The injection site of PHA-L in cat 453 is located laterally in the scGP (fig. 2a and 2c). 
The injection is small and compact and contains different types of labeled cells (see also 
previous case). In this case, some labeled cells are present along the injection track. 
Varicose fibers are found around the injection site but not ventral and lateral/medial to the 
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scGP nor in the "extended amygdala". Like in cat 479, a large bundle of labeled fibers 
runs in a caudal direction. In the rostral direction a bundle enters the nucleus accumbens 
directly. The greater part of these fibers become varicose within the far rostral areas of 
this nucleus especially along its lateral parts (fig. 7a and 7b). The central and medial parts 
of the nucleus accumbens are virtually free of PHA-L immunoreactive fibers. 
Some smooth non-varicose fibers are seen ascending through the nucleus accumbens and 
only become varicose after entering the caudate nucleus, innervating especially its lateral 
parts. This lateral zone is labeled all the way up to its most dorso-lateral tip. Again, the 
labeled area within the caudate nucleus is contiguous with the area labeled in the nucleus 
accumbens, forming one network of PHA-L immunoreactive fibers (fig. 7a and 7b). A 
few fibers are also found in the central parts of the caudate nucleus. Although single 
fibers can be observed within the olfactory tubercle as well as the diagonal band of Broca, 
the bed nucleus of the stria terminalis and the nucleus of the anterior commissure are not 
labeled in this case. 
PHA-L injections into the extended amygdala 
Dorsolateral injection: 
The injection of PHA-L in cat 347 is located immediately ventrolateral to the rostral parts 
of the globus pallidus (fig. 4b). This area contains moderate ENK-immunoreactivity (fig 
4a). Labeled fibers are found in the caudal regions of the nucleus accumbens but even 
more so in the bed nucleus of the stria terminalis. In the latter nucleus labeling is present 
in particular in the lateral division but some fibers are also present in the medial division. 
Many fibers are also seen in the bed nucleus of the anterior commissure (fig. 8a-c). Only 
a few single fibers are observed within the rostral parts of the nucleus accumbens. Hardly 
any fibers are found in the caudate nucleus. Many varicose fibers are found around the 
injection site as well as more rostrally in the low/moderate ENK-immunoreactive regions 
lateral to the scGP (fig. 8a,b). However, the sub-commissural part of the globus pallidus 
is virtually free of varicose fibers. Furthermore, many fibers are running in a region 
ventrally to the "striatopallidal system" (scGP and VP) and through the nucleus of the 
diagonal band of Broca and olfactory tubercle. These fibers occasionally show varico-
sities. 
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Medial injection: 
The injection of PHA-L in cat 405 is located ventromedially to the most rostral parts of 
the globus pallidus and lateral to the ventral pallidum in an area with relatively low ENK-
immunoreactivity (fig. 3a and 3b). Some fibers are running directly from the injection site 
towards the nucleus accumbens where they become varicose within the dorsolateral and 
ventrolateral parts (fig. 9a-c). However, the number of fibers found within the nucleus 
accumbens is relatively small compared to the more (rostro)-dorsal injections. No fibers 
are observed within the caudate nucleus but in contrast to all dorsal injections some fibers 
are found in the olfactory tubercle as well as in the diagonal band of Broca. Like in the 
previous case, many varicose fibers are found in the bed nucleus of the stria terminalis 
(the lateral division but not the medial division) and the nucleus of the anterior 
commissure. 
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Fig. 1-5 The distribution pattern of enkephalin immunoreactive fibers in the feline basal forebrain is shown in 
figs. la-Sa. The different injection sites of the anterograde tracer PHA-L are given in figs. Ib.c; 2b,c; 3b; 4b 
and Sb. 
Ventral injection: 
The injection of PHA-L in cat 316 is located in the ventral parts of the "extended 
amygdala" (fig. 5b). This area contains no ENK-immunoreactivity (fig. 5a). This case is 
our most caudal injection site and varicose fibers are observed in the olfactory tubercle 
and the nucleus of the diagonal band of Broca. Varicose fibers are also found in the bed 
nucleus of the stria terminalis (particularly in the medial division but also in the lateral 
division) and the bed nucleus of the anterior commissure. The caudate nucleus and the 
nucleus accumbens are free of labeled fibers. Finally, varicose fibers are found rostrally 
in the non-ENK immunoreactive regions ventral (and lateral) to the "striatopallidal 
system" (VP and scGP). 
PHA-L injections outside the striatopallidal and extended amygdala component 
rostroventral injection: 
The injection site in cat 3 is located in the non-ENK immunoreactive regions ventrolateral 
to the scGP and encompasses also dorsolateral parts of the olfactory tubercle (fig. 1c). 
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Many labeled varicose fibers are observed around the injection site, but also caudally in 
the ventral "extended amygdala". In this case scarse fibers are found within the nucleus 
accumbens. Very high densities of varicose fibers are found within the olfactory tubercle. 
Clusters of varicose fibers are also observed in and around the insulae of calleja. 
Furthermore, many fibers are found in the diagonal band of Broca (the horizontal part). 
Within the nucleus of the anterior commissure single fibers are found, whereas the bed 
nucleus of the stria terminalis is free of fibers. In cats 473 and 2, not described in the 
present report, the injection sites are smaller and more confined to the ventral regions. In 
these cases many fibers are found in the olfactory tubercle but not in the nucleus 
accumbens and/or caudate nucleus. 
rostrodorsal injection: 
The injection site in cat 492 is located ventrally in the putamen, immediately lateral to the 
internal capsula and also encompasses the utmost dorsal regions of the scGP (fig. lb). Al-
though some PHA-L is found along the injection track, it is free of labeled cell-bodies. 
Varicose fibers are found in the nucleus accumbens dorsolateral and ventromedial to the 
anterior commissure whereas other fibers penetrate directly the capsula intema and 
innervate the extreme lateral parts of the ventral caudate nucleus. Many varicose fibers 
are also found in the sub - and retro-commissural part of the globus pallidus. 
6.5 DISCUSSION 
Enkephalin inununoreactivity 
The distribution pattern of the enkephalin (ENK) immunoreactive fibers within the basal 
forebrain, as revealed in the present study, is in good agreement with previous reports 
dealing with this issue (Beckstead and Kersey, 1985; Groenewegen and Russchen, 1984; 
Sugimoto and Muzino, 1987). 
The peptidergic fibers have a ribbonlike appearance and are named "woolly fibers" 
(Haber and Nauta, 1983). It has been postulated that they represent striatal axons enshea-
ting dendrites of cells (Del Fiacco et al., 1982; Haber and Nauta, 1983). Furthermore, 
they form the basic elements of the dense immunoreactive plexus as present in the globus 
pallidus (fig. 3a, 4a and 5a; (Correa et al., 1981; Haber and Nauta, 1983; Groenewegen 
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and Russchen, 1984; Sugimoto and Muzino, 1987). In view of these and comparable find-
ings, it has been postulated that among other characteristics ENK-immunoreactivity might 
be an appropriate marker to label presumptive pallidal territory (peri-pallidal territory; 
Groenewegen and Russchen 1984; Russchen et al., 1985; Alheid and Heimer, 1988). In 
line with this hypothesis the dense and moderate plexuses present within the dorsal sub-
commissural substantia innominata of the cat have been referred to as the sub-commis-
sural part of the globus pallidus (scGP) and the ventral pallidum (VP) respectively (fig. 
2a; Groenewegen and Russchen, 1984). Both areas (scGP and VP) form a part of the 
"striatopallidal system" as introduced by Alheid and Heimer (1988). 
Caudal (and ventral) to the "striatopallidal system" an area is delineated that, as found in 
the rat, shares many characteristics with the central and medial amygdala and as such is 
called the "extended amygdala" (Alheid and Heimer, 1988). This area contains only 
dorsally some low/moderate ENK-immunoreactivity whereas ventrally it contains no 
ENK-immunoreactivity. 
Innervation of the caudate nucleus and the nucleus accumbens 
The present anterograde tracing study clearly shows that the strong ENK-immunoreactive 
scGP, innervates the nucleus accumbens and the caudate nucleus. Strikingly, the caudate 
nucleus seems to be almost exclusively innervated by the scGP and not by areas ventral 
and lateral to the scGP nor by the "extended amygdala". In contrast, the nucleus accum-
bens not only receives input from the scGP but also from the dorsal ENK-immunoreactive 
"extended amygdala". As such the ENK-immunoreactive dorsal "extended amygdala" 
shares some characteristics with the "striatopallidal system". However, it is important to 
stress that the densest networks of PHA-L immunoreactive fibers in the nucleus accum-
bens were found in cases 453 and 479 in which the injection sites were centered in the 
scGP proper. 
In a previous anterograde tracing study of the feline substantia innominata complex the 
peripallidal-striatal pathway, as outlined in the present study, has not been described 
(Troiano and Siegel, 1978). These apparently contradicting results can be explained by 
the fact that the latter study encompassed no dorsal injections whereas the peripallidal-
striatal pathway originates, as outlined above, exclusively from the ENK-immunoreactive 
scGP and dorsal ENK-immunoreactive "extended amygdala". 
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Fig. 6 The distribution pattern of PHA-L immunoreactive ñbers within the nucleus accumbens and caudate 
nucleus after an injection into the medial scGP (cat 479). For injection site see fig. 2b. 
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Fíe. 7 The distribution pattern of PHA-L immunoreactive fíbers within the nucleus accumbens and caudate 
nucleus after an injection into the lateral scGP (cat 453). For injection site see fig. 2c. 
Using the retrograde tracer HRP, Jayaraman clearly showed that the feline caudate 
nucleus is topographically innervated by peripallidal and pallidal cells (Jayaraman, 1983). 
Others have shown, using the fluorescent retrograde tracer Nuclear Yellow, that the head 
of the feline caudate nucleus is innervated by cells positioned within the dorsal substantia 
innominata complex (Fischer et al., 1983; Fischer et al., 1985; Fischer et al., 1988). 
Beckstead (1983) noticed in his study on the pallidostnatal pathway some HRP-positive 
neurons within the ventral pallidal territory after injections into the nucleus accumbens of 
the cat. Finally, in the rat it has been shown that the ventral striatum is innervated by 
neurons located in the ventral pallidum (Grove, 1988; Groenewegen, unpublished data). 
Taken together, our present findings confirm and extend the above mentioned retrograde 
and anterograde tracing studies. 
Innervation of the olfactory tubercle and the bed nucleus of the stria terminalis 
The present results indicate that the non-ENK immunoreactive region ventrolateral to the 
scGP preferentially innervates the olfactory tubercle rather than the nucleus accumbens. 
The ventral parts of the "extended amygdala" also projects to the olfactory tubercle. At 
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least in the rat and the hamster it is known that the rostro-ventral regions of the substantia 
innominata are mainly innervated by the olfactory tubercle whereas the dorsal regions are 
mainly innervated by the nucleus accumbens (Newman and Winans, 1980; Heimer et al., 
1987; Zahm, 1989). Although similar data are not available for the cat it can be pos-
tulated that the efferent connections of these parts of the basal forebrain reciprocates their 
input. 
Clear differences are found in the innervation of the medial and lateral parts of the bed 
nucleus of the stria terminalis by the dorsal and ventral parts of the "extended amygdala". 
The dorsal regions clearly innervate the lateral division whereas the ventral regions 
clearly innervate the medial division of the bed nucleus of the stria terminalis. These 
results are in agreement with findings in the rat and indeed nicely correspond with the 
input into these divisions by respectively the central and medial amygdaloid nuclei as 
discussed by Grove (1988; cf. Krettek and Price; 1978; de Olmos et al., 1985). Finally, 
our data suggest that the scGP proper sends no fibers into the bed nucleus of the stria ter-
minalis. These findings nicely correspond with the parcelation of the substantia in-
nominata introduced by Alheid and Heimer, since the scGP forms part of the "striato-
pallidal system" and not of the "extended amygdala" region (Alheid and Heimer, 1988). 
Topographic organization of the peripallidal-striatal pathway 
When comparing the results of cat 479 and 453 it is evident that the innervation of the 
nucleus accumbens and caudate nucleus by the scGP is topographically organized along a 
medio-lateral dimension. As far as the innervation of the nucleus accumbens is concerned, 
there is also evidence in favour of a topographic organization in the rostro-caudal 
dimension (compare cat 479, 405 and 347). The topographic innervation also extends 
caudally into the bed nuclei of the anterior commissure and of the stria terminalis. 
A topographic organization of the innervation of the caudate nucleus along the rostro-
caudal dimension is not clear. It is evident that the lateral injection (cat 453) into the 
scGP resulted in varicose fibers in the extreme rostral parts of the caudate nucleus and the 
nucleus accumbens. Following the medial injection (cat 479) the fibers were found more 
caudally in the caudate nucleus and nucleus accumbens. However, it is unclear to what 
extent this difference is also related to a more rostral respectively more caudal position of 
the injections into the scGP. 
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It has been clearly shown that the ENK-immunoreactive external segment of the globus 
pallidus innervates the body of the caudate nucleus topographically whereas the SUB-P 
immunoreactive entopeduncular nucleus (internal pallidal segment) has no such connection 
(Staines et al., 1981; Beckstead, 1983; Staines and Fibiger, 1984; Yun Shu and Peterson, 
1988). When considering the ENK-immunoreactive scGP as the most rostral part of the 
globus pallidus it is understandable that the scGP innervates the far rostral part of the 
caudate nucleus. This would suggest that the scGP forms an integral part of the external 
segment of the globus pallidus since the scGP not only resembles the globus pallidus in 
certain immunohistochemical characteristics, but also with respect to its (topographically 
organized) output to the striatum (Staines et al., 1981; Switzer et al., 1982; Groenewegen 
and Russchen, 1984; Staines and Fibiger, 1984; Beckstead and Kersey, 198S; Sugimoto 
and Muzino, 1987; Alheid and Heimer, 1988; Yun Su and Peterson, 1988). Finally, the 
present results indicate that the medial part of the nucleus accumbens is not innervated by 
the scGP nor by any other part of the basal forebrain investigated in the present study. In 
line with the above mentioned medio-lateral topography as well as in view of reciprocal 
connections (see below), it can be postulated that these medial regions will most probably 
be innervated by more medial regions of the "striatopallidal system", i.e. the feline 
ventral pallidum (VP; cf. Groenewegen and Russchen, 1984; Russchen et al., 1985). 
However, this remains to be verified, since we have not placed any injection in this area. 
Reciprocity 
It has been shown that the scGP is especially innervated by the central and lateral part of 
the nucleus accumbens (Groenewegen and Russchen, 1984). Taken together with the 
present findings, our data suggest that the latter area may be reciprocally connected with 
the scGP. However, whether the efferents of the scGP exactly innervate the area or the 
neurons of origin remains to be verified. In the case of the caudate nucleus reciprocity is 
less clear since the caudate afférents of the scGP have not been clearly defined yet. 
However, our data taken together with the findings reported in the literature suggest that 
at least part of the caudate area from where the scGP input originates is in tum innervated 
by the scGP, especially the medial parts of the far rostral caudate nucleus (Voneida, 
1960; Groenewegen and Russchen, 1984; Royce and Laine, 1984; Cools et al., 1989b). 
This kind of organization would agree with the general finding in the rat that areas 
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Fig. 8 Tbc distribution pattern of PHA-L immunoreactive fìbers within the caudate nucleus, nucleus accumbens 
and abut areas following an injection into the dorsal 'extended amygdala' (cat 347). For injection site see fig. 
4b. 
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Flg. 9 The distribution pattern of PHA-L immunoreactive fibers within the caudate nucleus and nucleus 
accumbens following an injection into the medial 'extended amygdala" (cat 405). For injection site see fig. 3b. 
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innervating the substantia innominata tend to be reciprocally connected with it (Grove 
1988a,b). However, additional evidence is also neccessary on this point. The more so, 
since no reciprocal connections have been observed in the present study between the 
anterodorsal part of the caudate nucleus and the scGP (Cools et al., 1989b; Cools et al., 
1975). 
Intrinsic connections 
Remarkable for all cases is the presence of varicose fibers around the injection site. These 
results confirm earlier findings in the rat (Grove, 1988). The intrinsic relationships 
however do not only involve the areas in the immediate vicinity. The data suggest that 
that rostral and caudal regions are interconnected. Furthermore, this interconnection 
seems to be organized in a somewhat layered manner: rostroventral to caudoventral (both 
non ENK-immunoreactive) and rostrodorsal to caudodorsal connections (both ENK-
immunoreactive; compare cat 347 with cat 316). However, injections into the scGP 
resulted in the presence of varicose fibers around the injection site only but not in the 
"extended amygdala" nor in areas ventrolateral or medial to the scGP. Furthermore, no 
varicose fibers are found in the scGP following injections outside the scGP. Two con-
clusions can be drawn on the basis of these results. Firstly, the "striatopallidal system" as 
well as the "extended amygdala" have strong intrinsic connections and secondly both 
systems are not interconnected. 
Comparison with other accumbens/caudate afférents 
The target neurons of the PHA-L immunoreactive fibers within the nucleus accumbens 
and caudate nucleus, labeled after injections into the scGP, are unknown. However, the 
distribution of fibers from the scGP, in particular to the central part of the nucleus 
accumbens continuous into the medial caudate nucleus (cat 479), is very comparable to 
the distribution of fibers from the parahippocampal area (perirhinal area), the amygdala 
(basolateral part) and the (pre - and infra) limbic cortex (Groenewegen et al., 1980; 1982; 
Kelley et al., 1982; Room et al., 1985; Witter and Groenewegen, 1986; Ragsdale and 
Graybiel, 1988). This suggests a convergence of inputs from limbic related structures (see 
above) and pallidal related structures within the nucleus accumbens/caudate nucleus. As 
such, this connectivity pattern suggests a strong limbic related role for the peri-
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Fig. 10 a. Representative picture of anterogradely labeled PHA-L immunoreactive fibers within the nucleus 
accumbens (cat 479). Note the elaborate distribution of PHA-L immunoreactive fibers within the central nucleus 
accumbens (ACBc) and the absence of these fibers within the medial nucleus accumbens (ACBm). b. 
Magnification of part (see box) of fig. 10a. c. Typical PHA-L immunoreactive cells labeled following an injec­
tion of PHA-L into "striatopallidal system". 
pallidal-striatal pathway (see below). Furthermore, the difference in the distribution of 
anterogradely transported PHA-L within the nucleus accumbens following injections into 
the lateral and medial scGP may reflect differences in the connectivity patterns of the 
medial and lateral scGP. It has been observed in the rat that the caudo-medial part of the 
nucleus accumbens is especially innervated by the paraventricular thalamic nucleus, 
ventral subiculum, and caudal basolateral amygdaloid nucleus whereas the rostro-lateral 
part of the nucleus accumbens, is innervated by the dorsal subiculum, the rostral 
basolateral amygdaloid nucleus and centromedial thalamic nuclei (Groenewegen et al., 
1990). Although similar findings in the cat are not yet available, it can be suggested that 
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subtle differences might also exist in the afferent input from the scGP. However, it is 
evident that more data are neccessary on this point. 
Functional implications 
It is important to indicate that the peripallidal-striatal pathway is one of several afferent 
systems of the striatum and that the functional implications may be manifold. However, 
some interesting suggestions can be made. 
Firstly, the anterodorsal caudate nucleus, i.e. a subregion of the caudate nucleus which is 
delineated on the basis of its susceptibility to the dopaminergic drugs DPI and er-
gometrine (r-CRM), is known to innervate the scGP (Cools et al., 1975; 1989b). In the 
present experiments we have not obtained any evidence that the r-CRM receives an input 
from the scGP, which implies a lack of direct functional feedback. Although an indirect 
pathway cannot be excluded (Kubozono et al., 1986; Fischer et al., 1988). this finding 
can be of significance for oro-facial dyskinesia, i.e. a syndrome selectively elicited from 
the r-CRM (Cools et al., 1975; 1989b; Spooren et al., 1991). Neural systems which 
receive no or only an indirect functional feedback might be less stable and are therefore 
more vulnerable for drugs. As such, a reduced functional feedback to sites involved in 
oral motor control, such as the r-CRM, might provide a neuro-anatomical explanation for 
the L-DOPA and neuroleptic induced dyskinesias (Sigwald et al., 1959; Klawans et al., 
1980; Cools et al., 1989a). 
Secondly, the nucleus accumbens itself as well as certain of its inputs such as the 
hippocampus and the dopaminergic afférents, have been implicated in the pathology of 
schizophrenia (Kovelman and Scheibel,· 1986; Bogerts et al., 1987; Bridge et al., 1987; 
Jeste and Lohr, 1989; Suddath et al., 1989; Ellenbroek and Cools, 1990; Swerdlow et al., 
1990). Although especially the latter input is thought to play a crucial role in the 
pathophysiology of schizophrenia, it can be hypothetized that certain symptoms of 
schizophrenia are related to a reduced functional feedback. Since pathological processes at 
this level will only indirectly involve dopaminergic processes, these patients should be 
difficult to treat with neuroleptic drugs, i.e. dopamine antagonists. Interestingly, a 
subgroup of schizophrenic patients with predominantly negative symptoms are indeed 
known to be poor responders to neuroleptic drugs (Waddington and Youssef, 1986). 
Furthermore, they have been found to have higher cognitive deficits compared to other 
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schizophrenics and they are predisposed to the development of oro-facial dyskinesia 
(Waddington and Youssef, 1986; Kaiser, 1989). The scGP is implicated to play a crucial 
role in both syndromes; oro-facial dyskinesia and cognitive deficits (Whitehouse et al., 
1982; Cools et al., 1989b). Therefore, it can be suggested that the presently outlined 
peripallidal-striatal pathway may be part of the neuroanatomical substrate that links the 
above mentioned syndromes. 
Thirdly, in the case that the peripallidal-striatal pathway originates from the islands of 
cells belonging to the "corticopetal magnocellular system", which are embedded into the 
"striatopallidal system" and "extended amygdala", this pathway is likely to be involved in 
mnemonic processes. Recently, the nucleus accumbens has been found to be involved in 
memory processes, especially processes in which retrieval of external cues are involved 
(Ploeger and Cools, 1990; Scheel-kniger et al., 1990). Although especially the hippocam­
pus is implicated in these functions, the pallidal-striatal pathway may contribute in these 
processes. The more so since the scGP has been found to project to the cingulate cortex 
which in tum is strongly interconnected with the hippocampus (Fischer et al., 1988; 
Musi! and Olson, 1988; Rouiller et al., 1990). 
Future combined neuro-anatomical and neuropharmacological research is required to 
investigate the mentioned hypotheses on the functional role of the peripallidal-striatal 
pathway. 
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¡sub-commissural part of the globus palhdus 
¡substance P-immunoreactivity 
¡stna terminalis 
¡stria terminalis, lateral division 
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7.1 ABSTRACT 
The stnatopallidal and amygdaloid components of the substantia innominata complex can 
be visualized using enkephalin immunoreactivity. The efferent connections of these 
components towards the mediodorsal thalamic nucleus, subthalamic nucleus, lateral 
hypothalamic area and midbrain were investigated in the cat, using Phaseolus vulgaris -
leucoagglutinin (PHA-L) as an anterograde label. The position of these efferents in the 
midbrain was compared with the distribution of somatostatin- and tyrosine hydroxylase-
like immunoreactivity. The results indicate that the highly enkephalin immunoreactive 
subcommissural part of the globus pallidus, which forms part of the stnatopallidal 
component projects to the (dorso)medial tip of the subthalamic nucleus and the adjoining 
lateral hypothalamic area. The extended amygdala preferentially projects to the lateral 
hypothalamic area. This pathway is topographically organized along a dorso-ventral 
dimension. Furthermore, the subcommissural part of the globus pallidus as well as the 
extended amygdala project to a specific region in the ventral mesencephalon lateral to the 
roots of the oculomotor nerve. This region is somatostatin- and tyrosine hydroxylase-
immunoreactive and encompasses AIO and A9 regions and is especially heavily labeled 
following injections into the subcommissural part of the globus pallidus. Subsequently, 
varicose fibers run through the substantia nigra pars compacta, towards a region in the 
supra-nigral tegmentum, i.e. the peripeduncular nucleus which is characterized by 
somatostatin- but not tyrosine-hydroxylase immunoreactivity. This region was labeled 
over its whole rostro-ventral and medio-lateral extent following injections into the dorsal 
parts of the extended amygdala. The peripeduncular nucleus is also innervated by the 
subcommissural part of the globus pallidus and by the ventral extended amygdala although 
to a much lesser degree. Ventrally, this output region slightly overlaps with the tyrosine 
hydroxylase immunoreactive retrorubral field (A8) but in general the latter area received 
no input from the stnatopallidal or from the amygdaloid components of the substantia 
innominata complex. 
In addition, the central gray as well as the "mesencephalic locomotor region" also receive 
an input from these parts of the brain. The "mesencephalic locomotor region" only was 
labeled with passing varicose fibers whereas in the central gray the varicose fibers 
appeared to terminate extensively. The latter area was strongly labeled especially 
following injections into the extended amygdala, mostly its ventrolateral and ventromedial 
parts. Finally, the mediodorsal thalamic nucleus receives a limited input from the striato-
pallidal (the sub-commissural part of the globus pallidus) and extended amygdala 
components of the substantia innominata complex in the cat. These results are discussed 
in view of the possible role of these output regions in oro-facial dyskinesia. 
7.2 INTRODUCTION 
The substantia innominata encompasses several components of basal forebrain systems 
(for review see: Alheid and Heimer (1988)). This compartmentalization becomes apparent 
when using immunohistochemistry for the peptides enkephalin (ENK) and/or substance-P 
(SUB-P; Switzer et al., 1982; Haber and Nauta, 1983; Groenewegen and Russchen, 1984; 
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Russchen et al., 1985). Basically, the area can be subdivided into three components 
(Alheid and Heimer, 1988): 
A) the striatopallidal component, i.e. a rostroventral extension of the globus pallidus 
which in turn can be sub-divided into at least two sub-regions, the sub-commissural part 
of the globus pallidus (scGP: high ENK- and low SUB-P immunoreactivity) and the 
ventral pallidum (VP: moderate ENK- and high SUB-P immunoreactivity; Groenewegen 
and Russchen, 1984; Russchen et al., 1985; Alheid and Heimer, 1988). B) the extended 
amygdala component (EA) which is located caudal to the scGP and ventral to the globus 
pallidus (Alheid and Heimer, 1988). This area shares many characteristics with the 
amygdala and can also be sub-divided into at least two subregions, i.e. a dorso(lateral) 
region (dEA) which is low/moderate ENK-immunoreactive and shares many 
characteristics with the central amygdaloid nucleus, and a ventral region (vEA) which dis-
plays no ENK-IR and shares many characteristics with the medial amygdaloid nucleus (de 
Olmos et al., 1985; Alheid and Heimer, 1988). C) The magnocellular-corticopetal 
component, which consists of dispersed islands of cortical projection neurons embedded in 
the striatopallidal and the extended amygdala regions (Alheid and heimer, 1988). This 
component may be compared with the nucleus basalis of Meynert in man. It has been 
shown that these components not only differ in their composition of neuropeptides but 
also in their connectivity patterns (Troiano and Siegel, 1978a,b; Groenewegen and 
Russchen, 1984; Russchen et al., 1985; Alheid and Heimer, 1988; Spooren et al., 
1991c). 
From a functional point of view little is known about the above delineated regions. 
However, previously we obtained evidence that the scGP and the regions caudal to the 
scGP, i.e. the dorsal parts of the extended amygdala (dEA), play a crucial role in 
mediating oro-facial dyskinesia (OFD). OFD is a syndrome of abnormal involuntary 
movements of predominantly the oral region, that can be elicited from the matrix enriched 
rostrodorsal part of the caudate nucleus (Cools et al., 1976; Spooren et al., 1991a). OFD 
can also be elicited from the scGP/dEA itself (Cools et al., 1989a,b; Spooren et al., 
1989; Spooren et al., 1991b). Along which pathways these effects are funneled towards 
lower output stations is not known. Moreover, the efferents of the scGP and extended 
amygdala in the cat are not well documented. In contrast, in the rat major neural outputs 
of the ventral pallidal territory are known to reach, among others, the mediodorsal 
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thalamic nucleus, the subthalamic nucleus, the lateral hypothalamus and ventral mesen­
cephalic regions as well as the mesencephalic locomotor region (Mogenson et al., 1983; 
Young et al., 1984; Swanson et al., 1984; Haber et al., 1985; Grove, 1988). Furthermo­
re, evidence is available that motor effects elicited from the ventral pallidal territory in 
rats are funneled via some of these output stations, especially the mediodorsal thalamic 
nucleus and the mesencephalic locomotor region (Mogenson et al., 1985; Swerdlow and 
Koob, 1987). For these reasons it was decided to study the efferents of the different 
components of the feline substantia innominata towards the above-mentioned areas by 
using Phaseolus vulgaris - leucoagglutinin (PHA-L; Gerfen and Sawchenko, 1984). Since 
the PHA-L immunoreactive fibers terminated in midbrain regions which could not be well 
delineated by cytoarchitectonic criteria alone, the termination patters were compared to 
the distri-bution of tyrosine hydroxylase- and somatostatin-immunoreactivity in these brain 
regions. 
7.3 MATERIALS AND METHODS 
Subjects and surgical procedures 
Male cats (n=12; Animal Laboratory, University of Nijmegen) weighing 3.5 - 5.2 kg were used. Under deep 
anesthesia (pentobarbital 40 mg/kg, intra-pentoneally, Apharmo, Arnhem, the Netherlands) Phaseolus vulgaris -
leucoagglutinin (PHA-L; Vector Laboratories, Burlingame, USA; 25 /ig/fil) dissolved in 50 nM Trie-buffered 
saline (TBS; pH 7,4) was lontophoretically injected into various parts of the basal forebrain. The injections were 
made through glass micropipettes (tip diameter 10 - 25 /im) using a positive pulsed 10 - 12 5 μΑ DC current (7 
sec. on 7 sec. off) for 25-45 minutes. 
Fourteen to seventeen days after surgery, the cats were reanesthetized with pentobarbital (60 mg/kg, intra-
pentoneally) and transcardially perfused at a constant hydrostatic pressure with 500 ml normal saline (20°C; pH 
7 0), immediately followed by 2000 ml buffered ñxative contaimng 4% paraformaldehyde, 0.05% glutaraldehyde 
in 0.1% phosphate buffer, pH 7.4 at 4°C. Following perfusion the animals were tightly packed in ice and were 
kept in this position for at least 90 minutes after which the brains were removed Pilot studies had revealed that 
the latter procedure resulted in a better fixation of the brain then in cases in which the brain was removed 
immediately following the perfusion. Subsequently, the brain was post-fixed overnight in fixative at 4°C and 
then stored in a 0.1 M phosphate buffer (pH 7.4) contaimng 30% sucrose at 4°C until they sank. Then the 
brains were sectioned at a thickness of 50 μτη on a freezing microtome. Following sectioning free floating 
sections (2 adjoining sections out of 5 or 10) were incubated according to the following standard PHA-L 
immunohistochemical procedure. 
PHA-L iramunohistochemistry 
Following three nnses in 0 05 M Tns - buffered saline (TBS; pH 7.6) with 0 5% Triton X-100 (TBS-T; Sigma, 
St. Louis, U S.A.), the sections were overnight incubated under continuous gentle agitation in a biotinylated 
antiserum against PHA-L (biotinylated goat anti-phaseolus-vulgaris; Vector Laboratories (Burlingame, (CA); 
diluted 1:2000 ш TBS-T) at 20°C. Following three nnses of at least 15 minutes each in TBS-T, the sections 
were incubated with Vectastain* ABC kit (Vector laboratories Burlingame (CA); PK-4000 dilution 1:8000) in 
TBS-T in the presence of 0.1% bovine serum albumine (BSA) for 90 minutes at 20oC. Subsequently, the 
sections were nnsed in TBS-T (as described above) and Tris buffer (0 05 M Tns; pH 7.6). Following these 
rinses the sections were pre-incubated in 0 05 M Tns buffer (pH 7.6) contaimng 0.02% 3,3'- diamino benzidine 
(DAB, Sigma) and 0 3% nickel ammoniumsulfate (Fluka; Buch; Switzerland) and subsequently reacted in the 
presence of Η 20 2 (0.015%). The reaction was terminated by nnsing several times in Tris HCL buffer. The 
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sections were then mounted on glass slides and dried. Finally, every second section was dehydrated through 
ethanol and xylene and coverslipped with Entellan (Merck, Darmstadt, FRG), whereas the remaining sections 
were first counterstained with Cresyl violet before dehydrating and coverslipping. 
Peptide-immunohistochemistry 
The brains of three cats were used to study the distribution of tyrosine hydroxylase-like immunoreactivity (TH-
IR; n=2) and somatostatin-like immunoreactivity (SOM-IR; n=2) in the mesencephalon. Brain sections of one 
cat were alternately processed for TH-IR and SOM-IR. The cats were perfused with 500 ml saline followed by 
2000 ml Somogyi fixative containing 4% paraformaldehyde, 0.05% glutaraldehyde and 0.2% picric acid in 0.1 
M phosphate buffer (pH 7.4). Following perfusion the cats were tightly packed in ice (see above) and remained 
in this position for at least 90 minutes. Subsequently, the brains were removed and the mesencephalon was 
dissected and postfixed for four hours in Somogyi fixative containing 20% sucrose. Then the brain tissue was 
transferred to a 20% sucrose solution in 0.1 M phosphate buffer (pH 7.4) until it sank. Coronal 50 jim sections 
were cut on a freezing microtome. Three out of five sections were rinsed in TBS (specification see above) and 
preincubated in a solution containing 1% normal rabbit serum (TH-IR) or 1% pig serum (SOM-IR), 0.05% 
bovine serum albumine and 0.05 M Triton in TBS (NRS). Thereafter, the sections were incubated overnight with 
mouse anti-TH (INCSTAR, Stillwater, Minnesota, USA) or with pig anti-somatostatin (INCSTAR, Stillwater, 
Minnesota, USA) in NRS at 20°C. Following three rinses in TBS (Эх 15 minutes) the sections were ther. 
incubated for 90 minutes in rabbit-anti-mouse Peroxidase Dakopats P260 (1:100; TH-IR) or swine anti-rabbr 
Peroxidase Dakopats 2109 (1:1000; SOM-IR) in TBS containing 0.05% B5A. Finally, the antigen-antibody 
complex was visualized using a standard DAB-nickel procedure (see above). Every second section was 
counterstained for cresylviolet. 
The basal forebrain of two cats were immunostained for Leu-enkephalin (ENK-IR) as described before (Spooren 
et al., 1991c; Groenewegen and Russchen, 19S4). 
7.4 RESULTS 
Tyrosine hydroxylase and somatostatin immunoreactivity 
Tyrosine hydroxylase immunoreactivity 
The area presently investigated with respect to TH-IR encompasses, among others, the 
A8, A9 and AIO regions that give rise to the main dopaminergic input into the limbic and 
striatal parts of the brain (Jiménez-Castellanos and Graybiel, 1987). A brief description 
will be presented from midline to lateral midbrain areas (fig. la-d). 
Rostrally on the midline, the nucleus linearis intermedius is located which continues 
caudally into the nucleus linearis rostralis. Ventrally and laterally the latter continuous 
into the ventral tegmental area (VTA; fig. la-b, 2c) surrounding the roots of the oculo-
motor nerve. The borders of the VTA are somewhat difficult to delineate since on both 
sides (laterally and dorsomedially) the cells are continuous with respectively the substantia 
nigra pars compacta and the midline dopaminergic cell-groups. 
Cell-group A9 consists of at least two subgroups as already outlined by Jimenez-
Castellanos and Graybiel (1987), i.e. the denzocellular zone (SNC(dz)), which is 
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Fig. 1 The distribution of tyrosine hydroxylase immunoreactivity (TH-IR) in the mesencephalon of the cat from 
rostral (a) to caudal areas (d). Arrows in figure la indicate the TH-IR cells of the rostral portion of the SNC(cs). 
characterized by a very dense packing of TH-IR positive cells and fibers (fig. la-c; 
depicted in detail in fig. 2b), and the cell-sparse region (SNC(cs)) which is localized 
rostral and dorsolateral to the SNC(dz) (depicted in detail in fig. 2a). The SNC(cs) is in 
fact located within the dorsal parts of the substantia nigra pars reticulata (SNR; fig. la, 
2a) although the ventral parts of the SNR contain many TH-IR positive dendrites and 
axons originating from the TH-IR positive cells of the SNC(cs) (fig. 2a). 
Finally, cell-group A8, also called the retrorubral field (RRF; Berman, 1968), is localized 
dorsal to the SNC(dz). Rostrally it extends between the latter and the nucleus ruber, 
caudally it is localized just caudal to the nucleus ruber (fig. Ic-d; Berman, 1968). 
No TH-IR is found in the mesencephalic locomotor region (MLR; fig. 3b-c), i.e. the 
ventral and lateral part of the cuneiform nucleus and its boundary with the brachium 
112 
Fie. 2 Details of the main tyrosine hydroxylase immunoreactive (TH-IR) regions of the mesencephalon. 
conjunctivum (Shik et al., 1966; Grillner, 1975; Jordan et al., 1979; Shefchyk et al., 
1984). The pedunculopontine nucleus (PPTN), which abuts rostrally the posterior dor-
solateral parts of the substantia nigra and continues posterodorsally into regions dorsal to 
the lateral portion of the brachium conjuctivum (for review see ref. 29), was also free of 
TH-IR. 
Somatostatin immunoreactivity 
Rostrally, SOM-IR cells and fibers are found ventral in the mesencephalon and lateral to 
the roots of the oculomotor nerve (fig. 2c; 3) covering the TH-IR positive lateral AIO 
region and the medial substantia nigra (fig. 3a). The labeled region extends into dorso-
lateral direction through the TH-IR positive dorsal substantia nigra towards the supra-
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Fig. 3 The distnbution of somatostatin-like immunoreactivity (SOM-IR) in the mesencephalon of the cat from 
rostral (a) to caudal areas (d). Dots represent SOM-IR cells and wavy lines represent SOM-IR fibers. 
nigral tegmentum. Here, SOM-IR forms a wedge shaped field "on top of" the substantia 
nigra (fig. 3b-c). This area corresponds closely with the peripeduncular nucleus (PP) as 
outlined by Taber (1961). The PP is labeled over a wide range in all dimensions (fig. 3c; 
depicted in detail in fig. 4a). A few SOM-IR positive fibers are also found in the medial 
lemniscus itself. The substantia nigra pars reticulata, the mesencephalic locomotor region 
and the pedunculopontine nucleus are virtually free of SOM-IR. 
Two other regions are also clearly labeled with SOM-IR fibers and cells, i.e. the inter-
peduncular nucleus (fig. 3a-d, 4b) and the mesencephalic central gray (fig. 3d). The latter 
is differentially labeled in its various regions. Rostrally the whole central gray is diffusely 
labeled with very fine SOM-IR positive fibers and occasionally a positive cell. At more 
caudal levels the ventrolateral and ventromedial parts of the central gray are intensely 
labeled with SOM-IR cells and fibers, which were also present in the dorsal raphe nuclei. 
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Fig. 4 Details of somatostatin-like immunoreactive (SOM-IR) fibers in the peripeduncular nucleus (fig. 4a) and 
interpeduncular area (4b). Note the distribution of the ultra-fine SOM-IR fibers in the peripedunular area (fig. 
4a). Thin arrows indicate SOM-IR fibers and thin arrows indicate SOM-IR cells. 
Overlap of TH- and SOM-IR 
A few areas are marked by both TH-IR as well as SOM-IR, i.e. the lateral VTA, medial 
SN region, the ventral part of the PP and the ventro-medial/lateral part of the central 
gray. 
Anterograde tracing study 
The results of 7 different injections in and outside the striatopallidal and amygdaloid 
components of the substantia innominata complex will be presented: Two injections into 
the striatopallidal component (one medial and one lateral injection into the scGP (resp. cat 
479 and 453)), three injections into the extended amygdala component (one dorsal 
injection, one intermediate injection and one ventral injection (resp. cat 347, 405 and 
316)) and two "control" injections outside the substantia innominata complex (one 
injection ventrolateral to the scGP (cat 3) and one injection into the ventral putamen (cat 
492)) in order to compare the descending substantia innominata projections with those of 
some adjoining areas. The exact location of the injection sites will be described using the 
distribution of ENK-IR which can be used as markers for the different components of the 
substantia innominata complex (see introduction). Firtly, the distribution of PHA-L 
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immunreactive fibers in the subthalamc nucleus/lateral hypothalamic area and midbrain-
regions will be described (A) which are innervated by a single bundle of descending 
fibers and then the distribution in the mediodorsal thalamic nucleus (B). 
A) Projections to the subthalamic nucleus, lateral hypothalamic area and midbrain 
PHA-L injections into the striatopallidal components 
Injection into the medial part of the scGP: 
Cat 479 received an injection of PHA-L into the medial region of the highly ENK-IR sub-
commissural part of the globus pallidus (scGP; fig. 5a-b). The injection is totally confined 
to the scGP with no leakage along the injection track. A large bundle of labeled fibers 
departs into a caudal direction, through the medial forebrain bundle. At the level of the 
subthalamic nucleus many fibers become varicose forming a well delineated plexus of 
PHA-L immunoreactive fibers in the dorsomedial part of the subthalamic nucleus and the 
adjoining lateral hypothalamic area ((figs. 6a and 10b). Non-varicose fibers also run 
through this area as well as through areas ventromedial to the subthalamic nucleus. 
Caudally, fibers descend directly into the ventral tegmental area (VTA). These fibers 
form a dense plexus of PHA-L immunoreactive fibers lateral to the roots of the oculomo-
tor nerve (fig. 5c). This plexus extends into the caudal parts of the VTA and also enters 
the medial substantia nigra (SNR and SNC(cs and dz)). These fibers descend through the 
rostral parts of the substantia nigra in a lateral direction covering most of the denzo-
cellular part (SNC(dz)). Although varicosities are found within the substantia nigra the 
number of non-varicose fibers outnumber the varicose ones. Finally, the fibers run 
through the dorsolateral extension of the SNC(dz), i.e. the SNC(cs), to the supra-nigral 
tegmentum, i.e. the peripeduncular nucleus (PP). The labeled region in the peripeduncular 
area forms a wedge shaped labeled area "on top o f the substantia nigra and lateral to the 
retrorubral field (RRF) consisting of a relative dense but small plexus of varicose PHA-L 
immunoreactive fibers (fig. 5c). Single varicose fibers are found in the adjoining sub-
stantia nigra pars reticulata. At more caudal levels, the labeled area is found more central 
in the tegmental field. In the mesencephalic locomotor region only a few varicose fibers 
are found. The central gray is virtually free of varicose fibers. 
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Fig. 5 a) The distribution of ENK-IR in the substantia innominata complex of the cat and b) the injection of 
PHA-L at approximately the same level in the scGP of cat 479 (note thick arrows), c) The distribution of PHA-L 
immunoreactive fibers in the mesencephalon from rostral (r) to caudal (r) levels. 
Injection into the lateral part of the scGP: 
Cat 453 received an injection of PHA-L in the lateral part of the highly ENK-IR sub-
commissural part of the globus pallidus (scGP; fig. 10a). This injection is small and 
compact. However, there is some leakage of tracer along the injection track. A bundle of 
descending PHA-L immunoreactive fibers become varicose at the level of the subthalamic 
nucleus forming a dense plexus of fibers within the dorsomedial parts of the subthalamic 
nucleus and the adjoining lateral hypothalamic area at a site slightly more dorsal and 
lateral than in cat 479. From here fibers traverse into caudal direction forming a dense 
plexus of PHA-L immunoreactive fibers at the level of the lateral VTA and the medial 
regions of the substantia nigra. No fibers are found medial to the oculomotor nerve. From 
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the VTA/substantia nigra some varicose fibers migrate through the SNC(dz) and the 
ventral parts of the medial lemniscus into dorsolateral direction. Some varicose fibers are 
also found dorsal to the SNC(dz) and ventral to the nucleus ruber. The fibers then run 
through the SNC(cs) towards the peripeduncular nucleus (PP). Ventrolaterally within the 
peripeduncular nucleus a relatively small plexus of PHA-L immunoreactive fibers is found 
whereas again only single fibers can be observed in the adjoining substantia nigra pars 
reticulata. From these regions some fibers traverse into the mesencephalic locomotor 
region where only single varicose fibers are found. Within the ventromedial parts of the 
central gray single varicose fibers are found. 
PHA-L injections into the extended amygdala 
Dorsolateral injection into the extended amygdala: 
Cat 347 received a relatively large but compact injection of PHA-L in the dorsolateral 
ENK-IR region of the extended amygdala (fig. 7a-b). In this case the descending fibers 
form a dense plexus of PHA-L immunoreactive fibers completely medial to the dorso-
medial part of the subthalamic nucleus within the lateral hypothalamic area (fig. 6c). 
Ventrally, non-varicose fibers run through this part of the lateral hypothalamic area 
destined to more caudal areas. Compared with the striatopallidal injections, fewer fibers 
run through the lateral VTA/medial substantia nigra and consequently a smaller plexus of 
PHA-L immunoreactive fibers than in previous cases is found lateral to the roots of the 
oculomotor nerve. In this case most fibers run through the dorsal parts of the rostral sub-
stantia nigra to the peripeduncular nucleus. These fibers display some varicosities. 
The peripeduncular nucleus is extremely heavily labeled over most of its rostrocaudal, 
mediolateral and dorsoventral extent forming a wedge shaped terminal field "on top of" 
the substantia nigra. Some varicose fibers were also found in the adjoining substantia 
nigra pars reticulata. Subsequently, fibers run through the mesencephalic locomotor 
region, having some varicosities, into the ventrolateral part of the central gray. Some 
fibers are also found adjacent to the interpeduncular nucleus and the median raphe 
nucleus. 
118 
Fig. 6 The distibution of PHA-L immunoreactive fibers in the subtalamic nucleus and the lateral hypothalamic 
area of cat 479 (a), 3 (b), 347 (c) and 316 (d). 
Intermediate injection into the extended amygdala: 
Cat 405 received an injection of PHA-L in an area directly caudal to the scGP, centrally 
in the moderate ENK-IR medial extended amygdala (not shown; for details see ref. 104). 
A strong accumulation of varicose PHA-L immunoreactive fibers is found medial to the 
subthalamic nucleus within the lateral hypothalamic area. Some PHA-L fibers were also 
found in the dorsomedial tip of the subthalamic nucleus itself. Ventrally to this area non-
varicose fibers are found destined to more caudal areas. In contrast to cats 479 and 453 
but comparable to cat 347 fewer varicose PHA-L immunoreactive fibers are found within 
the ventral tegmental area although within the lateral regions and adjoining substantia 
nigra varicose fibers are present. However, there are some differences with previous 
cases (453 and 479) since the fibers already migrate towards the dorsolateral regions of 
the substantia nigra at relatively rostral levels. These fibers are mainly of the non-varicose 
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Fig. 7 a) The distribution of ENK-IR in the substantia innominata complex of the cat and b) the injection of 
PHA-L into the dorsal part of the extended amygdala of cat 347 (note thick arrows), c) The distribution of PHA-
L immunoreactive fibers in the mesencephalon from rostral (r) to caudal (c) levels. 
type although an incidental varicose fiber is found. Furthermore, the fibers migrate only 
through the dorsal parts of the substantia nigra (covering the SNC(dz) and the SNC(cs)) 
and the ventral regions of the medial lemniscus. Subsequently, most of these fibers enter 
the peripeduncular nucleus at which level many fibers become varicose. This area is 
heavily labeled over a wide range as in the previous case. Within the mesencephalic loco-
motor region also varicose fibers are found which traverse towards the central gray. 
Finally, varicose fibers are found within the medial and dorsolateral regions of the central 
gray. These fibers are distributed over a wide range. 
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Fig. 8 a) The distribution of ENK-IR in the substantia innominata complex of the cat and b) the injection site in 
the ventral part of the extended amygdala (note thick arrows), c) The distribution of PHA-L immunoreactive 
fibers in the mesencephalon from rostral (r) to caudal (c) levels. 
Ventral injection into the extended amygdala: 
Cat 316 received an injection of PHA-L into the most caudal regions of the ventral non-
ENK-IR extended amygdala (fig. 8a-b). The injection is compact and there are no labeled 
neurons along the injection track. Varicose fibers are found ventromedial to the sub-
thalamic nucleus in the ventral parts of the lateral hypothalamic area (fig. 6c). The sub-
thalamic nucleus itself is virtually free of fibers. Like in the two previous cases, fibers 
run along the subthalamic nucleus towards the peripeduncular nucleus either through the 
dorsal parts of the rostral substantia nigra or via the ventral tegmental area. Within the 
peripeduncular nucleus small plexuses of varicose fibers are found. The tegmental regions 
caudal and dorsal to the peripeduncular nucleus are not labeled, apart from some non-
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varicose fibers destined to the central gray. Within the ventrolateral and medial parts of 
the central gray relatively high numbers of varicose fibers are found (fig. 8c). 
"Control" injections 
Two injections have been made in areas adjoining the substantia innominata in order to 
compare them with their respective descending projections. 
Cat 3 received an injection of PHA-L in the non-ENK-IR regions ventrolateral to the 
scGP (fig. 9a-b). The injection is relatively small and compact with no labeled neurons 
along the injection track. Varicose fibers are found ventromedial to the subthalamic 
nucleus in the lateral hypothalamic area (fig. 6b). These fibers as well as other non-
varicose fibers run through this area destined to the substantia nigra and VTA. In this 
case the lateral VTA/medial substantia nigra is also labeled. From this site fibers run 
through the substantia nigra and ventral parts of the medial lemniscus towards the 
peripeduncular nucleus. Within the peripeduncular nucleus and the mesencephalic 
locomotor region single PHA-L immunoreactive fibers are found although these fibers 
occasionally show varicosities (fig. 9c). In contrast, within the ventromedial part of the 
central gray many varicose fibers are found. 
Cat 492 received an injection of PHA-L in the ventral regions of the putamen 
immediately dorsal to the scGP (not shown, for details see ref. 104). Single varicose 
fibers are found in the ventrolateral part of the subthalamic nucleus. Ventromedial to the 
subthalamic nucleus many non varicose fibers run through this lateral hypothalamic field. 
Furthermore, many varicose fibers are found in the substantia nigra, especially the pars 
reticulata. The remaining parts of the central tegmental field and the mesencephalic 
central gray are free of immunoreactive fibers. 
B) Projections to the mediodorsal thalamic nucleus 
Only incidental single varicose fibers could be detected in the mediodorsal thalamic 
nucleus following injections into the scGP (453 and 479) or extended amygdala (316, 347 
and 405). 
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Fig. 9 a) The distribution of ENK-IR in the substantia innominata complex of the cat and b) the distribtuion of 
PHA-L immunoreactive fibers in the mesencephalon from rostral (r) to caudal (c) levels. 
7.5 DISCUSSION 
General remarks 
The anatomy and, consequently, the function of the substantia innominata have long 
remained unknown. However, recent studies have disclosed important aspects of the 
anatomical organization of this basal forebrain region (Alheid and Heimer, 1988; Martin 
et al., 1991). The substantia innominata complex must be considered as a most hetero-
geneous area, with different input-output characteristics for various subregions (Troiano 
and Siegel, 1978a,b; Groenewegen and Russchen, 1984; Haber et al., 1985; Russchen et 
al., 1985; Grove, 1988a,b; Spooren et al., 1991c). The distribution of various neuroactive 
substances, immunohistochemically visualized, is most helpful in delineating various 
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subregions in the substantia innominata (Switzer et al., 1982; Haber and Nauta, 1983; 
Groenewegen and Russchen, 1984; Alheid and Heimer, 1988). In the present study we 
have used ENK-IR for delineating the pallidal and amygdaloid components within the 
substantia innominata complex. 
The principal finding of the present study is that the stnatopallidal and amygdaloid 
components of the feline substantia innominata innervate the subthalamic nucleus and the 
adjoining lateral hypothalamic area, the ventral tegmental area, the substantia nigra, the 
peripeduncular nucleus, the mesencephalic locomotor region and the mesencephalic 
central gray. The mediodorsal thalamic nucleus is only scarcely innervated. However, the 
projections of the stnatopallidal and the amygdaloid components of the substantia 
innominata to these areas are not identical. The small, but essential, differences between 
them will be discussed below. 
The mediodorsal thalamic nucleus 
The projections of the basal forebrain investigated in the present study, i.e. the striato-
pallidal (scGP) and amygdaloid components of the substantia innominata, towards the 
mediodorsal thalamic nucleus are at best scanty. At first sight these data may be 
surprising, since this pathway in the rat has been described as a typical ventral pallidal 
projection (Young et al., 1984; Haber et al., 1985). However, the present data are not in 
conflict with studies in which cats and monkeys have been used (Velayos and Reinosos-
Suarez, 1985; Russchen et al., 1987; Steriade et al., 1987; Hreib et al., 1988; Parent, 
1988). 
Investigations using retrograde techniques in the monkey and cat brain have indicated that 
the major input of the mediodorsal thalamic nucleus arise from areas ventral and 
dorsomedial to the scGP, i.e. areas not investigated in the present study (Velayos and 
Reinosos-Suarez, 1985; Russchen et al., 1987; Steriade, 1987; Hreib et al., 1988; Parent, 
1988). Thus, the vast majority of cells projecting to the mediodorsal thalamic nucleus, at 
least in the cat and monkey brain, seem to be located outside the scGP and extended 
amygdala. 
Given the fact that in the rat most neurons projecting to the mediodorsal thalamic nucleus 
are located within the boundaries of the ventral pallidum (Young et al., 1984), one may 
suggest on the basis of the present findings that the scGP as well as the extended 
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amygdala of the cat can not be considered as simply homologous to the rat ventral 
pallidum. 
Functionally, these findings imply that motor effects elicited from the scGP and the 
adjoining extended amygdala regions are evidently not directly funneled via the medio-
dorsal thalamic nucleus, indicating that there might exist a species difference between cats 
and rats in this respect (Swerdlow and Koob, 1987). But, even in rats, the role of the 
mediodorsal thalamic nucleus in motor activity is still under discussion (Mogenson and 
Wu, 1988; Mogenson et al., 1989; cf. Swerdlow and Koob, 1987). 
The subthalamic nucleus 
The present results indicate that the subthalamic nucleus and surrounding areas are 
innervated by the striatopallidal and amygdaloid components of the substantia innominata 
complex. The scGP innervates the medial tip of the subthalamic nucleus and the adjoining 
lateral hypothalamic area. The extended amygdala projects preferentially to the lateral 
hypothalamic area medial to the subthalamic nucleus. These results are in agreement with 
studies in the rat (Grove, 1988b; Groenewegen and Berendse, 1990). 
In the rat, both the medial part of the subthalamic nucleus and the adjoining lateral 
hypothalamic area are reciprocally connected with the ventral pallidal territory 
(Groenewegen and Berendse, 1990; Berendse and Groenewegen, 1991). In the monkey 
HRP injections involving the substantia innominata/ventral pallidal territory resulted in 
retrogradely labeled cells in the medial third of the subthalamic nucleus whereas injections 
of the anterograde tracer PHA-L into the dorsomedial tip of the subthalamic nucleus have 
been found to label fibers entering the scGP (Russchen et al., 1985; Smith et al., 1989). 
It seems likely that in the cat these connections are reciprocal as well, although direct 
evidence in favour of this suggestion is not yet available. 
The extended amygdala preferentially innervates the regions medially to the subthalamic 
nucleus proper i.e. the lateral hypothalamic area. In the rat the latter area contains 
neurons quite similar in morphology to those found in the subthalamic nucleus itself (Kita 
et al., 1987). A difference is that in the subthalamic nucleus the neurons are more closely 
packed. Furthermore, these hypothalamic regions have in the rat reciprocal connections 
with the olfactory tubercle (Groenewegen and Berendse, 1990; Berendse and 
Groenewegen, 1991). Our data suggest a close relationship between the striatopallidal 
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component and the subthalamic nucleus and the extended amygdala with the lateral 
hypothalamic areas. The latter is topographically ordered in the dorso-ventral dimension. 
Furthermore, our data show that possible borders between extra-pyramidal and limbic 
circuitry are difficult to draw at this level. 
Finally, the scGP/dorsal extended amygdala (dEA) and the subthalamic nucleus seem to 
be implicated in (drug-induced) motor disturbances like oro-facial dyskinesia and limb-
trunk dyskinesia (Gunne et al., 1984; Cools et al., 1989; Spooren et al., 1991a,b). 
Although both syndromes can co-occur, in most cases there exists a dominance for one of 
them (for review see: Waddington 1989). This suggests that both syndromes have 
different substrates which are possibly functionally related to each other. 
Projections from the striatopallidal and amygdaloid components of the substantia 
innominata to the midbrain and the characterization of target regions by TH-IR and 
soM-m 
Somatostatin-like immunoreactivity: 
Since the isolation of somatostatin in 1973 by Brazeae and coworkers in the ovine 
hypothalamus, many papers have been published on the distribution of this peptide in the 
brain (Brownstein et al., 1975; Eide and Parsons, 1975; Alpert et al., 1976; Kobayashi et 
al., 1977; Johanson and Hökfelt, 1980; Finley et al., 1981; Graybiel and Eide, 1983; 
Johanson et al., 1984; Vincent et al., 1985). 
The present data indicate that the lateral VTA/medial substantia nigra, the peripeduncular 
nucleus, the periaqueductal gray and the interpeduncular nucleus contain somatostatin 
immunoreactive cells and fibers. These findings are in agreement with the findings of 
Graybiel and Eide in the cat (Graybiel and Eide, 1983). However, some differences are 
apparent in the substantia nigra. In contrast to Graybiel and Eide (1983) we found no 
extensive distribution of SOM-IR positive fibers in the substantia nigra pars lateralis, 
although both studies used antibodies raised against the synthetic 14 amino-acid 
somatostatin peptide. The reason for this difference is at present unclear, although slight 
differences in the substrate antibody binding complexes may underly these dissimilarities. 
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Fig. 10 a) The injection site of PHA-L of cat 453 into the ENK-IR scGP in detail . Arrows indicate the varicose 
fibers around the injection site which indicate the connectivity of the injection site with the surrounding scGP 
areas (see chapter 6). 
b) The distribution of PHA-L immunoreactive fibers in the subthalamic nucleus and the lateral hypothalamic area 
following injection into the medial scGP (cat 479). 
c) The distribution of PHA-L immunoreactive fibers in the peripeduncular are following an injection into the 
dorsal ENK-IR extended amygdala area ( cat 347). 
d) A varicose fiber within the peripeduncular nucleus in detail. 
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Tyrosine-hydroxylase immunoreactivity: 
Many investigations on the distribution of catecholamine containing cells, especially cell-
groups A8, A9 and AIO, in the ventral mesencephalon in the rat (Dahlström and Fuxe, 
1964; Levitt and Moore, 1979), cat (Poitras and Parent, 1978; Wiklund et al., 1981) and 
monkey (Jacobowitz and Maclean, 1978; Feiten and Sladek, 1983) have been published. 
The present findings in the feline brain are in agreement with these earlier reported 
findings in the cat as well as with more recent ones Jiménez-Castellanos and Graybiel, 
1987; Jones and Beaudet, 198η. 
Projections to A8, A9 and AIO regions 
The present results indicate that the striatopallidal component as well as the extended 
amygdala project to both the ventral tegmental area (AIO) and the substantia nigra pars 
compacta (A9). In contrast, the retrorubral field (A8) is only partially innervated. Both 
scGP and amygdaloid components of the substantia innominata project upon the same 
ventral mesencephalic region i.e. an area near and/or lateral to the roots of the oculo­
motor nerve encompassing the TH-IR and SOM-IR positive lateral VTA and medial 
substantia nigra. 
Generally, the borders between the AIO and the A9 regions are far from clear at this 
level. Poirier et al. (1983) have found that the compacta type of neurons in the rat, cat 
and monkey, extend ventromedially from the substantia nigra proper and invade the 
adjacent area of the VTA, whereas Philipson (1979) has, in addition, found that the 
dorsolateral neurons of the VTA are in continuity with the most dorsomedial located 
compacta neurons (Philipson, 1979; Poirier et al., 1983; cf. Halliday and Tork, 1986). 
On the basis of the location of the dopaminergic cells it is evident that this part of the 
brain is a transition area where well defined delineations between A9 and AIO are 
difficult if not impossible to give. 
In the rat it has been shown that most destination areas of the efferents of the substantia 
innominata complex have reciprocal connections with it (Grove, 1988 a,b). However, in 
the cat it is unclear to which degree the scGP and extended amygdala in the cat receive 
reciprocal input from these dopaminergic regions. Although substantial evidence suggests, 
especially in the rat, that all three regions, i.e. the A8, A9 and AIO, contribute to the 
(non- or) dopaminergic innervation of the ventral pallidum/substantia innominata region, 
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this still awaits further elucidation, especially in the cat (Lindvail and Bjorklund, 1979; 
Deutch et al., 1988; Smith et al., 1989). In view of the fact that only the dorsal parts of 
cell group A8 were labeled in the present study, it can be concluded that at least the A8 is 
not reciprocally connected with these rostral parts of the forebrain. 
The existence of a pallidonigral projection has been demonstrated in various species by 
means of retrograde and anterograde axonal transport (Nauta, 1979; McBride and Larsen, 
1980; Staines and Fibiger, 1984; Totterdel et al., 1984; Fischer, 1989). In all of these 
studies the globus pallidus (or the external segment of the globus pallidus) is recognized 
as the major source of the pallidonigral projection. The substantia nigra pars reticulata has 
been found to be the main target of these projections. Recent evidence even indicates that 
especially the non-dopaminergic neurons of the substantia nigra projecting to the superior 
colliculus, receive a GABA containing input from the globus pallidus (Smith and Bolam, 
1990; 1991). The scGP shares many characteristics with the globus pallidus 
(Groenewegen and Russchen, 1984; Russchen et al., 1985; Alheid and Heimer, 1988; 
Spooren et al., 1991c). Moreover, the scGP has been suggested to be an integral part of 
the globus pallidus (Haber et al., 1990). However, the present findings show that the 
scGP innervates only a small region in the ventromedial corner of the SNR and very 
scarcely the lateral regions of the SNR. Most PHA-L immunoreactive fibers were found 
in the TH-IR regions. Although the scGP and dorsal extended amygdala may of course 
impinge upon the non-dopaminergic neurons projecting to the colliculus superior, it seems 
more likely that the TH-IR cells/fibers form the main target of these axons. As such, 
these findings suggest that next to similarities also distinct differences exist between the 
scGP and the globus pallidus proper. 
If the fibers descending from the scGP and extended amygdala indeed make contact with 
the TH-IR cells, this may have effects on diverse regions in the brain. Firstly, fibers may 
impinge upon the A9 and AIO neurons which innervate the nucleus accumbens and the 
caudate nucleus (Jiménez-Castellanos and Graybiel, 1987; see also functional 
implications). Secondly, the lateral VTA and adjoining substantia nigra in the rat 
encompass cells which have highly collateralized axons which can influence the function 
of widely separated basal forebrain areas such as the caudate nucleus and putamen, the 
nucleus accumbens, the septum, the olfactory tubercle, the prefrontal cortex, 
simultaneously in varying combinations (Fallon, 1988). Afférents of the scGP and 
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extended amygdala may also impinge upon these strongly collateralizing neurons although 
they have not yet been identified in the cat. Finally, in a recent study in the rat a major 
descending dopaminergic pathway has been identified originating from the dopaminergic 
cell-groups in the ventral mesencephalon (Copray et al., 1990). Therefore, the descending 
projections from the scGP/dEA may also have effects upon one or more of the descending 
dopaminergic brainstem systems. 
The penpeduncular nucleus, the mesencephalic locomotor region and the central 
gray: 
A major problem in the studies on descending forebrain projections is posed by the lack 
of easy recognizable cyto-architectonic borders in the mesencephalic tegmental regions. 
Many attemps have been made to delineate regions on the basis of additional criteria like 
connectivity patterns, immunohistochemical characteristics and functional aspects. So far, 
these studies are primarily limited to rats (Rye et al., 1987; 1988; Jones and Cuello, 
1989; Spann and Grofova, 1989), and are not yet available in the cat. In order to 
delineate the descending substantia innominata projections in the cat in more detail, we 
used the distribution of TH-IR and SOM-IR in the tegmental regions in the present study. 
The present data indicate that an area in the supra-nigral tegmentum is extensively 
innervated. This part of the tegmentum has been first recognized as a distinct part of the 
tegmentum by Taber who labeled it nucleus peripeduncularis (Taber, 1961). The 
penpeduncular nucleus is characterized by SOM-IR but not TH-IR and easy to 
differentiate from the more ventromedially located TH-IR retrorubral field (A8; RRF), 
which is TH-IR but not SOM-IR as well as from the more caudally located mesencephalic 
locomotor region (see results), which is not TH-IR or SOM-IR (Shik et al., 1966; 
Herman, 1968; Grillner, 1975; Jordan et al., 1979; Rye et al., 1987; 1988). 
The penpeduncular nucleus is labeled over its whole dorso-ventral and medio-lateral 
extent following injections into the ENK-IR parts of the extended amygdala (cats 347 and 
405). It is also labeled following injections into the scGP and ventral extended amygdala 
regions but in a less extensive way. Preliminary retrograde findings using cholera toxin 
subunit В (CTB) as a retrograde tracer confirm these anterograde findings (Spooren, 
chapter 10). 
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When comparing our results with the efferents of the ventral pallidum and extended 
amygdala as described in the rat some distinct differences become apparent. Firstly, fibers 
arising from the rat ventral pallidum also project to the central tegmental field (Haber et 
al. 1985; Groenewegen, personal communication). However, in this species the output of 
the VP strongly overlaps with the dopamine containing A8 cellgroup. In the cat too there 
exists an overlap between the distribution of TH-IR cells and the PHA-L immunoreactive 
fibers. However, this overlap is limited the caudo-dorsal parts of the retrorubral regions 
where only few TH-IR cells were detected. Since this overlap is by not extensive the 
main target of these PHA-L immunoreactive fibers is probably not formed by the TH-IR 
cells in the retrorubral areas. 
Secondly, Grove (1988b) has shown that the target of fibers arising from the sublenticular 
substantia innominata in the rat (which corresponds with the extended amygdala as 
defined by Alheid and Heimer) is the substantia nigra pars reticulata rather than the 
adjoining central tegmental field. In the present study we observed the opposite situation 
in the cat. Given these differences between the cat and the rat, one may conclude that 
there are species differences. However, it has to be noted that the efferents of the ventral 
pallidum as defined in the cat, medially to the scGP, which also forms part of the 
striatopallidal component of the substantia innominata complex, have not been 
investigated in this study. 
The finding that the projections from the substantia innominata to the peripeduncular 
nucleus especially originate from its dorsal enkephalin immunoreactive parts is in 
agreement with the concept of the extended amygdala as defined by Alheid and Heimer 
(1988), since the central nucleus of the amygdala is described to have strong projections 
to the peripeduncular nucleus (Hopkins and Holstege, 1978; cf. Russchen, 1982). 
Furthermore, the destination of the fibers descending from the extended amygdala into the 
supra-nigral tegmentum nicely coincides with the distribution of somatostatin 
immunoreactivity in this part of the brain. When combining the fact that the central 
amygdala encompasses SOM-IR cells and that it shares its output to the peripeduncular 
nucleus with the dorsal parts of the extended amygdala, it could be postulated that this 
pathway contains somatostatin and probably also G AB A, since both have been shown to 
co-exist in several other structures (Oertel et al., 1983; Hendry et al., 1984; Somogyi et 
al., 1984; cf. Inagaki et al., 1983). However, direct proof is at present lacking. 
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In our study, the mesencephalic locomotor region was also labeled, especially following 
injections into the dorsal extended amygdala although the labeling was relatively weak 
compared to other parts of the mesencephalon. These findings are in agreement with 
findings in the rat (Grove, 1988b). Recent data indicate that locomotion inducing sites 
coincide very well with the pedunculopontine tegmental nucleus (PPTN). When using 
NADPH-diaphorase immunoreactivity as a marker for cholinergic activity in order to 
delineate the pedunculopontine tegmental nucleus, ал area is labeled extending 
rostroventrally from the core of the PPTN into the supra-nigral tegmentum (for review 
see Garcia-Rill, 1991). Since recent studies show that locomotor activity is also elicited 
from these rostral regions it has been suggested that these regions are an integral whole of 
the PPTN/mesencephalic locomotor region (Garcia-Rill, 1991). In this respect, the 
peripeduncular nucleus (PP) may form part of this functionally and anatomically defined 
complex. 
The central gray is also labeled in the present investigation. However, it is only 
extensively labeled following injections into the extended amygdala but not or only very 
scanty following injections into the scGP. It is also extensively labeled following 
injections into the area ventrolateral to the scGP. The projections from the extended 
amygdala to the central gray are discretely organized. Rostrally, all parts of the central 
gray were diffusely labeled except for its utmost dorsal parts whereas at more caudal 
regions especially the ventrolateral and ventromedial parts were labeled which have been 
shown to contain relatively high concentrations of serotonergic cells (Takeuchi et al., 
1982; Clements et al., 1985; cf. Mantyh, 1982). These findings are in agreement with 
findings in the rat (Grove, 1988b). Furthermore, like in the peripeduncular nucleus, the 
distribution of PHA-L immunoreactive fibers descending from the extended amygdala also 
coincides with the distribution of SOM-IR in the central gray. However, at present no 
specific evidence is available indicating that these descending fibers are indeed 
somatostatinergic. 
Functional implications 
It is important to realize that the input from the scGP and the extended amygdala into the 
different diencephalic and mesencephalic structures, as delineated in the present 
investigation, is only one out of many other afferent sources of these regions which 
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makes the functional relationships very complicated. Nevertheless, some interesting 
suggestions can be made. 
Firstly, the scGP and the dorsal parts of the extended amygdala have been found to play a 
crucial role in oro-facial dyskinesia which is a motor disturbance of the oral and facial 
muscles (Cools et al., 1989a,b; Spooren et al., 1989; Spooren et al., 1991a,b). The 
efferent connections of these regions have also been implicated in the control of 
movements, especially the subthalamic nucleus/lateral hypothalamic area and 
mesencephalic locomotor region (Grossman, 1987; Garcia-Rill, 1991). Their role in oral 
behaviour is less clear although the subthalamic nucleus and the pedunculopontine 
tegmental nucleus have been suggested to play some role in oral dyskinesias (Childs and 
Gale, 1983; Feger et al., 1989). Preliminary results of our current pharmacological 
experiments in the cat indeed indicate that the subthalamic nucleus/lateral hypothalamic 
area and the peripeduncular nucleus are somehow involved in the control of oral 
movements. 
Secondly, it has been found that the feline caudate nucleus encompasses at least two 
pharmacologically different subregions, i.e. the CRM and r-CRM (Cools et al., 1976). 
Recent evidence indicates that these two regions have different input and output channels 
(Cools et al., 1989a; Spooren et al., 1991a). The CRM is innervated by the SNC(dz) and 
SNC(cs) whereas the r-CRM is mainly innervated by cell group A8 (Spooren et al., 
1991a). In tum, effects elicited from the CRM are funneled via the SNR whereas effects 
elicited from the r-CRM are funneled via the scGP (Jaspers et al., 1989; Spooren et al., 
1991a). The present data indicate that the SNC(dz) and SNC(cs) are innervated by the 
scGP and extended amygdala, while in contrast the A8 receives only a limited input. If 
the fibers, as discussed above, make contact with the dopaminergic striatal projection 
neurons such a connectivity pattern would give new insight in the function of subregions 
of the caudate nucleus. In that case, the CRM or core region of the caudate nucleus may 
be influenced by cell-group A8 and its first and second order output station: A8 - > r -
CRM - > scGP - > A9 - > CRM - > SNR - > SCdl (cf. Cools et al., 1976; Jaspers et 
al., 1989). 
This has important functional consequences. The nigrostriatal pathway (A9->CRM) is 
involved in the ability to switch arbitrarily from one behaviour to another (Jaspers et al., 
1989). A stimulation of this pathway may enhance the ability of the animal to change or 
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modulate ongoing behaviour whereas an inhibition may in contrast limit this ability. Thus, 
although motor disturbances elicited from the scGP/dEA, are not organized via the 
nigrostriatal pathway they may nevertheless be influenced by it via the indirect inhibiting 
or stimulating effect of such a disturbance on the latter pathway. 
Thirdly, Jiménez-Castellanos and Graybiel (1989) recently showed in the cat that only the 
SNC as one of the three main dopaminergic afférents of the striatum receives input from 
the striatum itself. The latter suggests a feedback for the SNC. The AIO as well as the A8 
were found to lack such a feedback. However, the present study shows that the scGP, 
which is innervated by the nucleus accumbens, innervates in tum the AIO. The AIO itself 
is of course one of the main dopaminergic afférents of the nucleus accumbens (Jimenez-
Castellanos and Graybiel, 1987). These data at least suggest an indirect feedback for the 
AIO regions. In contrast cell group A8 even lacks such an indirect feedback. This is 
striking in view of the fact that at least in the rat, the A8 contributes considerably to the 
innervation of the ventral pallidum. The afférents of the ventral pallidum in the cat 
however have not been investigated in this respect (Deutch et al., 1988). Still, the present 
data indicate that cell-group A8 lacks at least considerable input from the substantia 
innominata complex which marks the relative lack of input from the basal forebrain to 
this cell-group. The exact functional significance of this finding remains to be elucidated 
in future studies. 
Conclusions 
In sum, the following regions are innervated by the scGP and extended amygdala: 
subthalamic nucleus/lateral hyothalamic area, VTA/SN, PPTN/MLR and central gray. 
These regions are innervated by a single diffuse bundle of descending fibers in which the 
amount of collateralization cannot be detected without further detailed retrograde 
experiments. Furthermore, most regions that receive an input from the scGP and extended 
amygdala are also marked by SOM-IR but not by TH-IR. Only the TH-IR ventral 
tegmental area and substantia nigra pars compacta are extensively innervated. 
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Abbreviations 
3 
э 
ас 
ACN 
BST 
CG 
CN 
cp 
CRM 
dEA 
EA 
ENK-IR 
GP 
1С 
IP 
LH 
lo 
ml 
mlf 
MLR 
Ρ 
PBg 
PHA-L 
Pn 
PP 
PPTN 
R 
r-CRM 
RRF 
scGP 
SUB-P 
SNC 
SNC(cs) 
SNC(dz) 
SNR 
SOM-IR 
STh 
Tu 
TH-IR 
vEA 
VP 
VTA 
:oculomotor nerve 
:third ventricle 
:anterior commissure 
¡nucleus of the anterior commissure 
:bed nucleus of the stna terminalis 
:central gray 
¡caudate nucleus 
¡cerebral peduncle 
:rostromedial caudate nucleus 
:dorsal extended amygdala 
¡extended amygdala 
¡enkephalin immunoreactivity 
¡globus palhdus 
¡internal capsule 
¡interpeduncular nucleus 
¡lateral hypothalamus 
¡lateral olfactory tract 
¡medial lemniscus 
¡medial longitudinal fasciculus 
¡mesencephalic locomotor region 
¡putamen 
¡parabigeminal nucleus 
¡Phaseolus vulgaris - leucoagglutinin 
¡pontine nuclei 
¡penpeduncular nucleus 
'pedunculopontine nucleus 
¡nucleus ruber 
¡rostrodorsal caudate nucleus 
•retrorubral field 
¡subcommissural part of the globus pallidus 
¡substance Ρ 
¡substantia nigra pars compacta 
¡substantia nigra pars compacta, cell sparse zone 
¡substantia nigra pars compacta, densocellular zone 
¡substantia nigra pars reticulata 
¡somatostatin immunoreactivity 
¡subthalamic nucleus 
¡olfactory tubercle 
¡tyrosine hydroxylase immunoreactivity 
¡ventral extended amygdala 
¡ventral pallidum 
¡ventral tegmental area 
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8.1 ABSTRACT 
The efferent connections of the striatopallidal, amygdaloid and corticopetal magnocellular 
components of the substantia innominata in the cat to the amygdala have been investigated 
using Phaseolus Vulgaris-leucoagglutinin (PHA-L) as an anterograde tracer. The dorsal 
and dorsolateral parts of the extended amygdala preferentially innervate the central but 
also the medial and basomedial amygdaloid nuclei. The ventromedial parts of the 
extended amygdala preferentially innervate the medial and basomedial but also the central 
amygdaloid nuclei. The subcommissural part of the globus pallidus and the abutting part 
of the extended amygdala preferentially project to the basolateral amygdaloid nucleus. 
These projections probably originate from the scattered cell groups of the corticopetal 
magnocellular component of the substantia innominata. The results are focussed on the 
role of the subcommissural part of the globus pallidus, the dorsal extended amygdala and 
the central amygdaloid nucleus in oral motor control. 
8.2 INTRODUCTION 
The amygdaloid complex is a heterogeneous group of distinct nuclear and cortical 
structures which have been shown to be differentially associated with a wide variety of 
functions ranging from the control of endocrine and autonomic functions to cognitive 
functions (Kaada et al., 1954; Kaku, 1984; Murray and Mishkin, 1985; Gaffan and 
Harrison, 1987; Price et al., 1987). However, involvement in motor aspects of behaviour 
have also been described (Kaada et al., 1954; Kaku, 1984). Stimulation of the central 
amygdaloid nucleus has been reported to elicit oral behaviour such as mastication and 
tongue protrusions (Kaku, 1984). Interestingly, oral behaviour is also elicited from 
regions adjoining the amygdaloid complex, i.e. the enkephalin immunoreactive dorsal 
parts of the substantia innominata complex. However, the latter region encompasses 
characteristics of other basal forebrain systems: a striatopallidal component, an 
amygdaloid component and a magnocellular corticopetal component (for review see 
Alheid and Heimer, (1988). Of these regions, the subcommissural part of the globus 
pallidus (scGP) as well as the abutting dorsal extended amygdala regions play a crucial 
role in oro-facial dyskinesia (OFD), i.e. a syndrome of abnormal involuntary movements 
of the oro-facial and tongue muscles (dEA; Cools et al., 1989; Spooren et al., 1989; 
1991a,b). In view of these findings it was decided to study the efferents of the scGP and 
extended amygdala to the amygdaloid complex using the anterograde tracer Phaseolus 
vulgaris-leucoagglutinin (PHA-L; Gerfen and Sawchenko, 1984). 
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8.3 MATERIALS AND METHODS 
Male cats (n=9; Animal Laboratory, University of Nijmegen) weighing 3.5 - 5.2 Kg were used. Under deep 
anaesthesia (pentobarbital 40 mg/kg, intra-pentoneally) Phaseolus vulgans-leucoagglutimn (PHA-L; Vector 
Laboratones, Burlmgame, USA) dissolved in 50 nM Tns-buffered saline (TBS; pH 7.4) was lontophoretically 
injected through glass micropipets (10 - 25 /un) using a positively pulsed 10 - 12.5 μΑ DC current (7 sec. on, 7 
sec. off) for 25-45 min. 
14 - 17 days after surgery, the cats were reanaestitized with pentobarbital (60 mg/kg, intra-pentoneally) and 
transcardially perfused at a constant hydrostatic pressure with 500 ml saline followed by 2000 ml buffered 
ñxative containing 4% paraformaldehyde and 0.05 % glutaraldehyde in 0.1 M phosphate buffer (pH 7.4; 4°C). 
After removal from the skull, the brain was post-ñxed overmgbt in ñxative containg 20% sucrose at 4°C until it 
sank. Then the brain was sectioned at a thickness of 50 /un on a freezing microtome. Following sectioning, free 
floating sections (2 adjoining sections out of every 5 or 10) were incubated according to a standard PHA-L 
immunohistochemical procedure, modified after Oerfen and Sawchenko (1984) and counterstained with cresyl-
violet (Spooren et al., 1991c). The nomenclature of the amygdaloid nuclei follows that given by Krettek and 
Pnce (1978). 
8.4 RESULTS 
The results of 7 different injections in and outside the striatopallidal and amygdaloid 
components of the substantia innominata complex will be presented: two injections into 
the striatopallidal component (one medial and one lateral injection into the scGP (resp. cat 
479 and 453)), three injections into the extended amygdala component (one dorsolateral, 
one intermediate and one ventral injection (resp. cat 347, 405 and 316)), and two 
injections outside the striatopallidal and amygdaloid components (one injection 
ventrolateral to the scGP (cat 3) and one injection into the ventral putamen (cat 492). 
Injections into the striatopallidal component of the substantia innominata: 
Following an injection into the medial scGP (cat 479; fig. 1) anterogradely labeled PHA-
L immunoreactive fibers are almost exclusively found in the basolateral amgydaloid 
nucleus (fig. 2). Some varicose fibers are found in the central as well as in the medial 
amygdaloid nuclei whereas single long non-varicose fibers are present in the lateral 
amygdaloid nucleus. The remaining parts of the amygdaloid complex are not labeled. 
Cat 453 received an injection of PHA-L into the lateral scGP. In this case some varicose 
fibers are found in the basolateral amygdaloid nucleus (not shown). The remaining parts 
of the amygdala are not labeled. 
Injections into the amygdaloid components of the substantia innominata: 
Following the injections of PHA-L into the dorsolateral part of the extended amygdala 
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(cat 347; fig 1) extremely high concentrations of anterogradely labeled PHA-L 
immunoreactive fibers are found in the medial part of the central amygdaloid nucleus as 
well as in the medial amygdaloid nucleus (fig. 3). However, the basomedial and 
basolateral amygdaloid nuclei also contain numerous varicose fibers. Only a few, mainly 
non-varicose, fibers are found in the lateral amygdaloid nucleus. Varicose fibers are also 
present in the endopiriform nucleus whereas single fibers are detected in superficial and 
deeper layers of the peri-amygdaloid cortex, the posterior part of the prepiriform cortex 
as well as in the perirhinal and amygdalo-hippocampal areas. 
Cat 405 received an injection of PHA-L into the dorsomedial part of the extended 
amygdala (cat 405; fig. 1). In this cat varicose fibers are predominantly found in the 
basolateral nucleus especially its ventral parts (fig. 4). Some fibers are present in the 
basomedial and central amygdaloid nuclei whereas single fibers are also detected in the 
basomedial amygdaloid nucleus. Long mainly non-varicose fibers are found in the lateral 
amygdaloid nucleus. The perirhinal area is also marked by varicose fibers. 
Finally, following the injection into the ventral part of the extended amygdala (cat 316; 
fig. 1) many varicose fibers are found in the medial as well as in the baso-medial 
amygdaloid nucleus (fig. 5). The central amygdaloid nucleus also contains varicose PHA-
L immunoreactive fibers. Single fibers are found in the basolateral and lateral amygdaloid 
nucleus. All parts of the endopiriform nucleus were also extensively labeled as well as the 
superficial and deeper layers of the periamygdaloid cortex, the posterior parts of the 
prepiriform cortex and amygdalo-hippocampal area. 
Injections outside the striatopallidal aod amygdaloid components of the substantia 
innominata complex: 
Following the injection into a region ventrolateral to the scGP (cat 3; fig. 1) some 
varicose fibers are detected in the central- and medial amygdaloid nuclei as well as in the 
basolateral- and basomedial amygdaloid nuclei. Within the endopiriform nucleus, 
especially the ventral division, a relative high concentration of PHA-L immunoreactive 
fibers are found. The periamygdaloid cortex is also marked by PHA-L immunoreactive 
fibers. Following the injection into the ventral putamen (cat 492; fig. 1) single fibers are 
found in the basolateral amygdaloid nucleus whereas the remaining part of the amygdala 
is not labeled. 
146 
8.5 DISCUSSION 
It has been shown that the substantia innominata complex has extensive connections with 
the amygdaloid complex (Russchen, 1982; Carlsen et al., 1985; Russchen et al., 1985; 
Grove, 1988). The present data show that each specific area of the substantia innominata 
complex of the cat is connected with specific parts of the amygdaloid complex which are 
in part comparable with the organization of these projections in the rat (Grove, 1988). In 
view of the parcellation of the substantia innominata complex into striatopallidal, 
amygdaloid and corticopetal components as introduced by Alheid and Heimer (1988) the 
organization of these projections seem to be distinctly organized. 
The dorsal and dorsolateral part of the extended amygdala preferentially innervate the 
medial part of the central amygdala. These brain regions have been postulated to form the 
central amygdaloid cell group (Alheid and Heimer, 1988). The ventromedial parts of the 
extended amygdala preferentially innervate the medial and basomedial amygdaloid nuclei. 
These brain regions have been postulated to form the medial amygdaloid cell group. 
Apparently, the different parts of the extended amygdala have specific and different 
relationships with the different amygdaloid groups. However, the projections from the 
extended amygdala are not restricted to a single amygdaloid group, since the dorsal and 
dorsolateral parts of the extended amygdala also project to the medial and basomedial 
amygdaloid nuclei whereas the ventromedial parts of the extended amygdala also project 
to the central amygdaloid nucleus. Taking these data together with findings from the 
literature indicating that these connections are reciprocal they suggest that the different 
parts of the amygdala and extended amygdaloid regions are extensively interrelated 
(Krettek and Price, 1978; Russchen, 1982; Russchen et al., 1985; Alheid and Heimer, 
1988; Grove, 1988a,b). 
The basolateral amygdaloid nucleus is especially innervated by the scGP as well as by the 
adjoining dorsal parts of the extended amygdala. In contrast, the lateral amygdaloid 
nucleus receives almost no input from these parts of the substantia innominata complex. 
These connections probably originate from the cholinergic cell groups that are scattered 
through the substantia innominata complex which constitute the magnocellular corticopetal 
component of the substantia innominata complex (Nagai et al., 1982; Carlsen et al., 1985; 
Alheid and Heimer, 1988). 
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Fig- 1 An overview of the localization of the different injection sites of PHA-L in the substantia innominata 
complex. 
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Fie. 2-5 The distribution of anterogradely labeled PHA-L immunoreactive fibers in the amygdaloid complex of 
cat 479 (fig. 2), 347 (fig. 3), 405 (fig. 4) and 316 (fig. 5). 
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The basolateral amygdala is a distinct amygdaloid nucleus. It shows some cortical features 
(see below) although it lacks an obvious laminar structure (Price et al., 1987). Like other 
cortical areas it is connected, often reciprocally, with several other cortical areas among 
others with motor and premotor cortices (Avendano et al., 1983; Sripanidkulchai et al., 
1984). The basolateral amygdaloid nucleus also projects heavily to striatal structures 
(Veening et al., 1980; Kelley et al., 1982; Ragsdale and Graybiel, 1988). The 
connections of the amygdala with the nucleus accumbens have been the subject of recent 
studies on stimulus reward association (Cador et al., 1989). An interesting finding with 
respect to the present investigation is the fact that the basolateral amygdaloid nucleus 
forms an additional important afferent source to the central amygdaloid nucleus (Krettek 
and Price., 1978). The substantia innominata complex as a whole thus seems to have 
extensive direct and/or indirect connections with the central amygdaloid nucleus. 
The periamygdaloid cortex was also labeled in the present investigation, especially 
following injections into the ventromedial and dorsolateral extended amygdala. This 
region however forms no part of the amygdaloid complex and its connectivity pattern is 
much more related to the olfactory cortex (Price, 1973; Krettek and Price, 1978; Alheid 
and Heimer, 1988). The endopiriform nuclei also form no part of the amygdaloid 
complex but their connections have much in common with the prepiriform cortex (Krettek 
and Price, 1978). 
Thus, the scGP/dEA has direct and indirect (reciprocal) connections with the central 
amygdaloid nucleus. The dorsal and dorsolateral parts of the extended amygdala share 
many characteristics with the central amygdaloid nucleus (Alheid and heimer, 1988), 
among others the involvement in oral motor control and some projection fields (Kaku, 
1984; Spooren et al., 1989; 1991a,b; chapter 7). Moreover, the central amygdala also 
projects to deep brainstem areas which indicates that it may influence (in)directly oro-
facial motor nuclei (Ohta and Moriyama, 1986; Takeuchi et al., 1988; Fort et al., 1989). 
However, its involvement in oro-facial dyskinesia elicited from the scGP/dEA is at 
present not clear and remains to be elucidated in future pharmaco-behavioural and 
anatomical studies. 
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з 
ас 
Acb 
AHi 
BL 
BM 
Ce 
CeL 
CeM 
CN 
dEA 
En 
GP 
1С 
LA 
lo 
opt 
Ρ 
РАС 
PCp 
PHA-L 
scGP 
st 
Tu 
vEA 
VP 
:tbird ventricle 
¡antenor commissure 
¡nucleus accumbens 
¡amygdalo-bippocampal area 
¡basolateral amygdaloid nucleus 
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¡putamen 
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¡stna terminalis 
¡olfactory tubercle 
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¡ventral pallidum 
8.6 REFERENCES 
Alheid G.F. and Heimer L., New perspectives in basal forebrain organization of special relevance for 
neuropsychiatrie disorders: the stnatopallidal, amygdaloid, and corticopetal components of substantia innominata, 
Neurosa. 27 (1988) 1-39. 
A vendano С , Pnce J L. and Amarai D G., Evidence for an amygdaloid projection to premotor cortex but not to 
motor cortex in the monkey, Brain Res. 264 (1983) 111-117. 
Cador M., Robbins T.W. and Eventi B.J., Involvement of the amygdala in stimulus-reward associations: 
interaction with the ventral striatum, Neurosa. 30 (1989) 77-86. 
Carleen J., Zaborsky L. and Heimer L., Cholinergic projections from the basal forebrain to the basolateral 
amygdaloid complex: a combined retrograde fluorescent and immunohistochemical study, J. Comp Neurol. 234 
(1985) 155-167. 
Cools A.R., Spooren W., Bezemer R., Cuypers E., Jaspers R. and Groenewegen H., Anatomically distinct 
output channels of the caudate nucleus and oro-facial dyskinesia: critical role of the sub-commisural part of the 
globus pallidas in oral dyskinesia, Neurosa. 33 (1989) 535-542. 
Fort P., Sakai K., Luppi P., Salvert D. and Jouvet M., Monoaminergic, peptidergic and cholinergic afférents to 
the cat facial nucleus as evidenced by a double immunostaining method with unconjugated cholera toxin as a 
retrograde tracer, J. Comp. Neurol. 283 (1989) 285-302. 
Gaffan, D., and Hamson S., Amygdalectomy and disconnection in visual learning for auditory secondary 
reinforcement by monkeys, J. Neurosa. 7 (1987) 2285-2292. 
151 
Gerfen CR. and Sawchenko P.E., An anterograde neuroanatomical tracing method that shows the detailed 
morphology of neurons, their axons and terminals: immunohistochemical localization of an axonally transported 
plant lectin, Phaseolus Vulgaris leucoagglutuun (PHA-L), Brain Res. 290 (1984) 219-238. 
Grove E.A., Neural associations of the substantia innominata in the rat:afferent connections, J. Comp. Neurol. 
277 (1988a) 315-346. 
Grove E.A., Efferent connections of the substantia innominata in the rat, J. Comp. Neurol. 277 (1988b) 347-
364. 
Kaada В., Stimulation and ablation of the amygdaloid complex with reference to functional representation. In 
Helefthenou B.E. (Eds.) The neurobiology of the amygdala, Plenum Press, New York, 1972, pp 145-204. 
Kaada B.R., Andersen P. and Jansen J., Stimulation of the amygdaloid nuclear complex in unanesthetized cats, 
Neurology 4 (1954) 48-64. 
Kaku T., Functional differentiation of hypoglossal motoneurons during amygdaloid or cortical induced rythmical 
jaw and tongue movements in the rat. Brain Res. Bull. 13 (1984) 147-154. 
Kelly A.E., Domesick V.D. and Nauta W.J.H., The amygdalostnata] projection in the rat - an anatomical study 
by anterograde and retrograde tracing methods. Neurosa 7 (1982) 615-630. 
Krettek J.E. and Pnce J.L., A description of the amygdaloid complex in the rat and cat with observations on 
intra-amygdaloid axonal connections, J. Comp Neurol. 178 (1978) 255-280. 
Murray, E. and Mishkin M., Amygdalectomy impairs cross-modal association in monkey. Science 228 (1985) 
604-606. 
Nagai T., Kimura H., Maeda T., McGeer P.L. Pemg P. and McGeer E.G., Cholinergic projections from the 
basal forebrain of rat to the amygdala, J. Neurosa 2 (1982) 513-520 
Ohta M. and Monyama Y., Supratngeminal neurons mediate shortest, disynaptic pathway from the central 
amygdaloid nucleus to the contralateral Ingemmai motoneurons in the rat. Comp. Biochem. Physiol. 83A (1986) 
633-641. 
Pnce J.L., An autoradiographic study of complementary laminar patterns of termination of afferent fibers to the 
olfactory cortex, J. Comp. Neurol. 150 (1973) 87-108. 
Pnce J.L., Russchen F.T., and Amarai DG., The amygdaloid complex. In Bjorklund Α., Hokfelt T. and 
Swanson L.W. (Eds.), Handbook of chemical neuroanatomy, Vol. 5, integrated systems (1), Elsevier, 
Amsterdam, 1987, pp 279-388. 
Ragsdale C.W. and Graybiel A.M., Fibers from the basolateral nucleus of the amygdala selectively innervate 
stnosomes in the caudate nucleus, J. Comp. Neurol. 269 (1988) 506-522. 
Russchen F.T., Amygdalopetal projections in the cat. П. Subcortical afferent connections. A study with 
retrograde tracing techniques, J. Comp. Neurol. 207 (1982) 157-176. 
Russchen F.T., Amarai D.G and Pnce J.L., The afferent connections of the substantia innominata in the 
monkey. Macaca fasciculans, J. Comp. Neurol. 242 (1985) 1-27. 
Spooren W.P.J.M., Cuypers E. and Cools A.R., Oro-facial dyskinesia and the sub-commissural part of the 
globus pallidus in the cat: role of acetylcholine and its interaction with GABA, Psychopharm. 99 (1989) 381-
385. 
Spooren W.P.J.M., Groenewegen H.J. and Cools A.R., Subregions of the caudate nucleus and their in- and 
output channels in oro-facial dyskinesia: a behavioural and retrograde tracing study in the cat, Brain res. 539 
(1991a) 85-93. 
152 
Spooren W.P.J.M., Piosik P.A. and Cools A.R., Dopamine Dl receptors in the subcommissural part of the 
globus palhdus and their role in orofacial dyskinesia, Eur. J. Pharm. 204 (1991b) 217-222. 
Spooren W.P.J.M., Veening J.G., Groenewegen H.J. and Cools A.R., Efferent connections of the striatopallidal 
and amygdaloid components of the substantia innominata in the cat: projections to the nucleus accumbens and the 
caudate nucleus, Neurosa. 44 (1991c) 431-447. 
Snpamdkulchai K., Snpamdkulchai B. and Wyss J.M., The cortical projection of the basolateral amygdaloid 
nucleus in the rat: a retrograde fluorescent dye study, J. Comp. Neurol. 229 (1984) 418-431. 
Takeuchi Y., Satoda T., Tashiro T., Matsushima R. and Uemura-sumi M., Amygdaloid pathway to the 
Ingemmai motor nucleus via the pontine reticular formation in the rat. Brain Res. Bull. 21 (1988) 829-833. 
Veening J.G., Cornelissen F.M. and Lieven P.A.J.M., The topical organization of the afférents of the 
caudatoputamen of the rat. A horseradish peroxidase study. Neurosci. S (1980) 1253-1268. 
153 

PART Π: ANIMAL RESEARCH 
CHAPTER 9 
THE MEDIAL SUBTHALAMIC NUCLEUS AND 
ADJOINING LATERAL HYPOTHALAMIC AREA IN 
ORO-FACIAL DYSKINESIA IN CATS: 
ROLE OF GABA AND THE INTERACTION WITH THE 
SUBSTANTIA INNOMINATA COMPLEX 
Submitted for publication 
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9.1 ABSTRACT 
Previously it was found that the subcommissural part of the globus pallidus and the 
adjoining dorsal parts of the extended amygdala (scGP/dEA) are involved in oro-facial 
dyskinesia (OFD). Anatomical tracing studies have indicated that the medial part of the 
the subthalamic nucleus and the adjoining lateral hypothalamic area (Sth/LH) has 
reciprocal connections with the scGP/dEA. In the present study the involvement of the 
Sth/LH in OFD and its possible interaction with the scGP/dEA was investigated. 
Picrotoxin (ΡΤΧ), i.e. a GABAergic antagonist, elicited OFD (quantified in terms of 
numbers of tongue protrusions) from the Sth/LH at relative low doses (50, 150, 250 ng/ 
0.5 μΐ) whereas a relative high dose PTX (500 ng/ 0.5 μϊ) was ineffective with respect to 
OFD. The most effective dose of PTX in eliciting OFD, i.e. 250 ng, was significantly 
antagonized by 50 ng muscimol, i.e. a GABAergic agonist, indicating GABA-specificity. 
Furthermore, OFD elicited from the scGP/dEA by 500 ng PTX was significantly 
attenuated by 50 ng muscimol into the Sth/LH whereas OFD elicited from the Sth/LH by 
250 ng PTX was significantly attenuated by 1000 ng kynurenic acid, i.e. a glutaminergic 
antagonist, but not by 100 ng muscimol into the scGP/dEA. The latter findings indicate 
that OFD in the cat is funneled from the scGP/dEA towards the Sth/LH as well as in the 
opposite direction. Within the scGP/dEA the OFD elicited from the Sth/LH is funneled 
via glutaminergic but not GABAergic neurotransmitter systems. Thus, the present findings 
indicate that the Sth/LH is involved in OFD and that it has a bidirectional functional 
interaction with the scGP/dEA. 
9.2 INTRODUCTION 
Oro-facial dyskinesia (OFD) is a syndrome of abnormal involuntary movements of the 
oral and facial muscles. It may occur in a variety of medicated and unmedicated people 
but predominantly in patients chronically treated with anti-psychotic drugs (Schonecker, 
1957; for review: Waddington, 1989). 
It has been hypothetized that OFD is due, at least in part, to alterations in dopaminergic 
systems (Klawans et al., 1980), although it is generally accepted now that it cannot 
simply reflect supersensitivity of dopamine receptors. Next to dopamine, GABA has also 
been suggested to play a crucial role in this syndrome (Fibiger and Lloyd, 1984) which is 
underlined by the therapeutic efficacy of some GABAergic drugs (Stahl et al., 1985). 
However, mechanisms underlying OFD are still poorly understood. 
In the cat OFD can be elicited by stimulating dopamine receptors within the anterodorsal 
part of the caudate nucleus (r-CRM; Cools et al., 1975; Spooren et al., 1991). The r-
CRM is predominantly innervated by cell-group A8 and is characterized by a relatively 
low content of striosomes (Desban et al., 1989; Spooren et al., 1991). OFD can also be 
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elicited from a first order output station of the r-CRM, i.e. the subcommissural part of 
the globus pallidus as well as from the adjoining extended amygdala regions (scGP/dEA; 
Cools et al., 1989a,b; Spooren et al., 1989; 1991b; Alheid and Heimer, 1988). 
Especially, the scGP/dEA has been found to play a crucial role in generating and 
mediating OFD in cats (Spooren et al., 1991a). 
Recently, we found, using Phaseolus vulgaris-leucoagglutinin (PHA-L) as an anterograde 
tracer, that the dorsomedial subthalamic nucleus and the adjoining lateral hypothalamic 
area (Sth/LH) receive a massive input from the scGP/dEA (Spooren et al., 1992; chapter 
7). Data from the literature suggest that this relationship is reciprocal (Berendse and 
Groenewegen, 1990; cf. Russchen et al., 1985; Smith et al., 1990), and that most 
probably the ascending connection is glutaminergic (Albin et al., 1989). In view of these 
findings, it was decided to investigate this reciprocal connection functionally in relation to 
oral dyskinesias. 
The aim of the present investigation was two-fold: 
Firstly, it was investigated (qualitatively and quantitatively) whether OFD-like effects can 
be elicited from the Sth/LH by means of local injections of the GABA antagonist 
Picrotoxin (PTX). This drug was chosen in view of the fact that PTX has previously been 
found to be effective within the subthalamic nucleus itself (Scheel-Kruger and Magelund, 
1981). The GABA-specificity can be investigated by means of combined injections with 
the GABA agonist muscimol (MSM). 
Secondly, if OFD-like effects can be elicited from the Sth/LH, the functional interaction 
of the scGP/dEA with the Sth/LH and vice versa can be investigated by means of local 
injections of drugs into both regions in order to (a) investigate whether OFD elicited from 
the scGP/dEA can be attenuated at the Sth/LH by means of local injections of MSM, and 
(b) determine whether OFD elicited from the Sth/LH can be attenuated at the scGP/dEA 
by means of local injections of kynurenic acid (KYN), i.e. a glutaminergic antagonist and 
(c) if so, investigate whether the effects elicited from the Sth/LH are funneled via 
GABAergic systems within the scGP/dEA, as found previously for the OFD elicited via 
cholinergic stimulation within the scGP/dEA (Spooren et al., 1989). 
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9.3 MATERIALS AND METHODS 
Subjects and surgical procedures 
Male cats (N=20, Age 12 - 13 months; Animal Laboratory, University of Nijmegen) weighing 3.S · 5.4 kg 
were used. Each group, composed of 7 or 8 cats, was housed in a cage (2x3x2 meter) with water and food 
available ad libitum. Under deep aneasthesia (40 mg/kg, intra-pentoneally; Apharmo, the Netherlands) the 
animals were stereotaxically equipped with stainless steel guide cannulas (inner diameter and outer diameter 0.55 
and 0.8 mm, respectively) aimed at the scCP/dEA (coordinates A 15.0, L 5.3, H -2.5, oL 7.0°, oC 5.0»; 
Snider and Niemer, 1964) and/or Sth/LH (coordinates A 8.0, L 3.4, H -4.0; Smder and Niemer, 1964). In order 
to avoid unnecessary damage to the target site, the cannulas were placed 2 mm above the target region. 
Apparatus 
Cats were tested in a soundproof observation cage (90x60x60 cm) with a plexiglass front panel. The cage was 
equipped with two ventilators which produced a constant background noise. 
Experimental procedures 
After recovering from the operation for a minimum penod of 3 days, the cats were placed in the observation 
cage to habituate them to the cage and to the experimental procedures (see below, each cat 3x1 h sessions on 
successive days). During the last habituation session the cats received a bilateral "dummy* injection. The 
experiments started after a minimum period of 7 days following the operation. 
After а 15-тш rehabituation to the observation cage, the expenment was started with a pre-injection period of 15 
mm. When cats received two sets of injections, the second injection was always of the drug inducing the OFD. 
The ammals' behaviour during the pre- and post-injection penod was recorded with the help of a closed TV-
circuit and stored on videotape. The tapes were used to evaluate the oro-facial dyskinesia and to count the 
number of tongue protrusions which are known to signal the end of the OFD-attack (Cools et al., 1989; Spooren 
et al., 1989, 1991a; 1991b) All injections were given with the help of a Hamilton syringe (5 /xl; sharpened tip). 
Tbe needle was lowered two mm below the end of the cannula in order to reach the chosen target site (see 
above). The injection itself lasted 15 seconds whereas the needle was kept in place for another 10 seconds. 
The pre-injection period was used to discard ammals that displayed abnormal tongue protrusions as a 
consequence of previous treatments. Since this only occurred in cats that received more than six injections the 
total number of treatments was limited to six (Cools et al., 1989a). 
Expenment 1 
In this experiment 8 cats participated equiped with cannullas directed towards the Sth/LH: They received the 
following drugs' Picrotoxin (PTX (Serva, Heidelberg, FRG). 250, 500, 50 and 150 ng, subsequently), muscimol 
(MSM (Serva, Heidelberg, FRG). 50 ng) and the combination PTX (250 ng) and MSM (50 ng) in a cocktail. 
The doses were chosen on basis of their efficacy within the scGP/dEA (Cools et al., 1989a). 
Experiment 2 
In this expenment 9 cats participated equipped with cannullas directed towards the Sth/LH and scGP/dEA. They 
received the following combination of drugs (scGP/dEA - Sth/LH): solvent - solvent, solvent - PTX (250 ng), 
MSM (100 ng) - PTX (250 ng), PTX (500 ng) - solvent, PTX (500 ng) - MSM (50 ng) and kynuremc acid 
(KYN (Sigma, St. Louis, USA): 1000 ng) - PTX (250 ng). 
All drugs were dissolved m stenle distilled water (NPBI, the Netherlands) except for KYN wich was dissolved 
in IN NaOH In case of the latter the pH was corrected and set on 7. All drugs were injected in a volume of 0.5 
μΐ 
Histological evaluation 
At the end of the expenments the cats were deeply aneasthetized with pentobarbital (60 mg/kg, intra-
pentoneally; Apharmo, Arnhem, the Netherlands) and transcardially perfused with saline followed by a 4% 
paraformaldehyde solution. Tbe brain were removed and subsequently cut on a freezing microtome in sections of 
30 pm. The sections were stained for cresyl violet in order to estimate the location of the injection site. 
Statistics 
Wilcoxon matched-pairs signed-ranks test (two-tailed) was used for statistical analysis. 
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9.4 RESULTS 
Histological data 
Histological evaluation revealed that the injection sites were correctly placed into the 
target region in the Sth/LH as well as in the scGP/dEA (distribution Sth/LH: A 7.0 - 8.0, 
L 3.8 - 4.5, H -3.3 - -4.8; distribution scGP/dEA: A 14.0 - 15.0, L 6.2 - 5.5, H -2.0 - -
3.5). The distribution of injection sites in the Sth/LH region of the cats used in 
experiment 1 are shown in fig. 1. 
Fig. 1 The distribution of ¡DJections sites in the ventral diencephalon of the cats used in experiment 1. 
Experiment 1 
Dyskinetic movements 
Picrotoxin (PTX) injected into the STh/LH induced differential effects at different doses. 
At low doses (50 - 250 ng) PTX elicited a complete oro-facial dyskinetic syndrome which 
consisted of sudden attacks of tic-like contractions involving the ear, eyelid and cheek 
which were accompanied by tongue protrusions. The tongue protrusions were abnormal 
and consisted of curling upwards the lateral sides of the tongue and protruding the curled 
tongue via the left or right comer of the mouth, or curling the tip of the tongue upwards 
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and inwards against the palatum and then protruding it or pressing the tip of the tongue 
against the innerside of the cheek and then protruding it. These combinations of 
movements were previously also described to occur in OFD elicited from the scGP/dEA 
(Cools et al., 1989). At the high dose (500 ng) PTX elicited a combination of immobility 
and explosive motor activity. Most of the time the cats were in a fixed position 
(immobile), standing, sitting or in a position between these two extremes. All animals had 
a trunk torsion and their heads were either turned to a lateral side (lateral torticollis) or 
turned backwards (retro-torticollis). These positions were suddenly interupted by moments 
of jumping and falling of the animal in which the forelimbs made movements like 
clapping. Although incidentally OFD was seen in these cats generally there were no signs 
of OFD as described for the lower doses. However, all animals showed a peculiar 
grimace in which the comers of the mouth were pulled towards the ears. 
Quantitative effects 
Bilateral injections of PTX (50, 150, 250 ng) elicited a significant and dose-dependent 
increase in the number of tongue protrusions. The most effective dose was 250 ng 
whereas a dose twice as high lost its efficacy; a bell-shaped dose response relation was 
found (fig. 2). 
tongu· protrusloflB 
1001 
PTX О SO 160 260 600 ng 
Fie. 2 Median value of the number of tongue protrusions in 45 min. after bilateral injections of differential doses 
of Picrotoxin (PTX) or its solvent into the Sth/LH. * P<0.05, · · P<0.02, * · · P<0.01, number of animals -
8. 
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GABA-specificity 
The most effective dose of PTX (250 ng) was selected to determine GABA-specificity. 
The effect of 250 ng PTX was significantly attenuated by 50 ng muscimol, i.e. a dose 
which had no effect itself (fig. 3). 
tongu· protrusion« 
Figi 3 Median value of the number of tongue protrusions in 45 min. after bilateral injections of aolvent, 
Picrotoxin (PTX: 250 ng), muscimol (MSM: 50 ng) or their combination (PTX and MSM) into the Sth/LH. · 
P<0.05, *· P<0.02> ·** P<0.01, number of animals = 8. 
Experiment 2 
Interaction between scGP/dEA and Sth/LH 
PTX (500 ng) injected into the scGP/dEA elicited a significant increase in the number of 
tongue protrusions which was in tum significantly attenuated by local injections of 50 ng 
MSM into the Sth/LH. PTX (250 ng) injected into the Sth/LH elicited a significant 
increase in the number of tongue protrusions which was significantly attenuated by local 
injections of 1000 ng KYN, i.e. a dose which had no effects itself, 100 ng MSM into the 
scGP/dEA, however, had no effect (fig. 4). 
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Fût. 4 Median value of the number of tongue protrusions in 45 mm. after bilateral injections of vanous drugs 
into the seGP/dEA and Sth/LH. * P<0.05, ** P<0.02, * · * P<0.01, number of animals = 8. 
9.5 DISCUSSION 
The present study has two findings. 
Firstly, oro-facial dyskinesia (OFD), quantified in terms of numbers of tongue 
protrusions, was elicited from the Sth/LH by means of local injections of the GABA 
antagonist PTX and appeared to be dose-dependent and GABA-specific. 
However, OFD was only elicited by relative low doses of PTX (50 - 250 ng), whereas a 
high dose of PTX (500 ng) induced no OFD but a completely different syndrome. At this 
high dose the animals body and face were usually immobile and fixed in a certain 
position. This state was sometimes interrupted by moments of dyskinetic movements of 
the neck, pelvis and trunk. 
The two different effects (hypo- and hyperkinesia) have been described previously in the 
rat as an effect of PTX injections into the subthalamic nucleus itself (Scheel-Kruger and 
Magelund, 1981). However, in the rat the effects were elicited by the same dose of PTX 
although at different post-injection periods. In the present investigation, these effects were 
elicited by different doses of PTX. The differences between these studies can be explained 
in at least two ways: 
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a) species differences: different species may have different susceptibilities to the employed 
drugs, b) the neuroanatomical substrate: the main target of the present investigation was 
that part of the ventral diencephalon receiving input from the scGP and dorsal extended 
amygdala, i.e. the medial part of the subthalamic nucleus and adjoining lateral 
hypothalamic area (Spooren et al., 1992), rather then the subthalamic nucleus proper, 
which was the target in the rat (Scheel-Kruger and Magelund, 1981). 
Although these two possibilities may explain the differences found in the response to PTX 
in rats and cats, the underlying mechanism of this phenomenon (hypo- and hyperkinesia) 
is still unknown, although it has been suggested to be related to depolarization inactivation 
(Feger et al., 1989). The latter however is still under discussion. 
scGP/dEA S W l H 
0 [ GABA 
Glu 
Glu'' 
Ό 
soG0/clEA 
GABA α 
о-
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Glu 
STh/LH 
Fig. S a-b Hypothetical connectivity patterns between the scGP/dEA and Sth/LH. 
Cytoarchitecture readily distinguishes the subthalamic nucleus from the adjoining lateral 
hypothalamic area. However, the latter are may have various characteristics in common 
with the Sth proper. Ultra-structural analysis of the lateral hypothalamic nucleus adjoining 
the subthalamic nucleus has indicated that this region encompasses cells quite similar in 
morphology to those found in the subthalamic nucleus itself (Kita and Kitai, 1983). 
However, a major difference is the packing of the cells which is much higher in the 
subthalamic nucleus. The lateral hypothalamic are under discussion may thus be viewed 
as an extension of the subthalamic nucleus (see also: Berendse and Groenewegen, 1990). 
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This idea is strengthened by the results of the present study from a functional point of 
view since no apparent differences could be detected in animals that received injections in 
the medial subthalamic nucleus or those receiving injections in the adjoining lateral 
hypothalamic area. 
The second finding of the present investigation is that OFD is funneled from the 
scGP/dEA to the Sth/LH as well as in the opposite direction. OFD elicited from the 
Sth/LH was attenuated at the scGP/dEA by kynurenic acid (1000 ng), i.e. a glutaminergic 
antagonist, which is in accordance with the hypothesis that the efferents of the 
subthalamic nucleus are glutaminergic (Albin et al., 1989; cf. Robledo and Feger., 1990). 
These data suggest that OFD within the scGP/dEA can be elicited by means of 
stimulation of glutamate receptors. Preliminary results from our present investigations 
indeed suggest that this is the case (Spooren et al., unpublished observations). 
Furthermore, OFD elicited from Sth/LH was not attenuated by local injections of MSM 
(100 ng) into the scGP/dEA. These findings indicate that the effects elicited from the 
Sth/LH are in tum not funneled within the scGP/dEA via GABAergic systems. The 
connectivity pattern of the glutaminergic input thus seems different from that of 
acetylcholine (cf. Spooren et al., 1989). Although the exact interaction of glutamate with 
other systems within the scGP/dEA is unknown, at least two patterns of connectivity can 
be postulated (fig. 5). However, these possibilities remain to be investigated in future 
studies. 
In sum, the present study indicates that OFD can be elicited from the Sth/LH, which has 
reciprocal connections with the scGP/dEA. Furthermore, OFD is funneled from the 
scGP/dEA towards the Sth/LH as well as in the opposite direction. Within the scGP/dEA 
the effects elicited from the Sth/LH seem to be funneled via glutaminergic but not 
GABAergic systems. 
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PART Π: ANIMAL RESEARCH 
CHAPTER 10 
THE SUB-COMMISSURAL PART OF THE GLOBUS PALLIDUS, 
THE EXTENDED AMYGDALA AND THE PERIPEDUNCULAR NUCLEUS IN 
ORO-FACUL DYSKINESIA IN CATS: 
BEHAVIOURAL EFFECTS AND RETROGRADE TRACING STUDIES USING 
CHOLERA TOXIN SUBUNIT В 
Submitted for publication 
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10.1 ABSTRACT 
It has been shown that oro-facial dyskinesia, i.e. a syndrome of abnormal involuntary 
movements of the facial muscles, can be elicited from the sub-commissural part of the 
globus pallidus and the adjoining dorsal parts of the extended amygdala in cats. Until now 
it is unknown whether the peripeduncular nucleus, which receives input from these 
structures according to anterograde tracing studies, plays a role in the funneling of oro­
facial dyskinesia to lower output stations. In the present study the connection of the sub­
commissural part of the globus pallidus and dorsal parts of the extended amygdala with 
the peripeduncular nucleus was investigated anatomically, using Cholera Toxin subunit В 
as a retrograde tracer, and functionally, using intracerebral injections of GABAergic 
compounds. The anatomical data show that the sub-commissural part of the globus 
pallidus and dorsal parts of the extended amygdala were marked by Cholera toxin sub-unit 
В immunoreactive cells following injections of this retrograde tracer into the 
peripeduncular nucleus. Thus, it could be confirmed that the peripeduncular mucleus 
receives input from the sub-commissural part of the globus pallus and dorsal parts of the 
extended amygdala. Still, the oro-facial dyskinesia elicited from the sub-commissural part 
of the globus pallidus and dorsal extended amygdala by local injections of the GABA 
antagonist Picrotoxin (500 ng/ 0.5 μΐ) was only in part attenuated by local injections of 
the GABA agonist muscimol (100 ng/ 1 μΐ) into the peripeduncular nucleus. Only the 
number of tongue protrusions was significantly attenuated, but not that of the ear and 
cheek movements. Furthermore, tongue protrusions, but no additional oral movements, 
were elicited by Picrotoxin injections (375-500 ng) into the peripeduncular nucleus of 
otherwise untreated cats. These effects were dose dependent and limited to the dorsal 
parts of the peripeduncular nucleus. The ventral parts of the peripeduncular nucleus were 
ineffective in every respect in the present investigation. The data show that the 
peripeduncular nucleus does not funnel the oro-facial dyskinesia as elicited from the sub­
commissural part of the globus pallidus and dorsal parts of the extended amygdala to 
lower brain structures despite of the fact that it is innervated by the former regions. The 
finding that the peripeduncular nucleus itself is only involved in the modulation of the 
display of tongue protrusions may explain why manipulations with the peripeduncular 
nucleus only affected this aspect of the oro-facial dyskinesia elicited from the sub­
commissural part of the globus pallidus and dorsal parts of the extended amygdala. 
10.2 INTRODUCTION 
Oro-facial dyskinesia (OFD), i.e. a syndrome of abnormal involuntary movements of the 
oral region (for review see Waddington, 1989), has been shown to be elicited from the 
anterodorsal, i.e. the matrix enriched, part of the caudate nucleus (r-CRM) in the cat 
(Cools et al., 1976; Spooren et al., 1991a). These effects are funneled via the substantia 
innominata complex towards other structures in the brain (Spooren et al., 1991a). 
It has been shown that OFD can only be elicited from a circumscript region within the 
substantia innominata complex (Cools et al., 1989b). This region is characterized by 
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enkephalin immunoreactivity and encompasses the area just ventral to the anterior 
commissure (most rostral level: A 15.5 (Snider and Niemer, 1964)), i.e. the sub-
commisural part of the globus pallidus (scGP), as well as regions just caudal to this level 
(most caudal level: A 13.5 (Snider and Niemer, 1964)), i.e. the enkephalin immuno-
reactive (=dorsal) parts of the sublenticular substantia innominata (Cools et al., 1989b). 
The effective region as a whole was previously referred to as scGP (Cools et al., 
1989a,b,c; Spooren et al., 1989; Spooren et al., 1991a,b). Recently, however, a detailed 
nomenclature for the various components of the substantia innominata complex has been 
introduced, i.e. the striatopallidal component, the extended amygdala component and the 
magnocellular corticopetal component (for review see Alheid and Heimer (1988)). 
According to this new nomenclature the above-mentioned OFD-specific region consists of 
a subregion of the striatopallidal component, i.e. the scGP, and regions just caudal to the 
scGP, i.e. the dorsal parts of the extended amygdala (dEA). In order to comply with this 
nomenclature the OFD-region will be referred to by using the abbreviations of both 
components (scGP/dEA). 
In order to identify stations which receive input from the scGP/dEA we recently applied 
the anterograde tracing technique Phaseolus vulgaris - leuco agglutinin (PHA-L; Spooren 
et al., 1991c; Chapters 6,7 and 8). The results indicate that, among others, a circumscript 
region in the supranigral tegmentum, i.e. the peripeduncular nucleus (PP; chapter 7), was 
heavily labeled with anterogradely labeled PHA-L immunoreactive varicose fibers 
following injections into the scGP/dEA. 
In the rat the PP receives input from two cortical areas from which mastication can be 
elicited (Zhang and Sasamoto, 1990); furthermore, this area is directly and indirectly 
connected with the cranial nuclei V.VII and XII (Woolf and Butcher, 1989). Finally, in 
the cat the PP is involved in the integration of the oral sensory motor system (Dostrovsky 
et al., 1982). 
In view of these findings, three questions emerged. Firstly, is it possible to confirm that 
the feline PP receives input from the scGP/dEA, using a retrograde tracing technique. For 
that purpose, the tracer Cholera Toxin sub-unit В (CTB) was selected since this tracer has 
been shown to have a superior sensitivity (Fort et al., 1989; Luppi et al., 1990). 
Secondly, is the PP anyhow involved in the funneling of the OFD elicited from the 
scGP/dEA to other structures in the brain. For that purpose, local injections of 
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GABAergic compounds into the PP were given to modify OFD elicited by Picrotoxin 
injections into the scGP/dEA. Thirdly, is the PP itself involved in the display of OFD. 
For the latter purpose, effects of local injections of GABAergic compounds into the PP 
were studied in detail. The latter drugs were chosen in view of the fact that the basal 
forebrain input into the mesencephalon is probably GABAergic (Russchen et al., 1982; 
cf. Graybiel and Eide, 1983; Oertel, 1983; chapter 7). 
10.3 MATERIALS AND METHODS 
Subjects and surgical procedures 
Male cats (n=32; age: 12 - 13 months; Animal Laboratory, University of Nijmegen) weighing 3.7 - 5.7 kg were 
used. The cats were boused in groups of 7 or 8 cats in a cage (2x3x2 m) with water and food available ad 
libitum. The animals were bilaterally equipped, under deep anaesthesia (pentobarbital 40 mg/kg, intra-
pentoneally, Apharmo, Arnhem, the Netherlands), with stainless steel guide cannulas (inner and outer diameter 
of 0.55 and 0.8 mm, respectively) and were either aimed at the scGP/dEA (coordinates: A 15.0, L 5.3, H -2.5, 
at 5° and aP 7° (Snider and Niemer, 1964)) and the PP (coordinates: A 2.75, L 5.5 and H -3.0 (Snider and 
Niemer, 1964)) or at the PP alone according to previously reported procedures (Cools et al., 1976). In case of 
the latter two sites were selected within the PP: a dorsal region (group A: coordinates: A 2.75, L 5.5 and H -3.0 
(Snider and Niemer, 1964)) and a ventral region (group В coordinates: A 2.5, L 4.8, H -3.75, eL 7° (Snider 
and Niemer, 1964)). In order to avoid unnecessary damage to the target site, the guide cannulas were placed 2 
mm above the target region. 
Retrograde tracing experiments 
Experimental procedures 
Experiment 1: Two cats (960 and 482) equipped with cannulas aimed at the PP (group A) were randomly 
selected to participate in the retrograde tracing experiment in which the connections of the PP with the stnato-
pallidal and the amygdaloid components of the substantia innominata were investigated. Immediately following 
the operation these cats received bilateral injections of 0 1 - 0.3 μΐ of a 1% solution of the retrograde tracer 
Cholera Toxin Subunit В (CTB, Sigma C-777-1, st. Louis, USA) using a 5 /A Hamilton synnge (as described 
below). The total volume of CTB was delivered over a period of 30 minutes. Following a survival Urne of 7 
days, the cats were deeply reanaesthetized with pentobarbital (60 mg/kg as described above) and transcardially 
perfused at a constant hydrostatic pressure with 500 ml normal saline (pH 7.0; 4°C) immediately followed by 
2000 ml of a buffered fixative containing, 4% paraformaldehyde in 0.1 M phosphatebuffer (PB; pH 7,4; 4°C). 
Following perfusion the animals were tightly packed in ice and were kept in this position for at least 90 minutes 
after which the brains were removed (Taber, 1961). Subsequently the brains were post-fixed overnight in fixative 
at 4°C. Then they were stored m a 0.1 M PB containing 30% sucrose at 4°C until they sank. Then the brains 
were sectioned at a thickness of 50 дш on a freezing microtome. Following sectioning, free floating sections (2 
adjoining sections out of every 10) were incubated according a standard CTB immunohistochemical procedure 
described below. 
CTB immunohistochemistry 
Free floating sections were excessively rinsed (3 χ 15 min) m 0.05 M Tns-Buffered Saline (TBS). Following 
pre-treatment with a TBS solution containing 10% normal rabbit serum, 0.1 Bovine Serum Albumine (BSA; 
Sigma, St. Louis, USA) and 0.1 % Triton (TBS+; Sigma, St. Louis, USA) for 30 minutes, the sections were 
incubated overnight with goat anti-CTB (1:10 000; 4°C; List, Biological Lab., Campbell, USA) ш TBS+. Then 
the sections were excessively rinsed in TBS and subsequently incubated in rabbit anti-goat IgC(H+L)PO in 
TBS+ (1:200; Nordic, Tilburg, the Netherlands). Following, excessive rinsing (3 χ 15 min) the anti-body 
binding was visualized using standard DAB procedures The sections were then mounted on glass slides and 
dried. Finally, alternate sections were directly dehydrated through ethanol and xylene and coverslipped with 
Entellan (Merck, Darmstadt, FRG) whereas every other section was first counterstained with cresylviolet before 
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dehydrating and coverslipping. 
The distribution of retrograde!/ filled CTB-immunoreactive cells was analyzed as far as it concerned their 
location in the stnatopallidal and amygdaloid components of the substantia innominata in general and the area 
within the substantia innominata effective in eliciting oro-facial dyskinesia, in particular (Cools et al., 1989b). 
The differential components of the substantia innominata were visualized using enkephalin immunoreactivity in 
sections of the cat brain used in previous experiments (Spooren et al., 1991c). 
Behavioural study 
Experimental procedures 
Following recovery from the operation for a minimum period of 3 days, the cats were placed in the observation 
cage (see below) in order to habituate them to the cage and experimental procedures (see below; each cat 3x1 h 
session at successive days). During the last habituation session the cats received a bilateral "dummy* injection. 
After a minimum period of 7 days following the operation, the experiments were started. 
Following a period of 15 min rehabituation to the observation cage the experiment was started with a 15 mm 
pre-injection penod followed by the bilateral injections and a post-injection period of 45 min. The latter 
procedure was repeated in any additional experiment with the same animal; the inter-experimental interval was 7 
days or more. 
The behaviour of the animals dunng the pre- and post-injection period was stored on videotape with the help of a 
closed TV-circuit. Anerwards, the tapes were used to evaluate the oro-facial behaviour and to count the different 
components of an oro-facial-dyskinetic burst (see below). All injections were given with the help of a Hamilton 
syringe (5 μί; sharpened tip) The needle was lowered 2 mm below the end of the cannula in order to reach the 
chosen target site (see above). The injection itself lasted 15 seconds whereas the needle was kept in place for 
another 10 seconds. 
The pre-injection penod was used to discard animals which displayed abnormal tongue protrusions as a 
consequence of previous treatments. Since the latter only occured in animals that received more than six 
treatments, the total number of treatments was limited to six (Cools et al., 1989c). 
All drugs were dissolved in sterile distilled water (NPBI, The Netherlands) 
Apparatus 
Cats were tested in a sound-proof observation cage (90x60x60 cm) with a plexiglass front panel. The cage was 
equipped with two ventilators which produced a constant background noise. 
Treatments 
Experiment 2: In this experiment 10 cats equipped with cannulas directed towards the scGP/dEA and PP (dorsal 
coordinates) were used. These cats received local injections of solvent or muscimol (100 ng) into the PP (3 
minutes before the end of the pre-injection period) and local injections of solvent or Picrotoxin (500 ng) into the 
scGP/dEA (at the end of the pre-injection period). 
Experiment 3: In this experiment 20 cats equipped with cannulas directed either at the dorsal (group A) or the 
ventral part (group B) of the PP were used. These cats received the following treatments: Group A (n=12; 
dorsal region): Apart from a single pilot injection which vaned from cat to cat the following injections were 
given in a random order: solvent, muscimol (MSM; dose: 100 ng; Serva, Heidelberg, FRG), Picrotoxin (PTX: 
doses: 375 and 500 ng; Serva, Heidelberg, FRG) and their combination, PTX (500 ng) and MSM (100 ng) in a 
cocktail; Group Β (n=8; ventral region): These cats received injections of the following drugs: solvent, 
muscimol (100 ng) and PTX (375 ng). The doses were chosen on basis of their efficacy within the scGP/dEA 
(Cools et al., 1989c). 
All drugs injected into the PP were dissolved in a volume of 1 μ| whereas drugs injected into the scGP/dEA 
were dissolved in a volume of 0.5 μ\. The former volume was chosen ш view of the relative large extent of the 
target region. 
Dependent variables 
In experiments 2 and 3 three variables were chosen from a standardized ethogram in order to evaluate 
qualitatively and quantitatively the elicited oro-facial behaviours. This ethogram was based on previous findings 
in which the oro-facial dyskinesia was studied in detail (Cools et al., 1989c; Spooren et al., 1989). 
A) Tongue protrusions, i.e. protrusion of the tongue in which the tongue is clearly visible outside the mouth. 
B) ear movements, i.e. characteristic belike flapper movements of the ear, moving the ear as if tickling or 
irritation takes place. The movements are independent of auditory stimuli or contact with the wall or any other 
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object. One burst of these movements is denned as one event. 
C) cheek movements, i.e. relative fast contractions of the cheek which are independent of other behaviours such 
as licking or sniffing. One burst is defined as one event. 
Histological evaluation 
At the end of the experiments the cats were deeply anaesthetized with pentobarbital (60 mg/kg, intra-
pentoaeally; Apharmo, Arnhem, the Netherlands) and transcardially perfused with saline followed by a 4% 
paraformaldehyde solution. The brains were removed and subsequently cut on a cryostat in sections of 30 jim. 
The sections were stained with cresylviolet in order to estimate the location of the injection site. 
Statistics 
Wilcoxon matched-pairs signed-ranks test (two tailed) was used for statistical analysis. 
10.4 RESULTS 
Experiment 1 
The injection loci of the CTB injections into the PP are given in fig. la (see also fig. 2a). 
Photographs of CTB immunoreactive cells are given in fig. 2b-d. The distribution of 
retrogradely filled CTB immunoreactive cells in the striatopallidal and amygdaloid compo-
nents of the substantia innominata complex in both cats is comparable. The results of cat 
960 are described in detail below. 
Distribution of CTB immunoreactive cells in the different components of the substantia 
innominata complex: 
Cat 960 received a relatively large injection of CTB into the left PP (9601) and a 
relatively small injection into the right PP (960r; fig. la). Since the distribution of CTB-
immunoreactive cells in the striatopallidal and amygdaloid components of the substantia 
innominata is comparable in both hemispheres only a description will be given of the 
distribution following the small injection (960r). 
The injection of CTB into the right PP is small and compact but also slightly invades the 
adjoining substantia nigra. However, the distribution of CTB positive cells in the 
substantia innominata complex is comparable with cases in which the injection site is 
confined to the PP. Many retrogradely CTB-immunoreactive cells are found throughout 
the brain. Within the striatopallidal component of the substantia innominata complex 
retrogradely labeled cells are found in the dense enkephalin immunoreactive sub-
commissural part of the globus pallidus (scGP) as well as in the moderate enkephalin 
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immunoreacüve ventral pallidum (fig. lb and le cf. fig. lb' and 1c'; fig. 2c). However, 
only a limited number of cells are found in this area. Many labeled cells are also found in 
the moderate enkephalin immunoreacüve regions just lateral to the scGP. This labeled 
area continues caudally into regions just caudal to the scGP, i.e. the extended amygdala. 
Within the extended amygdala high concentrations of CTB-posiüve cells are found. 
However, the distribution of CTB-posiüve cells is limited to the moderate enkephalin 
immunoreacüve parts, i.e the dorsal regions (fig. Id cf. Id'; fig. 2d). The density of the 
CTB-posiüve cells is much higher in the extended amygdala than in the scGP. Many 
retrogradely labeled cells are also found in the bed nuclei of the stria terminalis and of the 
anterior commissure (fig. Ib-d). The highest concentration of CTB-positive cells is found 
in the central amygdala whereas the remaining part of the amygdala is free of labeled 
cells (fig. 2b). 
Experiment 2: 
Histological verification 
Histological verification revealed that the injection sites of 9 cats were correctly placed 
into the target regions: scGP/dEA (A 14.5-13.5, L 4.5-6.5, H -2.0-4.5 (Snider and 
Niemer, 1964)); PP (A 2.5-1.75, L 6.0-6.5, H -1.5-3.0 (Snider and Niemer, 1964)). The 
results of one cat had to be discarded since its injection site into the scGP/dEA was not 
correcüy placed (Cools et al., 1989b). 
Dyskinetic movements and quantitative evaluation 
Local injections of 500 ng Picrotoxin into the scGP/dEA elicited a full blown oro-facial 
dyskinetic syndrome which resulted in a significant increase in the number of tongue 
protrusions as well as in a significant increase in the number of cheek- and ear-
movements (figs. 3a-b; cf. Cools et al., 1989a,b; Spooren et al., 1989). The tongue 
protrusions elicited from the scGP/dEA were characterized by curling and have been 
described in detail previously (Cools et al., 1989c). OFD elicited from the scGP/dEA was 
modified by local injections of 100 ng muscimol into the PP; the number of tongue 
protrusions was significantly reduced but the number of cheek- and ear-movements did 
not change significantly (figs. 3a-b). 
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Fig. 1 a) Different injection sites of the retrograde tracer Cholera Toxin sub unit В (CTB) into the peripedun-
cular area (PP) of the cats 960 and 284. Ib-d The distribution of CTB-immunoreactive cells in the striatopallidal 
and amygdaloid components of the substantia innominata complex. Ib'-d' The distribution of enkephalin 
immunoreactivity in the striatopallidal and amygdaloid components of the substantia innominata complex at 
approximately comparable levels as respectively fig. Ib-d. 
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Fig. 2 a) A picture of a representative injection of CTB into the peripeduncular area (284r). 2b) Distribution of 
CTB immunoreactive cells in the central amygdala. 2c) CTB immunoreactive cells in the scGP. 2d) CTB 
immunoreactive cells in the dEA. 
Experiment 3 
Histological verification 
Histological verification revealed that the injection sites of eight cats of group A and six 
cats of group В were correctly placed into the target regions as defined by its output from 
the scGP/dEA (chapter 7; distribution Group A: A 1.5-2.5, L 5.5-6.5, H-1.5--3.0; 
distribution Group B: A 1.5-2.5, L 5.5-6.0, H-2.0-3.5; fig. 4; according to Snider and 
Niemer, 1964). The results of four cats of group A and 2 cats of group В had to be 
discarded since their injection sites were located outside the PP. 
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Dyskinetic movements and quantitative evaluation 
Local injections of muscimol (Group A and B: 100 ng) and picrotoxin (Group A: 375 and 
500 ng; Group B: 375 ng) into the PP elicited no oro-facial dyskinesia at all. Whereas 
muscimol was ineffective in every respect in both parts of the PP, picrotoxin elicited a 
significant increase in the number of tongue protrusions from the dorsal part of the PP 
(fig. 5). However, the tongue protrusions were small and flat, the tongue was not curled. 
No increase was found in the number of ear and cheek movements (not shown). 
Picrotoxin was ineffective in the ventral part of the PP (not shown). 
GABA-specificity 
The most effective dose of picrotoxin (500 ng) in eliciting tongue protrusions was selected 
to determine drug-specificity of the effects elicited from the dorsal part of the PP (Group 
A; fig. 5); the effect of 500 ng picrotoxin was significantly antagonized by 100 ng 
muscimol, i.e. a dose which had no effect when injected alone (fig. 5). 
10.5 DISCUSSION 
In a recent anterograde tracing study using PHA-L as an anterograde label, we found that 
the peripeduncular nucleus (PP) was marked by PHA-L immunoreactive varicose fibers 
following injections into the scGP/dEA (chapter 7). This pathway is investigated in the 
present study using the retrograde tracer cholera toxin subunit В (СТВ). 
The scGP as well as the dEA were marked by CTB immunoreactive cells even following 
small injections into the PP. However, the number of CTB labeled neurons in the scGP 
was much smaller than in the dEA. These results taken together with our anterograde 
tracing results (chapter 7), indicate the existence of a descending projection from the 
scGP/dEA to the PP. 
Next to the scGP and dEA, the bed nuclei of the anterior commissure and of the stria 
terminalis were also heavily labeled (Berman and Jones, 1982). However, the highest 
concentration of retrogradely labeled CTB-positive cells, was found in the central 
amygdaloid nucleus. The latter finding is in agreement with findings reported in literature 
(Hopkins and Holstege, 1978). 
The extended amygdala is delineated by those parts of the substantia innominata complex 
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tongue protrusion· 
ear movement· 
cheek movements 
Fie. 3 Experiment 2: The effects of local injections of solvent or Picrotoxin (PTX; 500 ng) into the scGP in 
combination with local injections of solvent or musimol (MSM; 100 ng) into the PP on the number of tongue 
protrusions (fig. 3a), ear movements (fig. 3b) and cheek movements (fig. 3c). Bars give median values of 9 cats. 
* Ρ < 0.05/** Ρ < 0.02/*·· Ρ < 0.01 
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Fig. 4 Expenment 3: The distribution of injection sites of the cats used in experiment 3. Filled dots indicate the 
injection sites of the cats of group A (n=8) and filled stars of the cats in group В (n=6). 
and abutting areas that share characteristics with the central and/or medial amygdaloid 
nuclei (Alheid and Heimer, 1988). Since all components of the dorsal compartment of the 
extended amygdala as defíned by Alheid and Heimer (1988), are heavily labeled in the 
present investigation, the present data underline the relevance of the above mentioned 
concept. Moreover, the PP may be an important structure in the connectivity pattern of 
the dorsal extended amygdala regiori. 
Despite the finding that the PP receives input from the scGP/dEA the behavioural data 
show that only a part of the OFD-syndrome elicited from the scGP/dEA is attenuated at 
the PP; only tongue protrusions but not ear and cheek movements are attenuated. 
Furthermore, no OFD-syndrome but only tongue protrusions are elicited from the PP 
itself. The latter effect, however, was dose-dependent and GABA- and locus-specific. 
These data together suggest that the PP is involved in the control of tongue movements 
per se rather then in the control of facial and oral movements as a whole which in turn 
indicates that the OFD-syndrome as elicited from the scGP/dEA is not funneled via the 
PP but probably via a differential pathway. 
Still, tongue protrusions elicited from the scGP/dEA are attenuated at the PP which may 
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Fie. 5 Experiment 3: The effects of local injections of solvent, Picrotoxin (PTX: 375 and 500), muscimol 
(MSM: 100 ng) and the combination Picrotoxin (500 ng) and muscimol (100 ng) into the dorsal PP on the 
number of tongue protrusions. Bars give median values of 8 cats. 
suggest that these protrusions are triggered through activation of the PP via the presently 
delineated pathway. However, in view of the role of the PP itself in oral behaviour it 
seems more likely that the scGP/dEA and PP impinge upon a mutual substrate which is 
directly involved in motor process of tongue protrusions (see below). 
In this respect it is interesting to note that the central amygdaloid nucleus which is 
strongly interrelated with the scGP/dEA has direct and indirect connections with the 
cranial motor nuclei (Krettek and Price, 1978; Russchen, 1982; Haber et al., 1985; 
Grove, 1988; Fort et al., 1989; chapter 7). Furthermore, mastication and tongue 
protrusions are also elicited from this part of the amygdala (Kaada, 1954; Kaku, 1984). 
Taking these findings together, it could be suggested that the central amygdaloid nucleus 
might be involved in the funneling of scGP/dEA elicited OFD towards the cranial motor 
nuclei. 
In the rat the supranigral tegmentum has also been shown to project to the cranial motor 
nuclei which in turn may explain the inhibitory effect of the PP on scGP/dEA elicited 
tongue protrusions (Woolf and Butcher, 1989). Clearly, these hypotheses on the role of 
the PP in scGP/dEA elicited OFD as well as the role of the PP itself in oral behaviour 
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await further elucidation. 
Summarizing, the present study clearly shows that the PP is involved in the control of 
tongue movements. The PP may therefore become a new target in future studies on the 
control of movement in general and that of the oral regions in particular. 
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PART Π: ANIMAL RESEARCH 
CHAPTER 11 
SUMMARY AND CONCLUSIONS 
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In chapter one a general introduction on tardive dyskinesia is presented. Tardive 
dyskinesia is an iatrogenic syndrome consisting of abnormal involuntary movements of 
the oral and facial muscles as well as of the extremities which occurs following longterm 
treatment with neuroleptics. Comparable involuntary movements also occur in a scala of 
other neurological diseases (Taylor, 1988; Waddington, 1989). However, it is unclear 
whether the underlying mechanisms of involuntary movements in the different 
neurological diseases can be compared. At present there is no adequate universally 
applicable diagnostic instrument or parameter available defining type and intensity of 
tardive dyskinesia. The syndrome is usually assessed by means of rating scales which is 
not a reliable procedure. Tardive dyskinesia is by no means an unitary syndrome since it 
can affect several parts of the body, but, its primary symptoms usually involve the 
'bucco-linguo-masticatory triad'. Tardive dyskinesia seems to be associated with several 
other neuropsychiatrie disorders and its display may depend, next to the use of anti-
psychotic drugs, on additional triggering factors, i.e. so-called risk factors (Waddington, 
1989). The pathophysiology of tardive dyskinesia is unknown although several hypotheses 
have been presented. These hypotheses are quite diverse probably due to the fact that 
tardive dyskinesia is not an unitary syndrome in which multiple causes may be 
superimposed. Furthermore, little is known about specific neuronal substrates which may 
be involved in tardive dyskinesia. Accordingly, the present thesis attempts to characterize 
functionally, pharmacologically and neuro-anatomically a number of brain areas which 
may be involved in the control of the oral and facial muscles. 
In chapter two several animal models are discussed which are currently used in the 
research of tardive dyskinesia. The choice of the species in this research is highly relevant 
regarding the complexity of the syndrome. Until now mostly rats have been used as an 
animal model primarily for pragmatic reasons. However, the oral musculature of the rat 
is relatively underdeveloped and tends to produce only simple motor patterns. Other 
investigators have used monkeys. Although monkeys have the distinct advantage above 
rats that they have a well developed oral musculature, research on and care of these 
animals are quite complex. In this respect cats are considered to be a reasonable 
alternative, being relatively easy to handle and having a well developed oral and facial 
musculature. 
Starting point for our research was the finding that oro-facial dyskinesia (OFD) in the cat, 
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consisting of tic-like contractions of the ear, eyelid and cheek, in combination with 
abnormal tongue protrusions, can only be elicited from a circumscript subregion of the 
caudate nucleus, i.e. the anterodorsal part of the caudate nucleus (r-CRM), but not from 
the anteromedial part of the caudate nucleus (CRM; Cools et al., 1976). The CRM and r-
CRM regions have been delineated on the basis of their differential susceptibilities to 
dopaminergic drugs. The CRM is delineated on the basis of its susceptibility to 
apomorphine and haloperidol whereas the r-CRM is delineated on the basis of its 
susceptibility to DPI and ergometrine (Cools et al., 1976). OFD has also been elicited 
from the dorsal parts of the substantia innominata complex, i.e. a first order output 
station of the r-CRM but not of the CRM (Cools et al., 1989a). Recently, it has been 
described that the substantia innominata encompasses at least three components: a 
striatopallidal component, an amygdaloid component and the corticopetal magnocellular 
component (Alheid and Heimer, 1988). The dorsal parts of the substantia innominata 
complex in the cat in which OFD can be elicited encompasses at least two of the above 
mentioned components: rostrally the highly enkephalin immunoreactive sub-commissural 
part of the globus pallidus (scGP), which forms part of the striatopallidal component, and 
the dorsal parts of the extended amygdala (dEA) which forms part of the amygdaloid 
component (Cools et al., 1989b). The region from which OFD is elicited in the cat will 
here be referred to by using the abbreviations of both components, i.e. the scGP/dEA. 
In chapter three of this thesis the above mentioned findings are extended. By means of 
retrograde tracing experiments it was found that the CRM and r-CRM parts of the 
caudate nucleus have a differential dopaminergic input. The CRM region was found to be 
primarily innervated by the substantia nigra pars compacta (A9). In contrast, the r-CRM 
region was found to be primarily innervated by the retrorubral field (A8). By means of 
local injections of DPI into the the CRM and r-CRM it was found that OFD, which was 
quantified in terms of numbers of tongue protrusions, was only elicited from the r-CRM 
but not from the CRM, confirming previous investigations in this respect (Cools et al., 
1976). Moreover, the effect elicited from the r-CRM varied according to the dose used. 
Finally, it was found that the OFD elicited from the r-CRM was attenuated by local 
injections of the GABA agonist muscimol into the scGP/dEA, indicating that OFD elicited 
from the r-CRM is funneled from the r-CRM to the scGP/dEA, in which GABAergic 
mechanisms play a role (fig. 1). 
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Chapter four evaluates the role of acetylcholine in the scGP/dEA in oral dyskinesias. The 
notion that the scGP/dEA contains cholinergic as well as cholinoceptive cells, in 
combination with the fact that acetylcholine appears to play a role in OFD raised the 
question whether acetylcholine in the scGP/dEA is involved in OFD, and if so, whether it 
interacts with GABA (see above; Kimura et al., 1982; Vincent and Reiner, 1987; Fischer 
et al., 1988; Gerlach 1974; Casey and Denney, 1977; Klawans et al., 1980; Monteiro et 
al., 1985). It was found that OFD could be elicited from the scGP/dEA by local 
injections of carbachol, i.e. a cholinergic agonist. The effect was dose-dependent and 
acetylcholine specific. Furthermore, the cholinergic effects in the scGP/dEA were found 
to be mediated via GABA and not vice versa. 
Chapter five evaluates the role of dopamine Dl receptors in the scGP/dEA in oral 
dyskinesias. Behavioural studies in the rat suggest that a specific subset of dopamine 
receptors are specifically involved in oral dyskinesias (see introduction), i.e the dopamine 
Dl receptor (Rosengarten et al., 1983; 1986). The exact location of action is unknown, 
although drugs acting on the dopamine receptors are thought to have their site of action 
within striatal structures. However, the dorsal part of the substantia innominata which 
corresponds with the scGP/dEA, contains relatively high amounts of the Dl receptors 
(Beckstead, 1988; Besson et al., 1988). In view of these findings the role of Dl receptors 
within the scGP/dEA was evaluated. The data indicate that the dopamine Dl agonist 
(+)SK&F38393 injected into the scGP/dEA elicited OFD. The dose-response curve was 
bell-shaped and the effect was Dl-specific. The OFD elicited by (±)SK&F38393 was 
highly comparable to the effects elicited by carbachol and Picrotoxin. At present two 
alternative sites of action can be postulated. Recent anatomical evidence indicates that the 
A8, A9 and AIO contribute to the innervation of the ventral pallidal area (Deutch et al., 
1988; Lindvall and Bjorklund, 1979; Smith et al., 1989; Voorn et al., 1986). 
(±)SK&F38393 might have affected post-synaptic terminals of one of these 
dopaminergic afférents. Furthermore, it is known that dopamine receptors are also located 
on the terminals of the striatal projection neurons (Aiso et al., 1987; Altar and Hauser, 
1987; Beckstead, 1988). So, (±)SK&F38393 might also have affected the pre-synaptic 
dopamine receptors located on the terminals of the efferents of the r-CRM within the 
scGP/dEA. 
Chapters six, seven and eight evaluate the efferent connections of the scGP/dEA. These 
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connections have been investigated using Phaseolus vulgaris-leucoagglutinin (PHA-L) as 
an anterograde tracer (Gerfen and Sawchenko, 1984). In these experiments the 
distribution of enkephalin immunoreactivity was used in order to visualize the differential 
components present in the substantia innominata (see above). 
In chapter six the ascending projections to the nucleus accumbens are described. It was 
found that the enkephalin immunoreactive scGP and dorsal parts of the extended 
amygdala project to the nucleus accumbens. This projection is topographically organized 
along a rostrocaudal and a mediolateral dimension. Furthermore, the scGP also projects 
to the caudate nucleus. This projection is topographically organized in a medio lateral 
dimension. The ventral parts of the extended amygdala do not project to these brain 
regions. 
Chapter seven deals with the descending projections of the substantia innominata complex 
to the subthalamic nucleus and lateral hypothalamic area, the midbrain and the 
mediodorsal thalamic nucleus. The distribution of PHA-L immunoreactive fibers in the 
midbrain was compared with the distribution of somatostatin- and tyrosine hydroxylase 
immunoreactivity. The results indicate that the scGP projects to the medial tip of the 
subthalamic nucleus and to the adjoining lateral hypothalamic area. The extended 
amygdala preferentially projects to the lateral hypothalamic area. This pathway is 
topographically organized along a dorso-ventral dimension. Furthermore the scGP and the 
extended amygdala project to a specific region in the ventral mesencephalon lateral to the 
roots of the oculomotor nerve. This region is somatostatin- and tyrosine hydroxylase 
immunoreactive and encompasses AIO and A9 regions and is especially heavily labeled 
following injections into the scGP. Subsequently, fibers run through the substantia nigra 
pars compacta, towards a region in the supra-nigral tegmentum, i.e. the peripeduncular 
nucleus which is characterized by somatostatin- but not tyrosine-hydroxylase 
immunoreactivity. This brain region is especially labeled following injections into the 
dorsal parts of the extended amygdala. The peripeduncular nucleus is also labeled 
following injections into the scGP and ventral parts of the extended amygdala but to a far 
lesser degree. Ventrally this output region slightly overlaps with the tyrosine 
immunoreactive retrorubral field (A8), but in general the latter area receives hardly any 
input from the substantia innominata complex. The mesencephalic locomotor region and 
the central gray are also labeled following injections into the dorsal parts of the extended 
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amygdala. Finally, only single PHA-L immunoreactive fibers are found in the 
mediodorsal thalamic nucleus. 
Chapter eight deals with the efferent connections of the substantia innominata complex to 
the amygdaloid complex. The dorsal parts of the extended amygdala preferentially 
innervate the central but also the medial and basomedial nucleus. The ventromedial parts 
of the extended amygdala preferentially innervate the medial and basomedial but also the 
central amygdaloid nuclei. The scGP projects to the basolateral amygdaloid nucleus. This 
projection probably originates from the scattered cell-group of the corticopetal 
magnocellular component of the substantia innominata. 
In sum, chapters six, seven and eight identify brain regions that receive input from the 
scGP/dEA. It was beyond the scope of the present thesis to evaluate phamacologically and 
functionally all the efferents of the scGP/dEA identified in the present study. Thus a 
selection had to be made. For this purpose the subthalamic nucleus and adjoining lateral 
hypothalamic area (Sth/LH) and the peripeduncular nucleus were selected. These brain 
regions are evaluated in respectively chapter 9 and 10. 
Anatomical data from the literature indicate that the connection of the scGP/dEA with the 
Sth/LH is possibly reciprocal (Russchen et al., 1985; Smith et al., 1989). In view of these 
findings, the involvement of the Sth/LH was evaluated as well as its posible interaction 
with the scGP/dEA. The data indicate that picrotoxin elicited OFD from the Sth/LH at 
relatively low doses whereas at relative high doses picrotoxin induced a completely 
different syndrome. The OFD elicited by picrotoxin was found to be GABA-specific. 
Furthermore, it was found that OFD elicited from the scGP/dEA is funneled via the 
Sth/LH and vice versa. OFD elicited from the scGP/dEA is funneled via descending 
GABAergic mechanisms in the Sth/LH whereas OFD elicited from the Sth/LH is funneled 
via ascending glutaminergic mechanisms. Unlike the cholinergic system in the scGP/dEA, 
GABAergic mechanisms are not involved in the expression of the glutaminergic 
subthalamic pathway. These findings clearly indicate that the Sth/LH is involved in OFD 
and that it has a bidirectional interaction with the scGP/dEA. 
In chapter 10 the connection of the scGP/dEA with the peripeduncular nucleus were 
investigated anatomically using cholera toxin subunit В (CTB) as a retrograde tracer and 
functionally using intracerebral injections of GABAergic compounds. The anatomical data 
show that the scGP/dEA was marked by CTB immunoreactive cells following injections 
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of this tracer into the the penpeduncular nucleus. Functionally, OFD elicited from the 
scGP/dEA was only in part attenuated by micro-injections of muscimol into the 
penpeduncular nucleus (PP). Only the number of tongue protrusions were significantly 
attenuated but not the ear and cheek movements. Furthermore tongue protrusions but no 
additional oral-facial movements were elicited by Picrotoxin injections into the 
penpeduncular nucleus. These effects were dose-dependent, GABA-specific and locus 
specific since they were only elicited from the dorsal parts of the penpeduncular nucleus 
(PP). The ventral parts of the penpeduncular nucleus (PP) were ineffective in every 
respect in the present investigation. The data show that the penpeduncular nucleus does 
not funnel OFD as elicited from the scGP/dEA to lower brain regions. The finding that 
the penpeduncular nucleus PP itself is only involved in the modulation of the display of 
tongue protrusions may explain why manipulation with the PP only affected this aspect of 
the OFD elicited from the scGP/dEA. 
When combining all the above mentioned findings into one schedule a complicated 
network of connections and possible interactions emerges (fig. 1). The relevance of the 
different individual factors in this schedule are discussed in the different chapters. In the 
present context some aspects of the summarized data will be addressed that are relevant 
for oro-facial dyskinesia and behaviour in general. 
Firstly, it has been hypothetized that OFD elicited from the caudate nucleus (r-CRM) is 
funneled towards the cranial nuclei (Cools et al., 1989). This pathway is in part disclosed 
in the present thesis. The data show that OFD in the cat is funneled from the anterodorsal 
part of the caudate nucleus (r-CRM) to the scGP/dEA and from the latter to the Sth/LH. 
However, ascending projections from the Sth/LH to the scGP/dEA play also a role. The 
penpeduncular nucleus (PP) is also found to be involved in some aspects of oral motor 
control although its role in oro-facial dyskinesia is not disclosed completely. 
Furthermore, several other brain regions identified as efferents of the scGP/dEA have 
been reported to be involved in oral motor control, such as the nucleus accumbens, the 
central amygdaloid nucleus and the central gray regions (Adametz and O'Leary, 1959; 
Kaku, 1984; Prinssen et al., 1992). However, apart from their own role in oral motor 
control no evidence is available indicating an involvement in OFD as described for the r-
CRM, scGP/dEA or Sth/LH. Nevertheless, the central amygdaloid nucleus and the central 
gray regions are known to have direct and indirect connections with the cranial nuclei, as 
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Fig. 1 Simplified coaoectivity pattern of the CRM and r-CRM related circuitry 
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well as with regions which are known to be important interface areas between higher 
brain regions and the motor nuclei, such as the supra-trigeminal area and the retro-
ambiguus area (Fort et al., 1989; Takeuchi et al., 1988; Holstege, 1989; for review: 
Holstege, 1990). Accordingly, connections of the former regions with the cranial nuclei 
may thus be mono- or bisynaptically. Still, the exact involvement of these circuitry 
patterns in OFD remain to be elucidated in future studies (see chapter 10). 
Secondly, although the CRM and r-CRM are clearly distinct sub-regions of the caudate 
nucleus (chapter 3) they are not independently acting units, for regions forming part of 
the A8 - r-CRM - scGP/dEA axis impinge upon the A9 associated structures at several 
levels and in addition also upon the AIO cell-group: a) A8 fibers projecting to the 
striatum have been described to run through the A9 and AIO regions where they make 
synaptic contact (Deutch et al., 1988), b) the scGP/dEA also projects to the A9 and AIO 
cell-groups (chapter 7) and c) the scGP/dEA projects directly (although diffusely) to the 
CRM (chapter 6), i.e. the main terminal field of the nigrostriatal projection neurons 
(chapter 3). The exact impact of this arrangement is not clear. However, it could 
suggested that, since the A9 group plays an inportant role in switching arbitrarily from 
one behaviour to another (Jaspers, 1991) whereas the AIO group plays an important role 
in switching behaviour with the use of 'cues' (van den Bos, 1991), the A8 (and possibly 
its first and second order output station) might be involved in the coordination of these 
different behavioural strategies. 
Over the relevance of such an arrangement in the understanding of oro-facial dyskinesia 
one can only speculate. Nevertheless, an involvement of cell-group A9 in dyskinesias is 
suggested by the finding that parkinsonian symptoms, such as rigidity, are the best 
predictor for the development of oro-facial dyskinesia five years later in patients receiving 
neuroleptics (Chouinard et al., 1986). Such parkinsonian symptoms are considered to be 
an expression of a reduced nigro-striatal activity. With respect to the circuitry patterns as 
outlined in fig. 1 these effects can now be explained as follows: the idea is that a 
dysfunction of the CRM-circuitry is not a dysfunction in itself but that it is a dependent 
variable of the function of the A8 - r-CRM - scGP/dEA axis which, as outlined in fig. 1, 
impinges upon the A9 related circuitry at several levels. A progressive dysfunction of the 
A8-related circuitry ultimately results in a dysfunction of its output stations which include 
the cranial nuclei resulting in OFD (see above; this thesis), but also of the A9 related 
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circuitry (fig. 1). The latter in tum may result in pseudo-parkinsonian symptoms. 
However, if so all patients suffering from oro-facial dyskinesia should have parkinsonian 
symptoms. Clearly, this is not the case. In this respect it could be suggested that only a 
sub-population of cells that form part of the A8 - r-CRM - scGP/dEA impinge upon the 
CRM circuitry which only then starts to dysfunction when the pathology includes the 
former population of cells. Evidently, this hypothesis is open for discussion and remains 
to be investigated in future studies. 
The clinical impact of the data presented in this thesis may be manifold (see above and 
the different chapters), but the present thesis at least indicates that the pathology of oro-
facial dyskinesia can be located in different structures in the brain. Furthermore, several 
neurotransmitter systems can be involved in thesame brain region. The latter may explain 
the variety of individual cases described in the literature (for review see Waddington, 
1989). 
Furthermore, this thesis shows that areas like the caudate nucleus and the globus pallidus 
and neurotransmitter systems like dopamine, GABA and acetylcholine may play an 
important role in oro-facial dyskinesia which is in agreement with several findings 
reported in literature. But most importantly, it has been shown that these systems may 
interact. Several of such interactions have been described in the present thesis: 
dopamine - GABA interaction between the r-CRM and scGP/dEA (chapter 3); a GABA -
acetylcholine interaction within the scGP/dEA (chapter 4); a GABA - GABA interaction 
between the scGP/dEA and the STh/Lh (chapter 9) and the scGP/dEA and the 
peripedunular nucleus (chapter 10), and a GABA - glutamate interaction between the 
Sth/LH and the scGP/dEA (chapter 9). In this respect it could be postulated that the 
different hypothesis on oro-facial dyskinesia as outlined in the introduction may describe 
the pathology of this syndrome at hierarchically different brain levels which in fact form 
an integral whole of the same neural system. The latter is underlined by the fact that the 
OFD elicited from the different brain regions and by the different drugs were quite 
similar. However, on the other hand it is unthinkable that OFD elicited from such 
different brain regions is completely identical and is accompanied by the same 
neurological symptoms simply because of the distinct neuronal substrates involved in each 
specific brain region. Such accompanying symptoms may accordingly reveal more about 
the specific neuronal substrate involved in each specific patient. The latter is illustrated by 
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the finding that oro-facial dyskinesias and limb-trunk dyskinesias, which were/(are) 
considered as a single entity, are accompanied by a heterogeneous set of neurological 
symptoms (see introduction). Accordingly, this may hold also true within a group of 
patients suffering from OFD in which the pathophysiology is located in different sites. 
However, no data are presently available indicating that such a heterogenity exists in 
patients suffering from oro-facial tardive dyskinesia. Still, detailed information of 
individual patients may reveal more about specific systems involved in these patients 
whereas such a detailed characterization will in the end allow a better and symptom 
specific pharmacotherapy. 
Abbreviation 
A8 
A9 
AIO 
Acb 
CeM 
CO 
CN 
CRM 
d£A 
LH 
PP 
PPTN 
r-CRM 
RF 
SCdl 
scGP 
SNR 
Sth 
:retronibraI area 
¡substantia nigra pars compacta 
:ventral tegmental area 
mucleus accumbens 
:central amygdaloid nucleus, medial division 
¡central gray 
¡caudate nucleus 
¡caput nuclei caudati, rostromedial part 
¡extended amygdala, dorsal part 
¡lateral hypothalamic area 
¡peripeduncular nucleus 
¡nucleus tegmenti pedunculopontinis 
¡remaining caput nuclei caudati, rostrodorsal part 
¡reticular formation 
¡superior colliculus, deeper layers 
¡subcommissural part of the globus pallidus 
¡substantia nigra pars reticulata 
¡subthalamic nucleus 
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SAMENVATTING 
In hoofstuk 1 wordt de klinische achtergrond van het proefschrift geschetst. Deze wordt 
gevormd door tardieve dyskinesie, gedefinieerd als een syndroom bestaande uit 
onwillekeurige en onvrijwillige bewegingen van de musculatuur van de mond, tong, 
aangezicht en extremiteiten. Echter de abnormale bewegingen in het aangezicht worden 
het meest geconstateerd. Dit syndroom wordt vooral beschreven by schizofrenie patiënten 
die chronisch behandeld zijn met neuroleptica, maar ook in een scala andere patiënten, 
zoals lijders aan de ziekte van Parkinson na chronische behandeling met L-DOPA. Op dit 
moment is er echter geen adequaat algemeen diagnostisch instrument voorhanden om 
eenduidig de diagnose te stellen. Hiertoe wordt op dit moment een procedure gevolgd 
waarbij gebruik gemaakt wordt van een waarderingsschaal. Deze methode is echter niet 
betrouwbaar. 
Uit neuropsychologisch onderzoek is komen vast te staan dat tardieve dyskinesie 
geassocieerd is aan verschillende andere neuropsychiatrische afwijkingen en de 
ontwikkeling van dit syndroom lijkt naast het gebruik van farmaca met anti-psychotische 
werking samen te hangen van bepaalde additionele factoren, zogenaamde risicofactoren. 
De pathofysiologie van tardieve dyskinesie is onbekend maar er zijn verschillende 
hypotheses gevormd. Deze hypotheses zijn erg verschillend hetgeen mogelijk veroorzaakt 
wordt door het feit dat tardieve dyskinesie vele verschillende vormen kent, en mogelijk 
meer dan een oorzaak kan hebben. Samengevat kan men stellen dat we te weinig weten 
van het neuronale substraat dat betrokken is bij tardieve dyskinesie om dit syndroom goed 
te begrijpen. Een multidisciplinair onderzoek naar dit substraat zou nieuw licht kunnen 
scheppen in de pathofysiologie van dit syndroom. 
In hoofstuk 2 worden de verschillende diermodellen beschreven die op dit moment 
gebruikt worden in het onderzoek naar tardieve dyskinesie. Ratten nemen een 
vooraanstaande plaats in bij dit onderzoek, voornamelijk vanwege pragmatische redenen, 
doch een nadeel is dat ratten een relatief minder ontwikkeld aangezichtsexpressie hebben. 
Contracties in de musculatuur van het gelaat kunnen dus eigenlijk niet goed bestudeerd 
worden bij deze dieren. Apen daarentegen hebben uiteraard een zeer goed ontwikkelde 
aangezichtsmusculatuur maar zijn nu juist om pragmatische redenen niet aantrekkelijk. 
Een redelijk alternatief is de kat. Dit dier heeft een goed ontwikkeld aangezicht wat de 
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bestudering van de fijne expressie mogelijk maakt. 
Als basis voor het dier-experimentele onderzoek bij de kat dient de eerder gedane 
ontdekking dat oro-faciale dyskinesieen, bestaande uit onwillekeurige bewegingen van 
oor, ooglid, wang en van tongprotrusies, slechts in een bepaald deel van de nucleus 
caudatus opgewekt kunnen worden n.l. het zogenaamde anterodorsale deel, ook wel r-
CRM genoemd, maar niet in zogenaamde CRM, i.e. het anteromediale deel van de 
nucleus caudatus. Het r-CRM en het CRM zijn in eerdere studies afgegrensd op basis van 
een differentiële gevoeligheid voor dopaminerge farmaca. Het CRM is gedefinieerd op 
basis van de gevoeligheid voor apomoiphine en haloperidol en het r-CRM op basis van de 
gevoeligheid voor DPI en ergometrine. 
OFD in de kat kan ook worden opgewekt vanuit de dorsale delen van van het substantia 
innominata complex, wat een "eerste-orde-output-station" is van het r-CRM, doch niet 
van het CRM. Volgens de meest recente classificatie bestaat de substantia innominata uit 
tenminste drie componenten van andere voorhersensysternen: een pallidale component, 
een amygdaloide component en een corticale magnocellulaire component. Het deel van het 
substantia innominata waarvan OFD kan worden opgewekt bestaat uit twee van deze 
componenten: het zogenaamde sub-commissurale deel van het globus pallidus (scGP) en 
het aangrenzende dorsale deel van de extended amygdala (dEA), die beiden gekenmerkt 
worden door het feit dat zij immunoreactief zijn voor enkefaline. Het gebied als geheel 
zal in de rest van dit verhaal worden aangduid als scGP/dEA. 
In hoofdstuk drie van dit proefschrift worden deze bevindingen aangevuld. Door middel 
van retrograde tracing is gevonden dat het CRM en het r-CRM door verschillende 
dopaminerge kemen geinnerveerd worden. Het CRM wordt voornamelijk geinnerveerd 
door cel-groep A9 terwijl het r-CRM voornamelijk wordt geinnerveerd door celgroep A8. 
Met andere woorden naast een verschillende dopaminerge gevoeligheid hebben deze 
subregios van de nucleus caudatus bovendien verschillende input-output relaties. 
Daarnaast werd gevonden dat bilaterale injecties van DPI in het r-CRM, doch niet in het 
CRM, oro-faciale dyskinesien opwekte, hetgeen eerder gedane bevindingen bevestigde. 
OFD, gekwantificeerd door middel van het tellen van het aantal tong protrusies, bleek 
tevens te varieeren met de dosering van DPI. Tenslotte werd gevonden dat OFD, 
opgewekt door middel van locale injecties van DPI in het r-CRM, geremd kon worden 
door locale injecties van de GABA agonist muscimol in het scGP/dEA. Dit duidt erop dat 
198 
OFD wordt gesluisd van het r-CRM naar het scGP/dEA, en dat in de expressie van OFD 
in het scGP/dEA G AB Aerge mechanismen een rol spelen. 
Hoofdstuk 4 evalueert de rol van acetylcholine in het scGP/dEA in OFD. Het gegeven dat 
het scGP/dEA cholinerge en cholinoceptieve cellen bevat, in combinatie met het feit dat 
acetylcholine een rol lijkt te spelen in OFD in de mens, deed de vraag rijzen of 
acetylcholine in het scGP/dEA betrokken is bij OFD in de kat en zo ja of er een interactie 
bestaat met GABAerge mechanismen in het scGP/dEA. De resultaten wijzen erop dat 
locale injecties van de cholinerge agonist carbachol in het scGP/dEA OFD kan induceren 
in de kat. Het effect was dosis afhankelijk en acetylcholine specifiek. Verder bleek dat de 
cholinerge effecten in het scGP/dEA via GABAerge mechanismen tot expressie komen 
doch dat het omgekeerde niet het geval is. 
Hoofdstuk 5 evalueert de rol van dopamine Dl receptoren in het scGP/dEA in OFD. 
Gedragsstudies bij de rat hebben aangetoond dat juist dit type receptor een belangrijke rol 
speelt in orale dyskinesieen. Het onderliggende neurale substraat is echter niet bekend, 
ofschoon wordt aangenomen dat Dl receptoren voornamelijk in het striatum een rol 
spelen. Echter de distributie van Dl receptoren is veel uitgebreider dan alleen maar het 
striatum. Gegeven het feit dat in het scGP/dEA o.a. ook relatief hoge dichtbeden aan Dl 
receptoren aanwezig zijn, werd besloten om de rol van deze receptor in OFD te 
bestuderen in het scGP/dEA in de kat. De gegevens tonen aan dat locale injecties van de 
Dl agonist SK&F38393 OFD induceert. Dit effect was dosis afhankelijk en Dl specifiek. 
Op dit moment kunnen twee verschillende mechanismen voor deze effecten gepostuleerd 
worden: (a) recente anatomische gegevens tonen aan dat het ventrale pallidum gebied 
waartoe het scGP/dEA behoort, wordt geinnerveerd door de dopaminerge celgroepen A8, 
A9 en AIO. OFD zou dus gemedieerd kunnen worden via dopamine receptoren 
gelokaliseerd op de pre- of postsynaptische zijde van deze dopaminergic input, (b) echter 
Dl receptoren komen ook voor op de pre-synaptische terminals van efferenten van het 
striatum. OFD zou dus ook via deze receptoren in het scGP/dEA gemedieerd kunnen 
worden. 
De hoofdstukken 6,7 en 8 evalueren the efferente verbindingen van het scGP/dEA. Deze 
verbindingen werden onderzocht d.m.v. de anterograde tracer Phaseolus vulgaris -
leucoagglutinin (PHA-L) . In deze experimenten werd de distributie van enkefaline 
immunoreactiviteit gebruikt om de verschillende componenten van het substantia 
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innominata complex te visualiseren. 
In hoofdstuk 6 worden de ascenderende verbindingen beschreven van de scGP/dEA naar 
de nucleus accumbens en de nucleus caudatus. De tracing experimenten geven aan dat de 
scGP/dEA projecteert naar de nucleus accumbens en dat deze projectie topografisch is 
gerangschikt in rostrocaudale en mediolaterale richting. De projectie van het scGP naar de 
nucleus caudatus is gerangschikt in de medio-laterale dimensie. 
Hoofdstuk 7 beschrijft de descenderende projecties van het scGP/dEA naar de nucleus 
subthalamicus en de laterale hypothalamus, de middenhersenen en de mediodorsale 
thalamus kern. De distnbutie van PHA-L immunoreactieve vezels in middenhersenen 
werd bovendien vergeleken met de distnbutie van somatostatine en tyrosine-hydroxylase 
immunoreactiviteit. 
De data geven aan dat het scGP projecteert naar de mediale tip van de nucleus 
subthalamicus en naar het aangrenzende deel van de lateral hypothalamus. De "extended 
amygdala" (dEA) projecteert voornamelijk naar de aangrenzende laterale hypothalamus. 
Deze projectie is topografisch gerangschikt in dorso-ventrale dimensie. Bovendien 
projecteren het scGP en de extended amygdala naar een specifiek deel van het ventrale 
mesencephalon, lateraal van de wortels van de oculomotor vezels, een gebied dat zowel 
SNC (A9) als VTA (AIO) gebieden omvat. Dit gebied is zowel somatostatine- als 
tyrosine-hydroxylase immunoreactief. Vervolgens lopen de vezels door de substantia nigra 
pars compacta naar het supra-nigrale tegmentum, i.e. de nucleus peripeduncularis. De 
nucleus peripeduncularis is somatostatine- maar niet tyrosine hydroxylase-immunoreactief. 
Dit gebied was sterk gelabeled na injecties in het dorsale deel van de extended amygdala. 
Ook na injecties in het scGP en de ventrale delen van de extended amygdala werden hier 
PHA-L immunoreactieve vezels gevonden maar in veel lagere hoeveelheden. 
Dit tegmentale gebied overlapt ventraal enigszins met de tyrosine-hydroxylase positieve 
retronibrale area, maar over het algemeen ontvangt deze cel groep geen input van het 
substantia innominata complex. Het mesencephale locomotor gebied en het centrale grijs 
waren ook gelabeld na injecties in het dorsale extended amygdala gebied. Echter er 
werden nauwelijks PHA-L immunoreactieve vezels gevonden in de mediodorsale thalamus 
kern na injecties in de substantia innominata. 
Hoofdstuk 8 beschrijft de verbindingen van het substantia innominata complex met het 
amygdaloid complex. De dorsale "extended amygdala" delen projecteren preferentieel 
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naar de centrale kern van de amygdala, maar daarnaast ook naar de mediale en 
basomediale kemen van de amygdala. De ventrale delen van de "extended amygdala" 
projecteren met name naar de mediale en de basomediale kernen, doch ook naar de 
centrale kem van de amygdala. Na injecties in het scGP werden vezels gevonden in de 
basolaterale kem van de amygdala. Deze laatste projectie behoort waarschijnlijk by de 
corticopetale magnocellulaire component waarvan de cellen verspreid liggen in het 
substantia innominata complex. 
Samengevat, kan worden gesteld dat in de hoofdstukken 6, 7 en 8 verschillende gebieden 
geïdentificeerd worden welke input ontvangen van het scGP/dEA. Het is onmogelijk om 
al deze gebieden te bestuderen op hun betrokkenheid in OFD. Daarom werden twee 
gebieden geselecteerd die op basis van literatuurgegevens interessant werden geacht m.b.t. 
hun eventuele betrokkenheid bij OFD. 
Hoofdstuk 9 evalueert de rol van het mediale deel van de nucleus subthalamicus en het 
aangrenzende deel van de laterale hypothalamus (Sth/LH) in OFD en de eventuele 
interactie met het scGP/dEA. Literatuur gegevens wezen erop dat de verbindingen tussen 
beide gebieden reciprook zijn. Locale injecties van de GABA antagonist Picrotoxine in het 
Sth/LH induceerde OFD in de cat. Dit effect was dosis afhankelijk en GABA-specifiek. 
Bovendien werd gevonden dat OFD, opgewekt ter hoogte van het scGP/dEA, wordt 
gesluisd via het Sth/LH gebied en vice versa. OFD in het Sth/LH wordt geschakeld via 
GABAerge mechanismen, doch OFD opgewekt in het Sth/LH wordt geschakeld in het 
scGP/dEA via glutamaterge mechanismen. De GABAerge neurotransmissie speelt hierbij 
geen rol. Deze data tonen aan dat het Sth/LH betrokken is bij OFD en dat het een 
bidirectioneel contact onderhoudt met het scGP/dEA. 
In hoofdstuk 10 wordt de verbinding van de scGP/dEA met de nucleus peripeduncularis 
anatomisch en functioneel onderzocht. De retrograde tracer cholera toxine sub-unit В 
werd gebruikt om de verbinding van de scGP/dEA met de nucleus peripeduncularis te 
bestuderen. De resultaten verkregen met deze retrograde tracer komen overeen met de 
anterograde resultaten. Ondanks het feit dat de nucleus peripeduncularis input onvangt van 
de scGP/dEA, kon alleen een deel van het OFD-syndroom, dat kan worden opgewekt in 
het scGP/dEA, worden geremd in de nucleus peripeduncularis: alleen de tongprotmsies 
doch niet de oor- en wangbewegingen. Bovendien werden alleen tongprotrusies, doch 
geen additionele effecten opgewekt door locale injecties van Picrotoxine in de nucleus 
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peripedunculans zelf. Deze effecten waren echter wel dosis-afhankelijk en GABA- en 
locus-specifiek. Deze data tonen aan dat OFD opgewekt ter hoogte van het scGP/dEA niet 
wordt gesluisd via de nucleus peripedunculans. Het feit dat de nucleus peripedunculans 
betrokken is bij bewegingen van de tong verklaart waarschijnlijk waarom manipulaties 
met dit hersengebied alleen effect heeft op de bewegingen van de tong en niet op de 
andere componenten van OFD opgewekt in het scGP/dEA. 
Hoofdstuk 11 geeft een samenvatting van deze data en plaatst ze in een klinisch kader. 
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Philipsen en Theo Arts en natuurlijk ook alle andere mensen die voor mij onbekend zijn 
gebleven. 
De afdeling fotografie ben ik bijzonder dankbaar voor hun fantastische afwerking van het 
fotografisch materiaal. 
Carly en Rob, jullie wil ik bedanken voor het feit dat jullie paranimf wilden zijn maar 
vooral ook omdat jullie er altijd zijn als het nodig is. 
Tenslotte wil ik natuurlijk Petra bedanken. De liefde waarmee jij me omringt is heel 
bijzonder en is voor mij een warme thuisbasis waar ik altijd op kan rekenen. Op dit 
moment staat een lastige periode voor de deur maar ik heb er een vast vertrouwen in dat 
deze overbrugbaar is. 
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Curriculum Vïtae 
Will Spooren werd geboren op 29 oktober 1963 te Hapert alwaar hij de lagere school 
bezocht in de periode 1970 - 1976. Na een kort verblijf op het Pius X college te Bladel 
werd de middelbare school verder afgemaakt op het Rythovius college te Eersel waar het 
VWO-diploma werd behaald in 1982. In datzelfde jaar werd aangevangen met de studie 
Biologie aan de Universiteit van Nijmegen. Het doctoraal met de afstudeervakken 
Dierfysiologie en Medische Fysica en Biofysica werd behaald op 28 januari 1988. Van 1 
januari 1988 tot 1 januari 1992 was hij werkzaam als assistent in opleiding (A.I.O.) aan 
de Katholieke Universiteit Nijmegen op de afdeling Farmacologie alsmede op de afdeling 
Anatomie en Embryologie. Het onderzoek dat hij in het kader van deze aanstelling 
verrichtte resulteerde in dit proefschrift. 
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Stellingen 
1) De subpallidale regio in de kat is een belangrijk 
tussenstation in het circuit dat betrokken is bij het mediëren 
van zowel striataal- als subthalamisch geïnduceerde 
dyskinetische bewegingen van het aangezicht en de mond. 
dit proefschrift 
2) GABAerge-, dopaminerge-, cholinerge- en glutamaterge-
neurotransmitter systemen in de subpallidale gebieden zijn in 
de kat betrokken bij de controle van orale en faciale 
spieren. 
dit proefschrift 
3) Het substantia innominata complex is heterogeen in 
farmacologie, anatomie en functie. 
dit proefschrift 
4) De duiding van de naam van het substantia innominata complex 
is niet langer volledig van toepassing op het hiermee 
gedefinieerde gebied. 
dit proefschrift 
5) Het blindelings opleiden van reeksen van zogenaamde A.I.O's is 
een typisch voorbeeld van struisvogel politiek. 
6) Het door de huisarts herhaald niet herkennen van de ziekte van 
Parkinson bij patiënten met typische Parkinson symptomen uit 
de bekende risico groep mag laakbaar genoemd worden. 
7) De opleiding tot huisarts dient beter te worden afgesteld op 
een geriatrische samenleving. 
8) Stellingen bij een proefschrift hebben niet langer een 
wezenlijke functie bij een promotie en zijn een restant van 
een verouderde promotie procedure. 
9) Deep down with the first death lies London's daughter, robed 
in the long friends, the grains beyond age the dark veins of 
her mother secret by the unmourning water of the riding 
Thames. After the first death there is no other. 
The refusal to mourn the death by fire of a child in London 
Dylan Thomas 
10) Vertrouwen is goed, controle is beter. 
Lenin 




